Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value
3037121	u-prot	— (—)	10320	24274	100.00%
3037121	u-prot	mg/l (mg/l)	3684	14276	0.00%
3037121	u-prot	g/l (mg/l)	3225	12265	2.61%
3037121	u-prot	mg/l______ (mg/l)	128	440	0.00%
3037121	u-prot	mg/L (mg/l)	56	224	0.00%
3037121	u-prot	MG/L (mg/l)	21	26	0.00%
3037121	u-prot	g/l_______ (mg/l)	16	79	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Kidney transplant status

459

652

8.72

319.11

13.2

4.1

663.41

307.68

mg/l

2.90

402

328

Implicit Sepsis

2708

8932

2.31

317.84

4.1

3.2

651.43

484.25

mg/l

0.88

1514

3891

Acute tubulo-interstitial nephritis

2174

7557

2.51

317.58

4.4

2.7

730.69

452.09

mg/l

0.88

1123

2971

Symptoms and signs involving the urinary system

2742

9373

2.28

314.48

3.6

3.3

823.47

445.42

mg/l

1.43

1248

4366

Dialysis

385

464

10.64

308.95

11.6

3.9

812.94

236.65

mg/l

8.69

341

209

Other medical care

2006

6263

2.82

307.65

5.0

2.8

306.15

545.57

mg/l

1.98

1308

2574

Other bacterial diseases, including avohilmo

3497

9905

2.27

307.65

4.3

3.2

541.35

504.61

mg/l

0.16

2003

4276

Any gastric operation

2357

4410

2.75

307.65

3.9

2.6

437.29

456.05

mg/l

0.08

1201

1769

Preparatory care for dialysis

461

577

10.63

307.65

10.8

3.2

899.85

369.78

mg/l

1.72

396

247

Glomerular diseases

1325

2451

6.24

307.65

8.3

3.1

909.75

302.83

mg/l

10.31

1062

1129

Asymptomatic human immunodeficiency virus [HIV] infection status

202

621.61

307.65

9.1

5.2

133.46

359.21

mg/l

1.57

195

Colorectal cancer, including Hilmo

1326

3580

3.72

307.65

5.8

2.7

297.38

638.53

mg/l

1.43

1000

1326

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

660

1267

5.94

307.65

3.1

2.9

539.60

408.52

mg/l

0.31

441

487

Renal failure

3190

5919

5.09

307.65

5.5

2.7

611.81

608.67

mg/l

0.01

2135

2365

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

1000

2556

4.29

307.65

6.4

2.7

173.81

486.06

mg/l

3.18

789

961

Medical observation and evaluation for suspected diseases and conditions

2131

3948

2.85

307.65

3.3

3.6

428.16

499.85

mg/l

0.38

916

2107

Colorectal cancer

1258

3308

3.95

307.65

6.0

2.7

301.52

524.27

mg/l

1.14

969

1240

Colorectal adenocarcinoma

1061

2830

4.02

307.65

6.0

2.7

319.48

461.24

mg/l

0.60

826

1078

GASTRO-related operations

2357

4410

2.75

307.65

3.9

2.6

437.29

456.05

mg/l

0.08

1201

1769

Heart failure, not strict

2790

7268

2.69

307.65

4.4

3.2

647.08

547.21

mg/l

0.39

1593

3118

Other bacterial diseases

3483

9792

2.44

307.65

4.4

3.2

601.27

519.32

mg/l

0.36

2032

4230

Human immunodeficiency virus [HIV] disease resulting in other conditions

602

159

441.33

307.65

9.2

3.9

130.45

362.91

mg/l

2.00

594

Human immunodeficiency virus [HIV] disease resulting in other conditions, including avohilmo

602

159

420.46

307.65

9.2

3.9

130.45

362.91

mg/l

2.00

594

Nephropathy related operations

805

1650

5.58

307.65

9.5

3.4

886.02

333.23

mg/l

4.68

690

793

Malignant neoplasm of kidney, except renal pelvis

619

1113

6.41

307.65

3.1

2.8

556.79

399.58

mg/l

0.36

420

432

Transplanted organ and tissue status

653

1171

6.40

307.65

10.1

3.6

655.59

310.48

mg/l

3.90

524

572

Secondary hypertension

682

748

10.73

307.65

10.6

3.1

611.12

249.68

mg/l

3.27

517

348

Glomerular disorders in diseases classified elsewhere

926

1523

7.20

307.65

7.1

3.0

875.61

333.70

mg/l

4.93

745

684

All chronic kidney diseases

3692

5848

5.56

307.65

5.7

2.6

597.50

423.89

mg/l

1.09

2507

2282

All kidney diseases

4527

9063

3.53

307.65

5.0

2.7

665.15

416.74

mg/l

2.05

2696

3643

Human immunodeficiency virus [HIV] disease, including avohilmo

629

180

238.29

307.65

9.1

3.9

131.86

355.47

mg/l

2.24

613

Renal tubulo-interstitial diseases

4187

9101

3.57

307.65

4.8

2.8

620.24

473.03

mg/l

0.93

2513

3698

Unspecified human immunodeficiency virus [HIV] disease

337

344.92

307.65

9.1

4.5

145.21

443.09

mg/l

1.42

327

Bacterial infection, other or unspecified, including avohilmo

2519

7511

2.89

307.65

4.5

3.1

678.86

501.82

mg/l

0.69

1519

3150

Malignant neoplasm of urinary organs, including Hilmo

712

1474

5.44

307.65

3.1

2.8

527.53

386.50

mg/l

0.37

469

570

Persons encountering health services for specific procedures and health care

3564

9842

2.20

307.65

4.8

2.9

484.82

540.34

mg/l

0.28

2030

4268

Care involving dialysis

710

971

8.97

307.65

10.0

3.3

883.96

388.69

mg/l

2.87

618

452

Human immunodeficiency virus [HIV] disease

629

177

269.12

307.65

9.1

4.0

131.86

358.25

mg/l

2.25

613

Fever of other and unknown origin

2160

7102

2.74

307.65

4.6

3.2

469.77

513.70

mg/l

0.19

1277

3171

Dialysis, with operation codes

893

1436

7.22

307.65

9.4

3.2

852.61

306.47

mg/l

4.98

759

645

Oxycodone

1894

4756

3.62

307.65

4.4

3.1

335.59

602.18

mg/l

1.70

1184

2026

Chronic kidney disease

2594

4297

6.70

307.65

6.0

2.7

614.28

551.00

mg/l

0.20

1789

1708

ILD medications: immunosuppressive drugs

2292

8613

2.50

307.65

5.8

3.1

471.28

457.10

mg/l

0.09

1332

3968

Bacterial infection, other or unspecified

2370

7092

2.97

307.65

4.5

3.1

691.69

503.67

mg/l

0.70

1433

2951

ILD medications: prednisolone, methylprednisolone, prednisone

3655

9476

2.20

307.65

4.4

3.0

521.12

464.43

mg/l

0.31

1896

4331

First line medication for Crohn's disease

3798

8929

2.36

307.65

4.8

2.7

516.71

458.07

mg/l

0.31

2111

3858

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

3666

10425

2.45

307.65

4.1

3.2

557.43

503.78

mg/l

0.26

2116

4538

Malignant neoplasm of urinary organs

646

1235

5.96

307.65

3.1

2.7

548.79

395.42

mg/l

0.37

433

479

Acute renal failure

1167

2937

4.33

307.65

5.2

2.6

776.51

466.55

mg/l

1.13

803

1148

Unspecified human immunodeficiency virus [HIV] disease, including avohilmo

360

103

348.35

307.65

9.1

4.2

143.04

413.44

mg/l

1.42

350

ILD medications

3691

9639

2.12

307.65

4.4

3.0

517.42

460.30

mg/l

0.32

1913

4437

Aplastic and other anaemias

1905

7001

2.61

301.30

4.2

3.1

469.92

651.92

mg/l

1.09

1109

3005

L04AD Calcineurin inhibitors

657

1393

5.32

296.57

12.2

3.3

720.60

305.38

mg/l

5.20

532

672

Implicit Sepsis, including avohilmo

2815

9392

2.21

295.55

4.0

3.2

638.89

495.45

mg/l

0.73

1552

4111

Malignant neoplasm of digestive organs, including Hilmo

1697

4675

2.80

292.69

5.2

2.9

342.47

578.20

mg/l

1.15

1194

1761

Anaemias

799

1109

4.84

292.06

5.2

3.5

483.36

445.32

mg/l

0.11

515

468

Implicit bacterial Sepsis, including avohilmo

1851

6160

2.61

288.59

4.4

3.1

727.64

494.32

mg/l

0.95

1119

2634

Bacterial Sepsis

1889

6309

2.59

288.00

4.4

3.1

693.15

489.00

mg/l

0.83

1149

2705

Malignant neoplasm of digestive organs

1577

4433

2.86

285.28

5.4

2.9

349.27

597.25

mg/l

1.14

1141

1663

Implicit bacterial Sepsis

1713

5736

2.68

282.85

4.5

3.1

728.25

508.04

mg/l

0.81

1048

2444

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

1087

3291

3.43

279.48

6.0

2.8

184.59

529.96

mg/l

3.74

853

1262

Clear cell adenocarcinoma of kidney

385

547

8.60

267.01

3.1

2.7

603.92

306.81

mg/l

0.48

253

194

Condition for Implicit Sepsis (Organ dysfunction codes)

2803

9425

2.12

264.46

4.0

3.2

637.54

497.10

mg/l

0.70

1534

4128

Malignant neoplasm of colon, including Hilmo

890

2555

3.74

262.04

5.7

2.7

339.21

469.29

mg/l

0.42

665

950

Need for immunization against other single viral diseases

252

227

16.40

253.85

8.9

4.8

246.85

384.81

mg/l

0.83

241

102

Other and unspecified anaemias

1699

6604

2.53

252.98

3.6

3.1

453.43

650.48

mg/l

1.15

965

2820

Inflammatory bowel disease treatment related agents

3579

10479

1.94

252.71

4.0

3.2

490.47

501.48

mg/l

0.05

1792

4907

Malignant neoplasm of colon

770

2074

4.03

251.55

5.8

2.6

362.44

518.91

mg/l

0.43

587

757

Other anaemias

1706

6645

2.51

251.06

3.6

3.1

452.20

647.86

mg/l

1.15

969

2841

Continuous positive airway pressure

835

1908

3.89

250.53

3.6

4.2

794.16

291.52

mg/l

1.09

375

980

Extracorporeal dialysis

454

814

6.63

250.49

10.2

3.6

1019.26

423.16

mg/l

2.06

391

383

Need for other prophylactic measures

432

737

6.92

250.34

2.3

3.9

216.88

492.46

mg/l

1.88

301

345

Oral corticosteroids

3329

10169

1.96

247.70

3.7

3.2

475.65

508.81

mg/l

0.16

1599

4718

Other dialysis

320

420

10.15

241.44

11.2

4.7

803.67

264.57

mg/l

6.74

289

207

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

2837

9641

2.04

240.68

4.0

3.2

640.45

480.88

mg/l

0.84

1534

4253

Unspecified kidney failure

561

1236

5.00

240.26

5.9

2.7

707.47

531.30

mg/l

0.31

431

464

Septicaemia

1609

6068

2.52

238.17

4.7

3.1

559.60

537.66

mg/l

0.06

976

2586

Glomerulonephritis

574

1314

4.90

235.84

10.4

3.3

990.53

388.71

mg/l

6.58

466

621

Explicit Sepsis

1673

6442

2.46

235.83

4.6

3.1

549.76

486.24

mg/l

0.24

1009

2795

Explicit Sepsis, including avohilmo

1699

6576

2.44

233.96

4.6

3.2

546.29

482.97

mg/l

0.24

1022

2854

Other septicaemia

1463

5549

2.60

231.82

4.8

3.1

575.13

560.37

mg/l

0.04

891

2342

Other septicaemia, including avohilmo

1484

5643

2.58

231.31

4.8

3.1

571.88

555.12

mg/l

0.04

902

2385

General symptoms and signs

3115

8054

1.98

228.19

3.7

3.3

472.11

492.78

mg/l

0.10

1591

3622

Tramadol

2348

6690

2.16

227.19

3.3

3.1

386.13

573.37

mg/l

1.38

1113

2909

Persons encountering health services in other circumstances, wide

3496

9717

1.89

225.10

3.5

3.4

426.80

566.73

mg/l

1.18

1548

4765

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

3009

9953

1.95

224.77

4.4

3.2

545.36

476.78

mg/l

0.41

1580

4607

Persons encountering health services in other circumstances

1462

5922

2.54

224.40

3.6

3.3

550.43

500.37

mg/l

0.13

607

2898

General examination and investigation of persons without complaint and reported diagnosis

1805

3941

2.44

220.57

3.5

3.6

702.84

500.04

mg/l

0.59

832

2105

Fitting and adjustment of other devices

1386

4880

2.61

219.21

2.8

2.6

863.77

609.67

mg/l

0.31

440

1962

Certain infectious and parasitic diseases

2777

7002

2.03

218.01

4.1

2.7

428.41

544.04

mg/l

0.60

1516

2767

Hypertensive diseases (excluding secondary)

1509

3472

2.60

217.07

5.4

3.2

485.48

370.92

mg/l

0.83

892

1513

Oedema, not elsewhere classified

1215

4568

2.71

212.15

3.9

3.1

538.49

465.10

mg/l

0.31

591

1940

Special screening examination for infectious and parasitic diseases

805

1710

3.56

209.98

4.6

3.5

309.43

433.18

mg/l

0.44

530

914

Pneumonia, organism unspecified

2835

10303

1.93

208.10

4.2

3.3

456.13

576.66

mg/l

0.75

1526

4683

L04AA Selective immunosuppressants

908

3083

3.12

203.72

8.2

3.2

601.86

389.41

mg/l

2.10

624

1377

Genitourinary diseases

1613

3337

2.48

203.04

4.9

3.1

530.98

245.95

mg/l

3.30

910

1725

Hypertension

2201

5967

2.13

201.94

4.9

3.0

478.60

436.10

mg/l

0.23

1246

2497

Hypertensive diseases

2202

5972

2.13

201.93

4.9

3.0

478.33

435.90

mg/l

0.23

1247

2499

Heart failure,strict

1724

5381

2.32

201.07

3.6

3.0

528.39

571.19

mg/l

0.14

967

2292

Persons encountering health services for other counselling and medical advice, not elsewhere classified

3297

9666

1.85

200.99

3.5

3.4

447.03

567.47

mg/l

0.74

1481

4753

Other special examinations and investigations of persons without complaint or reported diagnosis

1789

3949

2.35

200.71

3.3

3.6

440.95

499.85

mg/l

0.27

821

2107

Metabolic disorders

2817

9007

1.92

197.15

4.2

3.1

541.61

437.84

mg/l

0.55

1581

3934

Syphilis

247

300

10.52

197.01

6.8

3.8

226.94

280.30

mg/l

0.45

213

138

Syphilis, including avohilmo

247

300

10.52

197.01

6.8

3.8

226.94

280.30

mg/l

0.45

213

138

Colon adenocarcinoma

597

1611

4.02

194.74

5.8

2.5

407.80

515.97

mg/l

0.21

460

584

Early syphilis

173

133

20.37

193.02

6.5

3.9

143.27

351.56

mg/l

1.31

151

Diabetic nephropathy, excluding more controls

747

1866

3.55

190.80

5.7

3.1

913.33

663.30

mg/l

0.62

576

852

Influenza and pneumonia

3135

10807

1.83

190.20

4.2

3.2

470.98

564.87

mg/l

0.57

1685

4918

Opioids

2722

7401

1.94

189.76

3.5

3.0

425.31

554.31

mg/l

0.80

1377

3266

Any death

2100

7291

2.08

188.64

4.4

3.1

425.51

612.28

mg/l

1.10

1456

2916

Early syphilis, including avohilmo

177

147

17.62

187.29

6.4

3.9

142.48

331.35

mg/l

1.32

154

Pneumonias (Asthma/COPD co-morbidities)

3015

10965

1.83

187.29

4.2

3.3

462.82

554.81

mg/l

0.55

1635

5004

Gonococcal infection, including avohilmo

270

390

8.24

183.64

4.3

3.3

135.58

362.78

mg/l

3.38

198

172

Persons with potential health hazards related to communicable diseases

1235

5093

2.49

182.99

5.1

3.6

252.33

439.40

mg/l

5.29

938

2403

Infections, IBD-co-morbidities

579

1028

4.16

182.75

5.1

4.0

453.53

274.80

mg/l

1.13

356

565

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

2956

11006

1.83

181.96

4.2

3.3

452.09

565.48

mg/l

0.75

1590

5053

All pneumoniae

3014

11003

1.82

181.51

4.2

3.3

466.62

561.05

mg/l

0.57

1623

5038

Unspecified haematuria

1484

5398

2.32

180.11

4.0

3.3

986.84

459.32

mg/l

1.27

790

2627

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

498

1257

4.33

178.71

6.4

2.7

205.15

368.21

mg/l

5.84

389

480

Nephrotic syndrome

269

403

8.28

178.62

14.1

3.7

1391.89

239.51

mg/l

8.35

235

202

Hypertension, essential

2066

5774

2.07

176.20

4.0

2.9

455.13

444.94

mg/l

0.05

1128

2359

2640

8380

1.88

173.41

4.1

3.0

457.94

578.91

mg/l

0.67

1402

3644

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

2640

8380

1.88

173.41

4.1

3.0

457.94

578.91

mg/l

0.67

1402

3644

Diabetic nephropathy

756

2527

3.20

172.15

5.7

3.1

908.73

485.72

mg/l

2.16

582

1235

Adenocarcinoma and papilloma adenocarcinoma of rectum

477

1202

4.33

171.57

6.4

2.7

208.22

354.53

mg/l

4.69

374

454

Polyarthropathies

2078

6810

2.01

168.29

3.7

3.6

665.61

527.14

mg/l

0.43

1082

3397

Gonococcal infection

251

369

8.14

168.27

4.4

3.3

136.20

367.90

mg/l

3.00

182

155

Malignant neoplasm of rectum

476

1216

4.27

167.96

6.3

2.7

208.89

361.72

mg/l

4.92

370

459

Malignant neoplasm of rectum, including Hilmo

543

1537

3.81

164.88

6.1

2.7

212.71

520.18

mg/l

1.59

420

585

Malignant neoplasm

2367

7394

1.92

164.44

4.3

3.1

339.10

556.74

mg/l

2.01

1416

2979

Heart failure and antihypertensive medication

780

1658

3.18

164.35

4.2

3.1

578.48

347.70

mg/l

1.08

455

723

Osteopathies and chondropathies

1839

8523

2.03

163.62

3.4

3.3

485.47

520.97

mg/l

0.12

848

3817

Persons encountering health services for examination and investigation

1692

3949

2.19

162.54

3.4

3.6

455.49

499.85

mg/l

0.18

761

2107

Malignant neoplasm

2361

7407

1.91

161.93

4.3

3.1

338.92

554.58

mg/l

1.98

1413

2984

Antihypertensive medication - note that there are other indications

1629

3931

2.21

161.45

5.1

2.9

481.67

324.17

mg/l

1.51

929

1809

Cardiovascular diseases (excluding rheumatic etc)

1679

4543

2.16

160.97

4.7

3.2

468.58

362.48

mg/l

0.82

928

2078

Parasetamol

1929

4816

2.06

159.70

3.4

3.5

475.92

464.86

mg/l

0.05

906

2461

Other disorders of fluid, electrolyte and acid-base balance

1138

4576

2.44

158.44

4.1

3.0

1093.67

523.09

mg/l

1.40

640

1837

Malignant neoplasm, including Hilmo

2393

7549

1.88

158.33

4.2

3.1

344.97

549.51

mg/l

1.88

1420

3056

Infections with a predominantly sexual mode of transmission

968

3865

2.59

156.46

4.6

3.0

323.02

452.92

mg/l

1.03

606

1719

Malignant neoplasm, wide definition

2392

7571

1.88

156.34

4.2

3.1

345.30

548.52

mg/l

1.87

1422

3066

Malaise and fatigue

1600

6120

2.11

155.04

3.2

658.62

450.48

mg/l

0.70

785

2665

Autoimmune diseases excluding thyroid diseases

2990

9418

1.75

154.02

3.8

3.3

556.53

470.01

mg/l

0.40

1617

4394

Heart failure, strict

1896

6778

2.00

153.87

3.5

3.2

535.42

637.58

mg/l

0.45

1040

2992

Follow-up examination after treatment for conditions other than malignant neoplasms

1197

3391

2.41

153.48

3.1

3.5

362.71

409.56

mg/l

0.25

463

1787

Dental caries

906

3331

2.67

153.37

5.0

3.3

534.90

491.15

mg/l

0.18

580

1684

Hernia of abdominal wall, postoperative

575

1740

3.42

153.10

4.5

2.5

686.21

409.26

mg/l

0.53

323

665

Factors influencing health status and contact with health services

747

1174

3.27

152.76

3.5

2.7

468.03

670.72

mg/l

0.40

368

525

Colon adenocarcinoma, helper endpoint

597

1893

3.41

152.07

5.8

2.9

407.80

412.64

mg/l

0.01

460

790

Nausea and vomiting

983

3912

2.55

152.04

4.9

3.4

369.56

477.77

mg/l

0.78

561

1721

Presence of other devices

922

3615

2.63

150.88

3.0

2.9

805.62

539.10

mg/l

0.43

295

1582

All-cause Heart Failure

1866

6692

2.00

150.46

3.5

3.2

531.55

634.00

mg/l

0.44

1020

2947

Caries of dentine

820

2972

2.78

150.04

4.8

3.3

525.02

470.24

mg/l

0.24

511

1506

Type 2 diabetes, wide definition

2287

7886

1.87

149.99

3.8

3.2

633.97

543.86

mg/l

0.33

1280

3392

Complications of surgical and medical care, not elsewhere classified

2887

11372

1.73

147.31

3.7

3.2

749.02

494.30

mg/l

0.99

1415

5220

Other diseases of intestines

2951

9674

1.73

146.27

3.6

3.4

484.08

553.43

mg/l

0.30

1463

4614

Autoimmune diseases excluding thyroid diseases, strict definition

2886

9176

1.74

145.81

3.8

3.3

516.89

470.46

mg/l

0.21

1566

4289

Solid cancers

2259

7237

1.87

145.68

4.4

3.1

319.29

555.03

mg/l

2.18

1352

2875

Other diseases of urinary system

2816

9220

1.75

144.59

3.8

3.2

612.50

399.73

mg/l

1.29

1337

4457

Disorders resulting from impaired renal tubular function

268

494

6.45

143.91

10.3

4.0

1038.72

277.18

mg/l

1.54

228

Osteoporosis

993

3847

2.48

142.14

3.0

3.1

346.04

613.41

mg/l

1.23

410

1473

Solid cancers, including Hilmo

2295

7402

1.84

141.83

4.3

3.1

323.39

557.39

mg/l

2.23

1352

2968

Dyspnoea

2618

11061

1.74

140.09

3.4

3.3

547.09

524.97

mg/l

0.09

1228

5146

Dipeptidyl peptidase 4 (DPP-4) inhibitors

1757

7194

1.97

139.88

3.8

3.2

593.79

569.46

mg/l

0.06

947

3166

Other sexually transmitted chlamydial diseases

312

662

5.13

139.56

4.8

3.1

131.99

420.02

mg/l

3.38

228

317

Anaemia in chronic diseases classified elsewhere

211

318

8.24

139.47

10.4

3.6

636.29

445.16

mg/l

0.50

173

142

Nutritional anaemias

1627

8037

1.99

137.19

3.7

3.2

875.62

497.62

mg/l

0.93

870

3494

Systemic connective tissue disorders

1181

5473

2.24

136.84

3.6

3.2

387.10

489.88

mg/l

0.72

538

2272

Iron deficiency anaemia

1438

7024

2.07

136.79

3.7

3.2

622.62

444.87

mg/l

0.61

773

3010

Gout

1001

3672

2.44

136.59

4.4

3.4

855.98

608.01

mg/l

0.50

598

1841

Hypertensive Renal Disease

233

392

6.76

135.88

6.0

2.5

661.99

184.74

mg/l

8.48

160

133

Other and unspecified polyneuropathies, also in other diseases

755

2888

2.76

135.76

3.7

3.3

541.90

507.24

mg/l

0.11

382

1333

Insulin medication

1851

8258

1.91

135.69

3.9

3.4

634.27

512.08

mg/l

0.63

1127

3818

Isolated proteinuria

223

365

7.39

135.63

7.4

3.9

953.24

291.99

mg/l

6.99

190

170

Codeine

2386

7283

1.80

135.22

3.1

3.0

619.45

559.86

mg/l

0.15

1057

3198

Other disorders of urethra and urinary system

2050

7866

1.85

133.59

4.0

3.0

710.29

391.04

mg/l

1.09

1025

3620

Autoimmune diseases

3070

9466

1.67

132.34

3.7

3.3

516.56

468.38

mg/l

0.25

1639

4421

Any event in cancer register

2432

8174

1.77

131.98

4.2

3.1

341.61

529.91

mg/l

1.86

1414

3393

Other disorders of kidney and ureter

558

1856

3.22

130.79

6.9

3.3

780.84

389.15

mg/l

1.20

386

844

Other nutritional deficiencies

1939

9820

1.84

130.67

3.1

3.5

414.05

468.60

mg/l

0.48

974

4563

Complications of medical and surgical care

2160

11133

1.78

129.47

3.7

3.2

661.69

536.29

mg/l

0.46

1053

5013

Polyneuropathies and other disorders of the peripheral nervous system

818

3327

2.58

129.28

3.7

3.4

508.56

537.49

mg/l

0.10

418

1560

Viral Sepsis

772

3051

2.65

129.12

5.5

3.2

609.46

444.68

mg/l

0.96

487

1302

Infections with a predominantly sexual mode of transmission, including avohilmo

1140

4831

2.22

128.94

4.4

3.2

319.60

428.43

mg/l

1.00

697

2182

Other and unspecified disorders of skin and subcutaneous tissue

341

835

4.54

128.48

5.6

3.3

343.11

345.87

mg/l

0.01

133

351

Implicit viral Sepsis

769

3046

2.64

128.02

5.5

3.1

610.45

445.72

mg/l

0.96

486

1297

Erysipelas, including avohilmo

2025

8384

1.83

127.92

3.5

3.0

587.50

515.99

mg/l

0.26

1055

3537

Cardiovascular diseases

1531

4022

2.06

127.91

4.6

3.3

471.77

347.61

mg/l

1.12

857

1894

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

276

576

5.41

127.41

2.1

2.6

797.41

302.46

mg/l

0.49

150

203

Other and unspecified iron deficiency

1165

5522

2.18

126.63

3.6

3.2

550.35

446.98

mg/l

0.33

626

2363

Endocrine, nutritional and metabolic diseases

2046

5655

1.86

126.05

3.7

3.3

458.48

346.59

mg/l

1.14

1066

2537

Used for control exclusion in common control thyroid runs

2879

8818

1.67

123.99

3.7

3.4

573.58

457.92

mg/l

0.62

1513

4143

Disorders of lipoprotein metabolism and other lipidaemias

2269

7954

1.77

123.72

4.3

3.1

540.35

465.65

mg/l

0.33

1263

3382

Obesity and other hyperalimentation

1815

9455

1.84

123.21

3.1

3.4

425.31

458.77

mg/l

0.25

896

4382

Obesity

1807

9416

1.85

123.18

3.1

3.4

427.74

459.73

mg/l

0.24

890

4368

Hypertensive heart and/or renal disease

848

2528

2.54

122.93

4.1

2.7

572.95

445.41

mg/l

0.47

507

973

Hydronephrosis

434

1288

3.58

122.01

5.6

2.7

415.58

332.34

mg/l

0.37

313

502

L04AX Other immunosuppressants

1655

8982

1.89

121.58

4.1

3.4

337.57

507.01

mg/l

2.28

879

4142

Second line medication for Crohn's disease

1693

9258

1.87

121.14

4.1

3.4

337.45

500.54

mg/l

2.22

895

4253

Other disorders of skin and subcutaneous tissue, not elsewhere classified

577

2041

3.00

120.66

4.5

3.2

540.42

342.72

mg/l

1.08

267

886

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1982

9861

1.79

119.75

3.4

3.3

683.58

497.63

mg/l

0.46

973

4453

Insulin, intermediate and long-acting

1680

8877

1.87

119.57

3.9

3.4

637.16

494.94

mg/l

0.83

1017

4160

Obesity due to excess calories

1398

7229

1.99

119.45

3.2

3.5

478.62

451.62

mg/l

0.16

668

3354

Diseases of arteries, arterioles and capillaries (FINNGEN)

698

1795

2.78

119.05

3.5

3.2

692.33

376.52

mg/l

0.74

368

764

Other heart diseases

1177

3593

2.18

118.98

3.7

3.4

455.39

367.20

mg/l

0.64

639

1623

Gout, FINNGEN

1001

4567

2.26

118.74

4.4

3.1

855.98

490.94

mg/l

0.91

598

2158

Insulin, combination of fast acting with intermediate-acting or long-acting

1853

9471

1.82

118.52

3.9

3.4

634.60

523.43

mg/l

0.62

1128

4404

Implicit viral Sepsis, including avohilmo

1013

4665

2.24

118.44

4.9

3.1

725.31

422.74

mg/l

1.32

600

1960

Symptoms and signs involving the digestive system and abdomen

2694

8159

1.68

118.14

3.6

3.4

427.75

518.14

mg/l

0.57

1351

3935

Pure hypercholesterolaemia

2080

7563

1.78

117.37

4.2

3.0

638.27

475.99

mg/l

0.64

1089

3189

Other disorders involving the immune mechanism, not elsewhere classified

223

418

6.27

117.37

6.3

5.2

613.92

351.08

mg/l

1.27

182

217

IgA nephropathy (IgA glomerulonephritis)

183

285

7.76

116.75

7.1

4.3

696.72

281.47

mg/l

2.02

151

138

Intestinal infectious diseases

2667

12265

1.64

116.20

4.3

3.2

541.74

533.46

mg/l

0.03

1478

5594

Type 2 diabetes

2617

9235

1.67

114.89

3.7

3.2

617.11

481.71

mg/l

0.64

1341

3995

Headache

1739

7420

1.84

114.87

3.4

3.2

300.74

486.53

mg/l

2.46

741

3286

Diseases of oesophagus, stomach and duodenum

2886

10658

1.62

114.80

3.1

3.5

506.42

496.54

mg/l

0.04

1280

5113

Examination and observation for other reasons

1386

3923

2.03

113.52

3.3

3.6

700.96

500.21

mg/l

0.52

772

2099

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

881

1809

2.49

112.69

3.6

3.2

390.00

429.33

mg/l

0.13

414

844

Benign neoplasm of colon, rectum, anus and anal canal

1882

9141

1.78

111.49

3.2

590.01

568.26

mg/l

0.05

885

4083

Other soft tissue disorders, not elsewhere classified

2600

9067

1.66

111.29

3.2

3.6

374.29

553.35

mg/l

1.75

1133

4589

Unspecified urinary incontinence

391

1161

3.63

110.68

3.3

3.0

685.82

361.54

mg/l

0.52

114

459

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

210

394

6.27

110.52

6.4

5.3

643.68

339.57

mg/l

1.47

171

210

Liquid cancers, including Hilmo

1086

4623

2.14

110.20

3.3

3.0

763.14

582.90

mg/l

0.29

620

1769

ILD medications: azathioprine

507

1762

3.02

108.87

7.4

3.1

391.77

394.20

mg/l

0.01

346

799

Diabetes mellitus

2713

9784

1.63

108.15

3.6

3.3

551.87

471.50

mg/l

0.42

1419

4342

Abnormalities of breathing

2394

8294

1.68

107.45

3.6

3.5

576.38

459.16

mg/l

0.52

1136

4044

Certain infectious and parasitic diseases, including avohilmo

1825

5078

1.83

107.39

3.8

2.8

470.62

523.63

mg/l

0.19

915

2044

Abdominal and pelvic pain

2631

8158

1.64

106.25

3.5

3.4

591.12

518.25

mg/l

0.26

1273

3934

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

1057

3132

2.17

105.78

3.7

3.0

666.47

381.11

mg/l

0.90

527

1311

Diarrhoea and gastroenteritis of presumed infectious origin

2003

10621

1.71

105.62

4.6

3.3

592.09

525.14

mg/l

0.24

1115

4842

Gastro-oesophageal reflux disease

1919

9487

1.74

105.42

3.1

3.5

903.66

520.99

mg/l

0.82

730

4489

Disorders of mineral metabolism

370

1099

3.62

104.59

4.1

3.1

819.56

444.30

mg/l

0.50

208

461

Other sexually transmitted chlamydial diseases, including avohilmo

374

1113

3.54

104.43

4.5

3.1

154.07

425.90

mg/l

3.76

267

525

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

368

1095

3.65

104.24

2.8

3.1

322.86

389.43

mg/l

0.43

197

431

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

2497

9161

1.64

104.23

3.7

3.4

678.50

481.61

mg/l

0.93

1318

4052

Diabetes, varying definitions

2686

9794

1.61

104.12

3.6

3.3

552.87

471.74

mg/l

0.42

1398

4353

Erysipelas

1537

7379

1.83

101.29

3.6

3.0

594.39

523.18

mg/l

0.22

820

3112

Abnormal findings on examination of urine, without diagnosis

256

607

4.75

101.23

6.8

3.7

912.06

283.51

mg/l

7.40

202

279

Missing teeth due to accident, extraction or parodontitis

1796

9373

1.75

101.15

3.2

3.3

972.95

452.47

mg/l

1.14

666

4394

Autoimmune diseases related-to ILD

2330

12113

1.63

100.99

3.5

3.3

373.02

547.38

mg/l

2.19

1162

5617

Neoplasms

1880

5660

1.77

100.36

4.0

3.3

374.71

498.45

mg/l

1.10

1076

2512

Other systemic involvement of connective tissue (FG)

804

3550

2.30

99.83

2.8

3.2

268.65

609.55

mg/l

1.99

304

1495

Other functional intestinal disorders

1361

6696

1.89

99.27

3.7

3.4

353.65

558.36

mg/l

1.41

603

3076

Cystitis

2276

8294

1.66

98.76

3.6

3.1

878.16

386.95

mg/l

1.50

954

3889

Chronic nephritic syndrome

220

474

5.25

98.03

8.6

3.3

972.13

277.87

mg/l

4.61

179

203

Azathioprine

507

1867

2.84

97.80

7.4

3.3

391.77

469.73

mg/l

0.37

346

887

Disorders of other endocrine glands

1315

7027

1.89

96.66

4.3

3.5

537.75

395.23

mg/l

0.62

667

3190

Intestinal infectious diseases, including avohilmo, including avohilmo

3088

11339

1.54

96.51

4.0

3.2

521.77

546.14

mg/l

0.10

1616

5162

Gastrointestinal diseases

1457

3909

1.90

96.17

3.7

3.2

509.38

499.72

mg/l

0.03

710

1810

Colectomy operation

606

2464

2.59

96.07

4.9

3.2

456.93

430.24

mg/l

0.05

428

1052

Hypothyroidism (congenital or acquired)

567

1144

2.84

95.95

3.9

3.1

544.75

499.46

mg/l

0.10

291

471

Any reimbursement code in KELA

1347

3528

1.94

95.39

4.1

2.8

407.46

340.71

mg/l

0.45

714

1410

Disorders of calcium metabolism

300

830

3.93

94.84

4.2

3.1

937.19

407.91

mg/l

0.59

167

334

Multiple myeloma, including Hilmo

231

530

4.84

94.79

2.5

2.7

700.47

310.35

mg/l

3.45

156

188

Diabetes, insulin treatment (Kela reimbursement)

2657

10163

1.58

94.52

3.6

3.4

671.04

495.68

mg/l

0.85

1384

4563

Codeine or tramadol medication

2964

10573

1.54

93.87

3.1

3.3

632.71

534.10

mg/l

0.33

1333

4953

Gout, idiopatic and unspecified

846

4007

2.20

93.33

4.4

3.2

752.54

469.70

mg/l

0.68

506

1915

Pain in limb

2255

8916

1.63

93.29

3.2

3.6

419.07

558.61

mg/l

1.03

997

4493

Hypothyroidism, levothyroxine purchases

556

1136

2.80

92.22

3.7

3.0

545.99

486.67

mg/l

0.13

281

466

Hypothyroidism and >3 levothyroxin purchases

556

1136

2.80

92.22

3.7

3.0

545.99

486.67

mg/l

0.13

281

466

Sleep apnoea

2507

10113

1.59

92.11

3.1

3.4

612.03

498.26

mg/l

0.39

1090

4815

Heart failure and bmi 25plus

1120

3837

2.01

91.08

3.7

3.2

572.68

811.25

mg/l

0.69

603

1618

Hypoplasia of dental enamel

129

188

10.63

91.06

14.3

8.0

243.13

326.78

mg/l

0.78

119

152

Certain disorders involving the immune mechanism

625

2639

2.47

90.90

4.8

3.6

531.58

418.97

mg/l

0.59

394

1215

Complications of procedures, not elsewhere classified

2177

11006

1.62

90.85

3.7

3.2

817.37

499.39

mg/l

0.98

1083

5011

Benign neoplasm: Colon

1585

8675

1.76

90.82

3.2

639.79

520.74

mg/l

0.33

748

3877

Molar incisor enamel hypoplasia, with caries

119

161

11.15

88.83

12.2

8.2

226.45

313.38

mg/l

0.78

109

127

Other reaction to severe stress, and adjustment disorders

977

4950

2.02

88.31

4.4

3.4

290.54

435.80

mg/l

2.58

524

2285

Bleeding

2274

10127

1.60

88.24

3.8

3.4

565.33

547.78

mg/l

0.06

1204

4625

Cerebrovascular diseases (FINNGEN)

756

2368

2.29

88.16

3.5

3.3

649.15

343.47

mg/l

0.78

378

986

Cystic kidney disease

193

412

5.35

87.25

9.1

4.8

295.13

344.17

mg/l

0.35

137

202

Gout, unspecified

706

3199

2.30

87.25

4.6

3.1

467.58

430.30

mg/l

0.17

430

1509

Pain in joint

1557

5478

1.78

87.24

3.1

3.5

505.79

500.24

mg/l

0.01

666

2787

Finngen Rheumatological endpoints

2415

8763

1.59

86.98

3.4

3.5

317.07

574.08

mg/l

3.32

1125

4294

Other disorders of skin and subcutaneous tissue

2020

10651

1.63

86.83

4.0

3.2

666.80

533.15

mg/l

0.51

1029

4776

Diabetes medication

2704

10385

1.54

86.52

3.5

3.4

658.94

491.52

mg/l

0.81

1396

4675

Congenital malformations of the urinary system

282

800

3.86

86.27

8.1

4.5

309.00

289.84

mg/l

0.17

204

408

Gout, strict definition

644

2824

2.39

86.24

4.7

3.2

648.27

504.82

mg/l

0.29

394

1342

Asthma, unspecified (mode), excluding more controls

1312

5175

1.85

86.13

3.4

3.1

753.55

598.91

mg/l

0.30

578

2282

Congenital malformations of the urinary system, including avohilmo

290

841

3.75

85.67

8.0

4.4

311.21

292.50

mg/l

0.17

207

422

Liquid cancers

869

4038

2.10

85.64

2.7

2.9

893.90

500.98

mg/l

0.65

492

1564

Depression medications

612

1207

2.60

85.36

3.4

3.1

305.16

461.92

mg/l

0.64

298

507

Diverticular disease of intestine

1851

6972

1.68

85.35

3.0

3.2

543.72

623.55

mg/l

0.23

799

3122

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1687

9987

1.69

85.17

3.6

3.2

750.32

508.91

mg/l

0.87

822

4475

Paralytic ileus and intestinal obstruction

795

3815

2.15

84.00

4.8

3.2

544.07

370.62

mg/l

0.39

511

1672

Artificial opening status

254

683

4.06

83.93

6.2

3.6

290.86

272.71

mg/l

0.15

208

314

Disorders of parathyroid gland

683

3061

2.29

83.82

4.4

3.0

789.64

471.16

mg/l

0.65

304

1192

COPD/asthma/ILD related infections

2566

8380

1.55

82.55

3.7

3.0

382.28

578.91

mg/l

1.77

1275

3644

COPD/asthma related infections

2566

8380

1.55

82.55

3.7

3.0

382.28

578.91

mg/l

1.77

1275

3644

Anxiety disorders, excluding more controls

2131

8628

1.60

81.84

3.5

3.4

303.05

537.55

mg/l

3.17

1002

4052

Type 2 diabetes, definitions combined

2375

8948

1.57

81.44

3.3

3.2

562.68

483.52

mg/l

0.28

1145

3841

Type 2 diabetes, strict (exclude DM1)

2385

9002

1.56

81.15

3.3

3.2

564.41

484.02

mg/l

0.29

1153

3871

Cystic kidney disease, including avohilmo

197

456

4.88

80.47

9.0

4.5

299.78

333.75

mg/l

0.23

139

219

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

2663

11431

1.51

79.85

4.2

3.2

510.49

553.92

mg/l

0.17

1416

5184

Non-ischemic cardiomyopathy

968

3976

1.99

79.70

3.5

3.2

486.55

518.50

mg/l

0.11

528

1737

Insulin, fast-acting

1051

5671

1.90

79.16

4.3

3.5

603.86

476.60

mg/l

1.16

676

2688

Constipation

2391

10667

1.54

78.47

3.4

3.5

522.93

555.84

mg/l

0.10

1079

5056

Other heart diseases, wide

2251

8808

1.57

78.28

3.5

3.6

513.86

408.97

mg/l

0.66

1134

4161

Urinary track infection

1419

4036

1.79

78.03

3.7

2.8

502.33

304.83

mg/l

1.42

560

1648

Viral hepatitis, IBD co-morbidity

187

418

4.72

77.98

4.7

4.5

326.48

306.13

mg/l

0.06

134

246

Osteoporosis with pathological fracture (FG)

298

931

3.43

77.86

2.5

3.0

258.89

430.88

mg/l

0.87

337

Pain, not elsewhere classified

777

3802

2.10

77.81

3.1

420.03

447.49

mg/l

0.09

378

1618

Other systemic involvement of connective tissue

827

4155

2.05

77.47

2.9

3.1

271.90

409.83

mg/l

2.33

323

1681

Abnormal findings on diagnostic imaging of lung

1388

7731

1.74

77.42

3.4

3.2

736.12

514.24

mg/l

0.41

680

3462

Provisional assignment of new diseases of uncertain etiology

1492

8892

1.70

76.92

4.1

3.3

704.72

453.51

mg/l

1.12

774

4081

Type 2 diabetes, definitions combined, including avohilmo

2360

8936

1.55

76.84

3.3

3.2

586.71

476.64

mg/l

0.41

1129

3856

Presence of cardiac and vascular implants and grafts

1228

5077

1.82

76.70

3.3

3.0

859.75

480.21

mg/l

0.68

586

2386

Codes for special purposes

1493

8909

1.69

76.58

4.1

3.3

704.72

453.07

mg/l

1.12

774

4087

Infections of the skin and subcutaneous tissue

1604

9667

1.66

76.56

4.3

3.5

430.54

470.06

mg/l

0.30

931

4662

Asthma, unspecified (mode)

1360

5670

1.76

76.47

3.4

3.1

785.57

593.63

mg/l

0.40

591

2507

Sleep apnoea, including avohilmo

2564

10375

1.51

76.23

3.1

3.4

622.34

468.88

mg/l

0.60

1108

4962

Other bacterial intestinal infections

599

2682

2.32

76.00

4.3

3.1

393.59

388.26

mg/l

0.04

343

1145

Fentanyl

359

1257

2.99

75.95

3.9

2.8

289.03

390.35

mg/l

0.84

216

484

Reimbursement for rheumatic diseases

1527

9209

1.68

75.88

4.0

3.3

359.72

544.42

mg/l

2.50

742

4077

Other or unspecified ileus, impaction or obstruction

586

2611

2.33

74.99

4.9

3.1

425.62

403.60

mg/l

0.04

396

1150

Retention of urine

996

4298

1.92

74.95

3.3

3.2

1208.46

477.15

mg/l

0.91

481

2108

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1560

9588

1.65

73.07

3.6

3.2

773.63

421.32

mg/l

1.42

738

4304

Neurotic, stress-related and somatoform disorders

2253

10276

1.53

72.20

3.5

3.4

303.97

536.93

mg/l

4.15

1073

4759

Mood disorders, excluding more controls

2380

9323

1.52

71.70

3.4

3.3

497.57

526.13

mg/l

0.09

1085

4411

Other (not insulin) diabetes medications

2449

9639

1.51

71.62

3.3

3.2

630.15

502.27

mg/l

0.47

1192

4227

Disorders of lens

1688

6480

1.64

71.34

4.2

3.3

693.83

506.93

mg/l

0.65

850

3028

Benzodiazepine use

2599

11981

1.48

71.24

3.3

675.50

517.22

mg/l

0.41

1134

5660

Bacterial intestinal infections, IBD co-morbidities

597

2743

2.26

71.16

4.4

3.2

398.82

413.60

mg/l

0.11

342

1182

Atrial fibrillation and flutter

710

2164

2.16

71.02

3.1

636.13

343.67

mg/l

0.65

343

908

Other pulmonary diagnosis

1910

6037

1.61

70.92

3.7

3.1

462.22

575.42

mg/l

0.53

917

2717

Syncope and collapse

1181

5638

1.78

70.91

2.8

3.2

833.45

461.04

mg/l

0.61

543

2464

Atrial fibrillation and flutter with reimbursement

620

1745

2.30

70.79

3.3

3.1

633.35

387.59

mg/l

0.38

274

711

Excluding asthma or asthma-COPD overlap

1909

6037

1.61

70.73

3.7

3.1

435.91

575.42

mg/l

0.74

918

2717

Neurological diseases, wide definition

710

1639

2.22

70.72

3.4

3.8

366.10

255.44

mg/l

1.20

326

906

Insulin, fast-acting or short human

1057

5935

1.82

69.98

4.3

3.5

602.62

479.39

mg/l

1.16

680

2829

Other bacterial intestinal infections, including avohilmo

716

3544

2.08

69.96

4.1

3.1

380.90

420.97

mg/l

0.26

395

1526

Pain in throat and chest

2098

8104

1.55

69.80

3.3

3.4

508.69

461.89

mg/l

0.17

934

3939

Anxiety disorders

2267

10391

1.52

69.55

3.5

3.4

303.78

533.72

mg/l

4.12

1074

4815

Diseases of arteries, arterioles and capillaries

1799

8434

1.59

68.80

3.3

542.07

577.91

mg/l

0.12

913

3784

Multiple myeloma and malignant plasma cell neoplasms

232

674

3.78

68.78

2.5

3.3

701.12

361.04

mg/l

1.89

155

282

Other necrotizing vasculopathies (FG)

248

748

3.57

68.74

5.5

3.1

573.03

478.46

mg/l

0.19

153

322

Hypo-osmolality and hyponatraemia

566

2561

2.27

68.58

4.2

3.0

1432.60

478.54

mg/l

1.21

299

990

Other and unspecified syphilis, including avohilmo

22.53

67.78

7.9

4.7

176.27

266.69

mg/l

0.48

Multiple myeloma

153

332

5.18

67.61

2.5

2.6

791.15

253.83

mg/l

3.76

102

111

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

153

332

5.18

67.61

2.5

2.6

791.15

253.83

mg/l

3.76

102

111

COPD differential diagnosis

1891

6047

1.59

66.92

3.7

3.1

431.79

577.51

mg/l

0.78

911

2718

Heart failure and coronary heart disease

1252

5150

1.74

66.85

3.5

3.3

541.15

554.30

mg/l

0.04

661

2379

Other specific joint derangements/joint disorders

1856

7435

1.58

66.82

3.0

3.6

488.10

461.33

mg/l

0.09

799

3776

ILD differential diagnosis

1888

6047

1.58

66.35

3.7

3.1

431.77

577.51

mg/l

0.78

908

2718

Valvular heart disease excluding rheumatic fever

1233

5157

1.74

66.34

3.3

3.6

723.59

410.42

mg/l

0.98

618

2370

Non-rheumatic valve diseases

1223

5101

1.74

66.27

3.3

3.6

727.12

412.57

mg/l

0.97

611

2326

Polycystic kidney disease

152

335

5.16

66.21

9.3

4.6

325.22

315.08

mg/l

0.05

107

157

Disorders of choroid and retina

2114

9875

1.52

65.75

3.9

3.2

717.90

539.62

mg/l

0.69

1100

4463

Hyperparathyroidism

579

2683

2.21

65.63

4.8

2.9

874.51

479.27

mg/l

0.73

265

1025

Hyperlipidaemia, other/unspecified

1073

5527

1.78

65.16

4.6

3.0

380.83

475.72

mg/l

0.75

654

2324

Disorders of gallbladder, biliary tract and pancreas

2492

10663

1.47

65.14

3.4

3.3

516.34

555.90

mg/l

0.14

1201

4901

Obesity, other/unspecified

866

4679

1.89

64.95

3.0

3.3

336.32

407.52

mg/l

0.74

451

2109

Covid-19 confirmed case

1086

6282

1.77

64.75

4.4

3.2

826.52

514.45

mg/l

1.06

607

2872

Diseases of liver

960

5370

1.83

64.59

3.7

3.4

416.21

474.87

mg/l

0.32

518

2448

Any mental disorder

2741

9550

1.45

64.44

3.4

372.91

536.83

mg/l

1.28

1260

4568

Hyperkalaemia

244

759

3.44

64.28

3.9

3.0

850.90

397.34

mg/l

2.59

163

311

Neurological diseases

2093

6931

1.53

64.09

3.2

3.8

385.43

465.58

mg/l

0.67

969

3583

Intestinal stricture

900

4959

1.86

63.78

4.8

3.1

515.47

475.89

mg/l

0.08

592

2156

Anxiety (asthma-related co-morbidities)

1481

7003

1.63

63.62

3.2

3.5

332.23

404.74

mg/l

0.76

688

3342

Polyuria

659

3280

2.07

63.55

3.1

3.2

939.94

492.77

mg/l

0.38

278

1562

Nerve, nerve root and plexus disorders

2680

11267

1.45

63.24

3.3

557.97

550.56

mg/l

0.03

1112

5391

Symptoms and signs concerning food and fluid intake

361

1397

2.69

63.10

3.8

3.4

426.38

376.20

mg/l

0.13

183

616

Diabetic maculopathy, excluding more controls

345

1315

2.74

62.47

5.6

3.3

788.80

363.25

mg/l

4.76

258

580

Symptoms and signs involving the circulatory and respiratory systems

2422

8309

1.48

61.84

3.4

3.5

393.16

458.66

mg/l

0.54

1148

4058

Venous thromboembolism

1444

8757

1.62

61.61

4.2

3.1

814.03

522.63

mg/l

0.66

779

3800

Episodal and paroxysmal disorders

2719

9669

1.44

61.47

3.1

3.6

424.90

502.50

mg/l

0.42

1243

4731

All anxiety disorders

1505

7363

1.61

61.39

3.2

3.5

331.31

455.61

mg/l

1.39

700

3477

All influenza

741

3882

1.96

61.34

5.0

3.3

427.29

510.54

mg/l

0.48

419

1816

Moderate visual impairment, binocular

162

398

4.51

61.06

4.8

3.2

344.71

288.38

mg/l

0.56

156

Chronic laryngitis and laryngotracheitis

446

1937

2.40

61.02

3.0

3.2

699.94

438.31

mg/l

0.51

143

862

Hypertensive Heart Disease

641

2386

2.09

60.66

3.6

2.7

506.87

451.79

mg/l

0.15

364

922

Diseases of the skin and subcutaneous tissue

2430

8395

1.47

60.32

3.7

3.1

554.99

443.77

mg/l

0.60

1211

3847

Other diseases of pleura

1260

6706

1.67

59.55

3.7

3.2

749.43

509.96

mg/l

0.45

671

3097

Other retinal disorders

1720

8560

1.55

59.40

3.8

3.2

726.42

524.16

mg/l

0.79

902

3825

Primary_lymphoid and hematopoietic malignant neoplasms

721

3801

1.96

59.00

2.7

3.4

976.42

519.47

mg/l

0.66

425

1710

Biguanides

2347

9807

1.46

58.99

3.1

3.3

639.04

521.06

mg/l

0.40

1109

4396

Other CVD (FINNGEN)

329

929

2.80

58.94

3.3

2.9

660.54

257.70

mg/l

1.65

175

370

DVT of lower extremities and pulmonary embolism

1140

6835

1.70

58.77

4.3

3.1

897.16

482.46

mg/l

0.81

618

2958

Sleep disorders (combined)

2772

10307

1.42

58.02

3.0

3.5

680.35

493.70

mg/l

0.58

1212

4989

STROKE

1340

5577

1.64

57.94

3.1

3.5

556.77

372.46

mg/l

0.73

618

2483

Other necrotizing vasculopathies

274

969

3.01

57.92

5.3

3.1

622.07

422.49

mg/l

0.57

169

410

Pain (limb, back, neck, head abdominally)

1755

5718

1.56

57.38

3.6

369.49

517.17

mg/l

1.19

853

2902

Presence of other functional implants

1491

6518

1.59

56.63

3.8

3.0

541.06

505.28

mg/l

0.15

701

2880

Senile cataract

1516

5877

1.59

56.61

3.7

3.3

709.41

535.75

mg/l

0.49

737

2695

Diseases of the digestive system

1264

7832

1.63

56.33

3.7

3.3

1066.50

475.49

mg/l

1.29

680

3593

Depression

2350

11021

1.44

56.00

3.3

3.4

359.28

498.24

mg/l

1.57

1058

5187

Hypokalaemia

386

1639

2.45

55.66

3.8

2.9

499.41

439.28

mg/l

0.16

204

653

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

497

2269

2.20

55.48

6.2

4.3

545.15

406.29

mg/l

0.27

341

1152

Other problems related to primary support group, including family circumstances

355

1410

2.55

55.42

6.9

4.1

320.83

430.67

mg/l

0.76

224

718

Mood disorders

2529

11499

1.42

55.38

3.4

482.17

518.80

mg/l

0.13

1159

5413

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

2363

10495

1.44

55.24

3.4

3.3

611.42

544.54

mg/l

0.22

1131

4881

Rheumatoid arthritis

843

4182

1.82

55.20

2.9

3.3

287.26

494.09

mg/l

2.48

372

1901

2838

10363

1.40

55.10

3.7

3.1

457.39

548.52

mg/l

0.51

1400

4642

Mood [affective] disorders

2522

11499

1.42

54.92

3.4

482.62

518.73

mg/l

0.13

1157

5414

Other antidepressants

2549

9211

1.43

54.83

3.1

3.4

463.42

490.25

mg/l

0.10

1148

4478

Benign neoplasms

2401

9173

1.44

54.76

3.5

3.4

449.04

512.17

mg/l

0.31

1231

4421

Volume depletion

327

1298

2.63

54.65

4.7

3.2

1205.09

393.15

mg/l

0.56

202

532

Polymyalgia rheumatica

439

2002

2.29

53.72

2.6

2.9

224.32

428.17

mg/l

2.73

164

797

Hypothyroidism, strict autoimmune

1747

7649

1.52

53.71

3.4

3.1

514.87

479.83

mg/l

0.14

787

3356

Hypercalcemia

196

599

3.56

53.66

3.8

3.4

474.64

374.89

mg/l

0.36

106

250

Chronic tubulo-interstitial nephritis

151

385

4.23

53.65

7.2

3.0

488.18

405.32

mg/l

0.17

102

139

Type 1 diabetes

659

3467

1.94

53.65

5.0

3.8

989.15

405.23

mg/l

1.81

460

1703

Enterocolitis due to Clostridium difficile

365

1541

2.48

53.50

4.3

3.3

431.09

410.27

mg/l

0.12

216

649

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

517

2438

2.13

53.24

6.0

4.2

543.16

417.62

mg/l

0.24

345

1222

Ascites

265

962

2.91

53.12

5.6

3.1

439.53

500.88

mg/l

0.13

177

413

Other abnormal uterine and vaginal bleeding

589

2108

2.06

52.99

2.7

3.1

265.84

459.02

mg/l

2.04

185

843

Dermatitis

1607

10507

1.52

52.35

4.0

3.3

615.68

472.87

mg/l

0.59

814

4804

Chronic apical periodontitis

2738

11135

1.39

52.15

3.4

3.3

519.53

546.49

mg/l

0.10

1283

5176

Other symptoms and signs involving the digestive system and abdomen

469

2214

2.18

52.09

3.6

3.3

374.48

393.03

mg/l

0.08

190

904

Chronic periodontitis, including avohilmo

2431

11100

1.41

51.42

3.5

3.3

499.09

519.80

mg/l

0.10

1174

5090

Abnormal findings on examination of blood, without diagnosis

1264

7280

1.60

51.31

3.3

3.4

383.85

566.75

mg/l

1.80

709

3535

Low back pain

1926

8940

1.47

51.24

3.0

3.5

527.57

524.36

mg/l

0.01

869

4331

Symptoms and signs involving the skin and subcutaneous tissue

1817

11801

1.47

50.97

3.8

3.3

643.43

488.99

mg/l

0.52

882

5438

Other diseases of anus and rectum

803

4563

1.79

50.52

3.5

3.2

584.89

404.26

mg/l

0.38

364

2005

Iron deficiency anaemia secondary to blood loss (chronic)

486

2359

2.13

50.44

4.0

3.2

690.53

427.56

mg/l

0.44

266

970

Cardiac arrhythmias

1302

5291

1.60

50.14

3.1

3.5

521.81

331.81

mg/l

0.76

592

2427

Orthopaedic devices associated with adverse incidents

114

251

5.27

50.13

3.0

1030.46

268.22

mg/l

0.54

100

Other anxiety disorders

1092

5720

1.65

50.06

3.2

3.4

325.52

450.17

mg/l

1.11

516

2680

Disorders of thyroid, IBD co-morbidities

393

1156

2.38

50.05

3.1

3.8

1216.46

284.62

mg/l

0.98

191

602

Other arthritis (FG)

787

4485

1.79

49.69

3.2

3.4

580.85

426.63

mg/l

0.33

386

2082

Type 1 diabetes, wide definition, subgroup 1

542

2743

2.02

49.63

4.8

3.9

707.63

382.05

mg/l

4.84

375

1357

Acute peritonitis

237

843

2.99

49.58

8.0

3.4

804.51

437.77

mg/l

1.58

190

384

Periodontitis

2421

11112

1.40

49.35

3.5

3.3

501.35

519.30

mg/l

0.08

1169

5097

Dental operations

1503

5067

1.55

47.92

3.4

3.2

470.77

577.70

mg/l

0.45

639

2540

Use of hypnotics and sedatives

2567

10689

1.39

47.80

3.5

3.3

597.54

480.46

mg/l

0.45

1249

5020

Diseases of peritoneum

323

1361

2.48

47.64

6.6

3.2

744.66

395.30

mg/l

2.03

220

585

Ulcer of lower limb, not elsewhere classified

459

2232

2.13

47.59

3.7

3.2

1108.51

359.12

mg/l

1.83

276

988

Other and unspecified dermatitis

1344

8851

1.54

47.37

4.1

3.3

627.15

448.62

mg/l

0.68

677

3978

Coxarthrosis [arthrosis of hip](FG)

1321

5887

1.57

47.25

3.0

3.3

459.38

613.41

mg/l

0.60

528

2761

Pain associated with micturition

363

1613

2.34

47.19

3.4

3.2

2444.60

416.13

mg/l

0.87

128

712

Other cataract

1103

5113

1.63

47.15

4.1

3.3

465.02

571.81

mg/l

0.46

547

2354

Other predominantly sexually transmitted diseases, not elsewhere classified

423

1997

2.18

46.96

4.6

3.2

470.27

397.76

mg/l

0.20

248

895

Other specified/unspecified arthritis

701

3932

1.82

46.82

3.2

3.5

593.76

481.61

mg/l

0.20

350

1877

Dysphagia

672

3735

1.84

46.36

2.9

3.1

1012.53

506.17

mg/l

0.64

270

1654

Soft tissue disorders

2466

9157

1.39

46.27

3.2

3.6

483.87

555.61

mg/l

0.30

1104

4641

Renal cell carcinoma of kidney

137

364

4.08

46.17

3.4

2.6

628.26

292.69

mg/l

0.71

126

Conduction disorders

777

3575

1.78

46.12

3.3

3.5

562.17

438.93

mg/l

0.24

362

1643

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

623

3340

1.88

45.96

3.1

3.3

306.82

456.88

mg/l

1.86

284

1592

Diseases of the musculoskeletal system and connective tissue

1288

4131

1.58

45.44

3.7

4.0

373.63

416.81

mg/l

0.27

612

2248

Cellulitis

619

3380

1.88

45.38

4.2

3.4

490.69

370.04

mg/l

0.79

360

1605

Dependence on enabling machines and devices, not elsewhere classified

140

6.71

45.24

13.9

6.3

535.58

276.63

mg/l

1.55

Viral infections characterized by skin and mucous membrane lesions

1088

6910

1.60

45.11

5.5

3.4

435.16

439.84

mg/l

0.02

634

3243

Pulmonary heart disease, diseases of pulmonary circulation

859

5160

1.70

44.98

4.1

3.0

871.63

531.04

mg/l

0.47

489

2208

SLE (Finngen)

134

357

4.04

44.86

5.2

3.5

347.75

316.50

mg/l

0.15

147

Hard cardiovascular diseases

1964

8186

1.43

44.63

3.5

3.6

461.51

511.06

mg/l

0.29

927

3880

Depression or dysthymia

1617

5987

1.49

44.54

3.2

3.6

468.47

502.23

mg/l

0.10

725

2974

Dermatitis and eczema

2747

12124

1.35

44.50

3.8

3.4

824.09

468.27

mg/l

1.24

1356

5686

Asthma, excluding more controls

1582

5463

1.50

44.49

3.4

3.1

597.37

586.08

mg/l

0.02

739

2444

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

952

5066

1.65

44.46

3.0

463.13

378.22

mg/l

0.73

483

1900

Peripheral artery disease

1160

5894

1.58

44.17

3.4

3.1

525.55

619.80

mg/l

0.42

626

2652

Intracranial trauma

1329

5902

1.54

44.10

3.1

3.8

702.00

458.68

mg/l

0.57

607

3084

Dorsalgia

2379

9172

1.39

44.03

3.0

3.5

409.65

519.16

mg/l

0.77

1064

4470

Adenocarcinoma and Papillary adenocarcinoma of kidney

131

6.84

43.90

3.1

175.02

217.84

mg/l

0.50

L01XE Protein kinase inhibitors

203

715

3.05

43.57

4.3

3.3

306.88

381.12

mg/l

0.37

164

311

Diseases of the eye and adnexa

1818

6325

1.45

43.38

3.7

3.5

450.78

443.03

mg/l

0.03

939

3121

Asthma (only as main-diagnosis), excluding more controls

1477

5463

1.51

43.37

3.2

3.1

618.54

586.08

mg/l

0.06

675

2444

Coagulation defects, purpura and other haemorrhagic conditions

539

2863

1.94

43.18

4.5

3.4

424.63

412.60

mg/l

0.05

328

1301

Bronchitis

2653

11860

1.35

43.15

3.8

3.2

523.60

544.86

mg/l

0.06

1362

5371

Cerebrovascular diseases

1824

8912

1.44

43.08

3.1

3.4

518.59

541.87

mg/l

0.08

888

4060

Haemorrhage from respiratory passages

906

4913

1.66

42.97

3.6

3.4

506.07

420.44

mg/l

0.38

460

2366

Amyloidosis, other/unspecified

102

233

4.93

42.56

3.2

2.9

727.21

264.50

mg/l

2.15

Any operation in hilmo

8.20

42.41

4.9

1.4

226.80

123.00

mg/l

1.41

Type 1 diabetes, wide definition

552

2966

1.90

42.31

4.8

3.8

698.84

372.46

mg/l

5.20

381

1454

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

484

2493

1.99

42.25

4.3

3.1

455.01

416.13

mg/l

0.11

283

1142

Implicit fungal Sepsis, including avohilmo

234

897

2.74

42.25

4.2

3.4

659.53

249.50

mg/l

1.59

139

360

Myalgia

613

3408

1.84

42.24

3.0

3.4

322.88

350.56

mg/l

0.23

249

1578

Pre-eclampsia or eclampsia

479

2461

1.99

42.18

3.4

3.0

574.36

392.21

mg/l

1.52

256

899

Visual impairment including blindness (binocular or monocular)

250

993

2.65

42.10

4.5

3.6

392.16

324.31

mg/l

0.73

129

433

Pregnancy hypertension

849

4594

1.68

42.07

3.1

3.0

451.26

382.77

mg/l

0.51

440

1728

Amyloidosis

115

290

4.40

42.04

3.3

3.0

705.30

240.97

mg/l

2.50

112

Renal tubulo-interstitial disorders in diseases classified elsewhere

7.80

41.84

7.8

3.3

644.50

252.46

mg/l

1.38

Symptoms and signs involving cognition, perception, emotional state and behaviour

2326

11443

1.37

41.80

3.3

3.4

423.24

522.76

mg/l

0.54

1048

5455

Familial hypercholesterolemia

431

2147

2.07

41.79

4.2

3.0

424.66

518.21

mg/l

0.39

230

898

Pre-eclampsia

447

2250

2.04

41.76

3.4

3.0

591.47

372.52

mg/l

1.99

238

826

Pre-eclampsia or poor fetal growth

631

3533

1.81

41.63

3.3

2.9

512.29

347.37

mg/l

2.08

325

1386

Atherosclerosis, excluding cerebral and coronary sclerosis

1091

5511

1.58

41.62

3.3

3.1

515.43

573.93

mg/l

0.26

570

2484

Other obstetric conditions, not elsewhere classified

626

2161

1.86

41.38

2.8

3.0

329.15

463.06

mg/l

0.70

333

869

Hyperplasia of prostate

876

2962

1.70

41.29

3.3

3.6

539.63

506.93

mg/l

0.06

414

1789

Hypothyroidism, drug reimbursement

252

672

2.67

41.26

3.9

2.9

302.58

207.27

mg/l

1.22

122

232

Abnormalities of heart beat

898

5398

1.64

41.14

3.3

3.2

1111.71

413.44

mg/l

0.78

367

2478

Microscopic polyangiitis

9.77

41.09

12.1

3.4

556.93

172.17

mg/l

2.14

Pulmonary embolism

778

4666

1.70

41.05

4.3

3.0

923.95

499.82

mg/l

0.56

448

1992

therapeutic use

139

406

3.74

41.00

3.2

3.4

892.43

277.61

mg/l

0.71

168

Glucagon-like peptide-1 (GLP-1) analogues

744

4411

1.72

40.92

3.2

3.5

463.38

375.86

mg/l

0.49

368

2042

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

744

4411

1.72

40.92

3.2

3.5

463.38

375.86

mg/l

0.49

368

2042

Diseases of oral cavity, salivary glands and jaws

1399

4817

1.51

40.90

3.5

3.2

433.96

625.82

mg/l

0.97

606

2325

Late syphilis

155

5.93

40.66

7.9

3.6

409.24

291.07

mg/l

0.73

Pulmonary heart disease

778

4680

1.70

40.60

4.3

3.0

923.95

499.27

mg/l

0.56

448

2004

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

255

695

2.64

40.56

3.0

4.1

302.78

307.65

mg/l

0.02

133

381

Substance abuse, excluding more controls

1297

7293

1.50

40.10

3.4

747.26

494.39

mg/l

0.65

656

3669

Spondylopathies

1861

7838

1.42

40.08

3.0

3.5

468.80

540.87

mg/l

0.26

797

3734

Explicit bacterial Sepsis

308

1375

2.32

39.62

4.1

3.3

465.55

318.72

mg/l

1.53

187

604

Seropositive rheumatoid arthritis

604

3394

1.81

39.43

3.2

283.72

462.34

mg/l

1.85

277

1423

Recurrent or chronic depression

904

3885

1.64

39.17

3.2

3.6

333.16

425.95

mg/l

0.85

366

1900

Explicit bacterial Sepsis, including avohilmo

312

1407

2.29

39.16

4.1

3.4

458.31

317.79

mg/l

1.48

191

617

Other noninfective gastroenteritis and colitis

657

3812

1.76

39.11

4.4

3.5

327.48

448.27

mg/l

0.83

366

1762

Intestinal adhesions without obstruction

258

1075

2.50

39.02

5.2

3.2

257.04

427.27

mg/l

1.22

159

459

Cholelithiasis, broad definition with cholecystitis

2050

9958

1.38

39.00

3.2

575.56

554.88

mg/l

0.05

906

4461

Streptococcal septicaemia

272

1161

2.44

38.99

4.1

3.3

477.01

378.90

mg/l

0.69

168

500

Other diseases of the digestive system

858

5347

1.64

38.91

3.6

3.2

881.13

433.73

mg/l

1.13

463

2431

Convulsions, not elsewhere classified

558

3051

1.84

38.83

3.5

3.4

439.37

407.56

mg/l

0.16

322

1430

Right hemicolectomy

208

788

2.80

38.73

5.3

3.1

204.44

388.10

mg/l

1.41

152

314

Hypoplasia of dental enamel , including avohilmo

158

495

3.30

38.55

13.0

6.1

241.43

313.04

mg/l

1.00

139

327

Fall on same level

2704

10921

1.33

38.53

3.4

3.5

583.89

456.61

mg/l

0.53

1254

5302

Psychiatric diseases

2299

8502

1.37

38.53

3.4

3.5

434.47

514.57

mg/l

0.37

1046

4146

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

605

2110

1.83

38.52

2.7

3.0

336.87

381.41

mg/l

0.33

319

847

Other dorsopathies, not elsewhere classified

2381

9190

1.36

38.52

3.0

3.5

463.59

518.69

mg/l

0.28

1073

4482

Polycystic ovarian syndrome, consortium definition

1568

6251

1.45

38.49

3.1

3.0

273.88

443.78

mg/l

3.16

559

2461

Asthma

1657

5975

1.44

38.39

3.3

3.1

581.80

580.57

mg/l

0.00

773

2682

Spinal stenosis

1274

6334

1.50

38.34

3.0

3.4

435.97

568.60

mg/l

0.70

524

2952

Drug-induced cataract

115

311

4.09

38.22

9.6

3.8

491.29

314.89

mg/l

0.81

133

Substance use, excluding alcohol

490

2625

1.91

38.15

3.8

3.5

410.79

423.65

mg/l

0.04

242

1286

Henoch-Schönlein purpura nephritis (HSPN)

14.56

38.15

9.2

3.0

461.21

390.26

mg/l

0.19

Asthma (only as main-diagnosis)

1541

5975

1.46

37.91

3.2

3.1

611.94

580.57

mg/l

0.06

694

2682

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

2186

12660

1.36

37.71

4.2

3.3

572.84

485.64

mg/l

0.34

1148

5897

Irritable bowel syndrome

646

3778

1.74

37.33

2.9

3.1

657.38

374.11

mg/l

0.44

247

1591

Other disorders of lacrimal gland

919

5880

1.59

37.23

3.4

3.1

766.26

393.79

mg/l

0.98

386

2490

Streptococcal septicaemia, including avohilmo

273

1192

2.38

37.16

4.1

3.3

475.13

372.00

mg/l

0.76

169

517

Enlarged lymph nodes

401

2027

2.03

37.14

3.4

3.3

359.05

351.66

mg/l

0.04

211

894

Postmenopausal osteoporosis with pathological fracture

226

911

2.62

37.09

2.3

2.7

235.95

389.53

mg/l

0.98

300

Disorders of the thyroid gland

2235

10807

1.35

36.96

3.3

614.97

524.12

mg/l

0.31

1026

5062

Cholelithiasis

1964

9810

1.38

36.95

3.1

3.2

588.89

558.13

mg/l

0.08

845

4382

Noninfectious colitis NAS

386

1933

2.06

36.92

4.4

3.4

377.88

433.35

mg/l

0.17

212

860

Molar incisor enamel hypoplasia

164

535

3.14

36.89

12.9

6.1

269.92

402.23

mg/l

0.84

142

360

Chronic periodontitis, complicated

1360

9200

1.46

36.86

3.9

3.3

677.19

475.84

mg/l

0.84

732

4205

Percutaneous Coronary Intervention

1854

8155

1.40

36.83

3.6

506.41

481.56

mg/l

0.12

848

3834

Coxarthrosis

1191

5140

1.51

36.47

3.0

3.4

422.92

553.58

mg/l

0.55

488

2496

Cough

996

6065

1.55

36.40

3.5

996.76

442.64

mg/l

0.81

447

2870

Non-invasive ventilation

523

2487

1.84

36.09

3.7

3.9

390.33

306.17

mg/l

0.80

221

1185

Drug-induced osteoporosis with pathological fracture

201

4.88

35.87

3.2

3.5

304.67

280.31

mg/l

0.08

Hernia

2186

10850

1.35

35.84

3.5

3.4

635.89

492.11

mg/l

0.38

1016

5055

Diseases of the ear and mastoid process

2653

10138

1.32

35.74

3.3

3.4

359.85

535.32

mg/l

2.12

1208

4934

Systemic lupus erythematosus

134

416

3.45

35.71

5.2

3.2

347.75

323.88

mg/l

0.11

164

Problems related to lifestyle

278

1242

2.31

35.66

3.1

3.3

286.69

399.73

mg/l

1.05

137

628

Gingivitis and periodontal diseases

2377

9232

1.34

35.58

3.6

3.4

486.30

506.02

mg/l

0.09

1118

4338

Inflammatory diseases of female pelvic organs

1372

6504

1.46

35.49

3.0

346.01

487.47

mg/l

1.08

507

2520

Noninfective enteritis and colitis

1121

7549

1.50

35.44

4.0

3.5

352.21

495.17

mg/l

1.13

591

3554

Diseases of male genital organs

1163

3880

1.53

35.40

3.9

4.1

593.01

473.70

mg/l

0.33

621

2426

Diseases of the respiratory system

1458

5064

1.46

35.33

3.5

3.1

455.71

524.17

mg/l

0.29

677

2267

Acute upper respiratory infections of multiple and unspecified sites

1807

9608

1.39

35.23

4.1

3.2

388.42

509.28

mg/l

1.17

965

4352

COPD (mode)

747

3560

1.67

35.19

3.0

348.80

538.46

mg/l

1.14

371

1550

Obesity related asthma

852

5429

1.60

35.17

3.0

3.4

627.77

438.87

mg/l

0.41

390

2486

Other joint disorders

2002

7664

1.37

35.10

3.0

3.6

604.43

501.43

mg/l

0.27

900

3895

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

394

2023

2.00

35.07

4.0

2.8

365.66

468.49

mg/l

0.39

221

772

Ischemic heart diseases

1918

8367

1.38

35.04

3.6

498.95

494.15

mg/l

0.02

891

3932

Complications of internal orthopaedic prosthetic devices, implants and grafts

604

3540

1.75

34.97

3.2

3.0

560.87

413.39

mg/l

0.46

238

1474

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

1078

4818

1.53

34.90

3.4

2.8

685.59

577.73

mg/l

0.17

466

1768

Diabetes mellitus in pregnancy

588

2119

1.79

34.72

2.9

3.0

458.61

459.01

mg/l

0.00

283

863

Coronary revascularization (ANGIO or CABG)

1841

8161

1.38

34.66

3.6

505.66

481.09

mg/l

0.12

841

3839

Chronic gastritis

682

4135

1.68

34.62

2.9

3.2

1125.83

497.27

mg/l

0.61

315

1763

Special screening examination for other diseases and disorders

272

1216

2.29

34.59

3.3

3.7

562.60

515.77

mg/l

0.09

639

Malignant neoplasm of skin

1117

5057

1.51

34.51

3.4

2.8

653.32

563.07

mg/l

0.15

495

1852

Purpura and other haemorrhagic conditions

379

1935

2.02

34.40

4.6

3.5

343.44

391.15

mg/l

0.40

236

882

Caries of dentine, including avohilmo

1896

7079

1.38

34.30

3.5

3.4

534.48

474.25

mg/l

0.22

877

3399

Major coronary heart disease event

1963

8670

1.37

34.25

3.6

510.04

509.66

mg/l

0.00

907

4083

Concussion

1119

5847

1.50

33.96

3.1

3.8

763.33

452.47

mg/l

0.61

494

3056

Late syphilis, including avohilmo

210

4.64

33.90

7.6

3.5

396.36

257.79

mg/l

1.07

Candidiasis, including avohilmo

755

4720

1.63

33.84

3.5

3.2

872.99

401.76

mg/l

0.58

368

2060

Other diseases of hard tissues of teeth

1334

4757

1.47

33.84

3.6

3.2

500.04

618.26

mg/l

0.32

601

2309

Polyarthrosis

520

2640

1.81

33.80

3.0

3.3

232.98

481.58

mg/l

2.26

181

1104

Arthropathies

2058

7708

1.36

33.76

3.3

3.7

412.34

500.22

mg/l

0.54

982

3933

GI-bleeding

836

5356

1.59

33.75

3.6

3.2

840.48

431.64

mg/l

0.98

452

2442

Other malignant neoplasms of skin (=non-melanoma skin cancer)

1038

4678

1.53

33.29

3.4

2.8

708.09

584.95

mg/l

0.19

444

1717

Conductive and sensorineural hearing loss

1879

9216

1.37

33.26

3.1

3.4

493.17

515.11

mg/l

0.07

779

4364

Other (seronegative) rheumatoid arthritis, wide

488

2732

1.83

33.21

2.9

3.1

275.56

421.24

mg/l

1.87

219

1102

Asthma (mode)

1610

6047

1.41

33.15

3.4

3.1

553.39

577.51

mg/l

0.05

741

2718

Hypothyreosis and Thyroxine purchase for inclusion criteria

2134

10525

1.34

33.11

3.4

3.3

574.95

512.53

mg/l

0.22

956

4816

Disorders of lacrimal system

1074

7164

1.50

33.02

3.3

3.2

702.82

471.41

mg/l

0.58

438

3069

Isolated proteinuria with specified morphological lesion

130

5.82

32.98

7.5

3.8

955.38

207.80

mg/l

3.01

Lower back pain or/and sciatica

2531

12121

1.31

32.95

3.0

3.4

469.13

551.86

mg/l

0.37

1139

5689

Arthropathies in other diseases classified elsewhere

132

427

3.29

32.86

5.6

3.8

506.27

583.57

mg/l

0.16

194

Hypothyroidism, other/unspecified

2051

10112

1.35

32.75

3.4

3.3

559.29

504.69

mg/l

0.19

931

4641

Malignant neoplasm of skin, including Hilmo

1151

5243

1.49

32.72

3.4

2.9

634.69

558.95

mg/l

0.13

511

1947

Primary hyperparathyroidism

312

1515

2.14

32.71

3.6

3.1

1122.85

377.54

mg/l

0.56

111

583

Diseases of pulp and periapical tissues, including avohilmo

2482

9832

1.32

32.68

3.3

3.4

513.91

557.69

mg/l

0.16

1140

4670

Other disorders of ear

2153

10519

1.33

32.43

3.2

3.5

478.08

535.66

mg/l

0.23

911

5080

Excessive, frequent and irregular menstruation

826

2766

1.62

32.42

3.1

3.2

373.49

449.62

mg/l

0.33

302

1147

Immunodeficiency with predominantly antibody defects

110

322

3.71

32.36

4.4

4.7

451.32

345.99

mg/l

0.43

152

Menorrhagia

724

2458

1.67

32.35

2.9

3.2

368.10

454.74

mg/l

0.30

233

1009

Immunodeficiencies

167

622

2.84

32.24

4.9

4.1

609.85

321.86

mg/l

0.73

105

292

Haemorrhoids and perianal venous thrombosis

808

5151

1.58

32.18

3.1

503.28

425.83

mg/l

0.32

315

2253

Personality disorders, excluding more controls

528

3035

1.76

32.17

2.8

3.3

259.78

484.00

mg/l

3.03

245

1459

Gastroduodenal ulcer

652

3971

1.67

32.12

3.4

3.1

804.02

484.23

mg/l

0.71

338

1803

SLE, ICD10

124

393

3.38

32.00

5.5

3.1

353.31

308.21

mg/l

0.22

149

SLE, strict definition

124

393

3.38

32.00

5.5

3.1

353.31

308.21

mg/l

0.22

149

Falls/tendency to fall

2460

9447

1.31

31.96

3.4

3.5

490.21

453.12

mg/l

0.15

1132

4611

Dizziness and giddiness

1776

10221

1.36

31.90

3.1

3.3

489.52

535.82

mg/l

0.15

753

4747

Fibromyalgia

233

1014

2.37

31.86

2.5

3.6

208.74

440.75

mg/l

1.39

412

Osteomyelitis

210

879

2.50

31.74

4.6

3.6

1191.11

414.85

mg/l

0.75

133

413

Viral hepatitis

205

848

2.52

31.61

4.8

3.7

315.40

427.72

mg/l

0.54

146

423

Rheumatoid arthritis, including avohilmo

906

5999

1.54

31.51

2.9

3.2

284.37

451.63

mg/l

2.55

402

2510

Emergency coronary revascularization (for ACS)

1994

9027

1.35

31.51

3.5

493.84

506.05

mg/l

0.06

908

4259

Vocal cord dysfunction

289

1199

2.16

31.49

3.6

4.0

266.50

316.23

mg/l

0.32

138

582

Diseases of pulp and periapical tissues and dental caries

1575

5806

1.41

31.47

3.5

3.3

555.67

499.66

mg/l

0.16

704

2765

Sub-endpoint used in defining T1D endpoints

707

4354

1.62

31.42

4.9

3.6

962.90

412.09

mg/l

1.80

482

2125

Dental caries, including avohilmo

1746

6539

1.38

31.38

3.5

3.3

568.72

487.64

mg/l

0.28

795

3099

Follow-up care involving plastic surgery

125

402

3.29

31.32

3.5

2.6

367.98

285.99

mg/l

0.53

146

Statin medication

1435

5737

1.42

31.25

4.1

3.1

558.74

403.17

mg/l

1.12

728

2612

Donors of organs and tissues

151

5.10

31.18

1.8

3.1

601.59

312.08

mg/l

0.94

Viral hepatitis, including avohilmo

211

891

2.46

31.07

4.8

3.6

327.81

425.71

mg/l

0.47

151

443

Maternal care for other known or suspected fetal problems

434

1454

1.90

31.06

2.5

3.2

305.03

514.36

mg/l

0.91

185

644

Chromophobe cell carcinoma of kidney

9.04

31.01

3.3

2.2

257.41

300.40

mg/l

0.18

Panic disorder

347

1778

2.00

30.97

3.0

3.2

300.02

459.30

mg/l

1.40

157

812

Diabetic retinopathy, excluding more controls

687

2347

1.68

30.77

4.8

3.1

723.79

657.06

mg/l

0.16

427

1053

Seronegative rheumatoid arthritis

298

1455

2.11

30.64

2.6

3.2

242.00

481.45

mg/l

2.06

123

597

Sensorineural hearing loss

1784

8832

1.36

30.63

3.1

3.4

539.15

527.74

mg/l

0.03

734

4166

Other acute lower respiratory infections

1300

8812

1.42

30.59

4.0

3.4

680.29

499.36

mg/l

0.32

683

4136

Follow-up examination after treatment for malignant neoplasms

235

1044

2.31

30.57

3.7

3.3

464.91

370.95

mg/l

0.17

115

511

Gingival hyperplasia

146

523

2.99

30.54

12.4

4.2

646.22

270.82

mg/l

1.17

120

276

Benign neoplasm: Sigmoid colon

499

2884

1.77

30.53

3.4

3.2

498.00

404.80

mg/l

0.34

233

1305

Hernia of abdominal wall

1091

7546

1.47

30.47

3.9

3.4

568.72

492.22

mg/l

0.20

560

3577

Supplementary factors related to causes of morbidity and mortality classified elsewhere

769

4954

1.58

30.36

3.6

3.5

892.11

445.51

mg/l

0.81

350

2341

Acute upper respiratory infections

2457

11423

1.30

30.25

3.8

3.2

439.66

571.52

mg/l

1.01

1212

5170

Failure and rejection of transplanted organs and tissues

156

5.02

30.16

7.8

4.8

505.73

262.67

mg/l

1.86

Disorders of eyelid, lacrimal system and orbit

2044

11394

1.33

30.13

3.3

572.61

539.07

mg/l

0.10

877

5314

Malignant neoplasm of rectosigmoid junction, including Hilmo

110

337

3.50

30.06

7.2

2.6

244.70

296.72

mg/l

0.52

117

Other viral hepatitis

178

709

2.62

29.80

4.7

3.8

312.66

413.45

mg/l

0.40

127

360

Amputation

296

1460

2.10

29.74

4.1

3.2

651.80

386.47

mg/l

2.67

171

654

Other diseases of liver

453

2565

1.81

29.68

3.7

3.4

378.45

415.17

mg/l

0.19

220

1139

Other/unspecified dorsalgia

882

5801

1.52

29.68

3.0

3.4

336.65

528.03

mg/l

1.84

361

2676

Diabetic retinopathy, strict definition

481

2454

1.79

29.67

5.3

3.3

719.81

555.40

mg/l

0.85

337

1234

Pleural effusion

419

2321

1.85

29.66

3.5

3.1

454.23

479.55

mg/l

0.09

252

1045

Injuries to the head

2625

12211

1.28

29.66

3.4

680.54

463.43

mg/l

0.95

1272

5770

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

388

2101

1.90

29.58

3.1

3.6

366.48

388.82

mg/l

0.15

220

1032

Idiopathic gout

270

1296

2.16

29.28

4.2

3.4

1331.46

422.56

mg/l

0.73

155

605

Gastric ulcer

454

2587

1.80

29.10

3.5

3.1

965.52

495.08

mg/l

0.71

225

1148

Visual disturbances and blindness

1266

9061

1.41

29.00

3.5

3.3

414.34

463.96

mg/l

0.28

582

4126

Fracture of lumbar spine and pelvis

595

3643

1.66

28.95

3.0

3.1

549.69

506.29

mg/l

0.06

284

1529

Weight loss

304

1531

2.06

28.93

3.1

3.6

489.89

357.23

mg/l

0.33

145

682

Urolithiasis

784

5136

1.55

28.77

3.3

3.4

610.01

491.45

mg/l

0.23

394

2484

Carpal tunnel syndrome

1392

8758

1.39

28.74

3.2

3.3

579.27

520.86

mg/l

0.20

525

4028

DVT of lower extremities

474

2746

1.77

28.70

4.2

3.1

1011.81

335.39

mg/l

1.13

228

1192

Systemic lupus erythematosus, unspecified

110

347

3.40

28.70

5.1

3.3

341.22

285.27

mg/l

0.27

132

Other diseases of blood and blood-forming organs, wide

548

3302

1.70

28.69

4.4

3.3

472.78

388.21

mg/l

0.36

342

1477

Other disorders of veins

938

6270

1.49

28.67

2.7

3.2

647.41

479.55

mg/l

0.32

374

2656

Dorsopathies

2366

9278

1.30

28.66

3.0

3.6

391.02

515.00

mg/l

1.00

1072

4560

Acute sinusitis

1160

7432

1.43

28.66

3.8

3.2

469.68

462.44

mg/l

0.03

572

3359

Sulfasalazine

624

3879

1.63

28.65

3.0

3.2

356.90

396.16

mg/l

0.17

308

1735

Benign neoplasm: Transverse colon

309

1571

2.04

28.64

3.1

3.3

1233.83

409.39

mg/l

0.67

161

707

Other viral hepatitis, including avohilmo

182

748

2.53

28.50

4.7

3.8

329.73

424.43

mg/l

0.37

130

379

Diseases of external ear

871

5851

1.51

28.33

3.7

3.4

301.82

490.40

mg/l

2.65

395

2742

AV-block

461

2256

1.78

28.23

3.3

3.4

730.91

503.62

mg/l

0.28

222

1031

Basal cell carcinoma, including Hilmo

1015

4701

1.48

28.23

3.3

2.8

545.28

583.48

mg/l

0.07

434

1715

Other viral diseases

663

4184

1.60

28.15

5.1

3.8

810.98

400.55

mg/l

1.20

417

2084

Other gastritis (incl. Duodenitis)

538

3243

1.69

28.07

3.4

3.2

687.82

515.71

mg/l

0.26

278

1446

Diabetic neuropathy

348

1849

1.94

28.01

5.0

3.4

627.36

604.35

mg/l

0.08

225

952

Amputation of toe

221

999

2.31

28.01

4.1

3.1

721.98

433.93

mg/l

1.87

127

450

Charcot foot

195

4.31

27.99

7.1

3.7

630.85

202.22

mg/l

3.94

Methotrexate

331

1731

1.96

27.97

2.9

3.0

270.97

439.03

mg/l

1.66

149

717

Cutaneous abscess, furuncle and carbuncle

620

3875

1.63

27.93

4.3

3.4

439.61

364.55

mg/l

0.83

381

1820

Type of accident

711

4593

1.57

27.80

3.6

3.5

929.28

435.84

mg/l

0.82

318

2155

Peripheral artery operations in Hilmo

342

1814

1.94

27.75

4.0

3.2

617.81

490.79

mg/l

0.53

193

833

Exposure to unspecified factor

2382

12694

1.29

27.74

3.5

3.4

738.17

486.25

mg/l

0.81

1194

5967

Generalized anxiety disorder

375

2042

1.87

27.70

2.8

3.3

217.71

430.72

mg/l

3.31

140

955

Paracetamol or NSAID medication

394

1051

1.92

27.61

3.5

5.1

278.74

314.62

mg/l

0.36

188

646

Other pleural conditions

297

1508

2.04

27.61

3.6

3.4

1105.35

416.23

mg/l

0.81

159

669

Other obstructive and reflux uropathy

129

454

2.98

27.57

3.8

3.3

2131.86

385.09

mg/l

0.49

188

Allergic purpura

114

377

3.23

27.47

5.4

3.9

388.83

285.89

mg/l

0.78

168

Hypothyroidism, strict autoimmune, 3 medication purchases required

1905

9759

1.32

27.34

3.4

3.2

494.86

484.73

mg/l

0.04

836

4379

Injuries to the abdomen, lower back, lumbar spine and pelvis

996

6815

1.46

27.24

3.2

3.3

464.85

557.66

mg/l

0.22

463

3076

Stroke, including SAH

1499

7942

1.37

27.23

3.0

3.3

556.70

568.19

mg/l

0.03

729

3601

Fibrosis and cirrhosis of liver

229

1062

2.24

27.22

3.2

3.4

498.43

405.42

mg/l

0.19

138

458

Supervision of high-risk pregnancy

357

1120

1.95

27.20

3.0

3.2

292.63

607.88

mg/l

0.94

183

429

Wegener granulomatosis

196

4.31

27.16

7.3

3.4

345.93

278.65

mg/l

0.36

Infections of genitourinary tract in pregnancy

223

1021

2.25

27.11

3.1

2.9

287.47

366.77

mg/l

0.40

105

394

Speech and linguistic disorders, excluding more controls

215

907

2.29

26.96

5.4

5.0

234.15

462.62

mg/l

2.13

136

497

Acute nephritic syndrome

252

3.80

26.87

10.5

3.9

878.05

195.66

mg/l

2.39

114

Calculus of kidney and ureter

718

4692

1.56

26.72

3.3

3.4

618.82

506.44

mg/l

0.20

363

2267

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

623

3941

1.60

26.62

3.1

3.3

306.82

416.34

mg/l

1.55

284

1858

Unspecified nephritic syndrome

273

3.66

26.61

7.9

3.8

1045.06

231.99

mg/l

1.86

118

Chronic viral hepatitis

149

576

2.70

26.60

4.6

3.8

343.25

439.47

mg/l

0.30

108

293

Stroke, excluding SAH

1433

7618

1.37

26.49

3.0

3.3

558.16

538.93

mg/l

0.05

691

3447

Abnormal weight loss

277

1395

2.06

26.43

2.8

3.6

326.95

359.52

mg/l

0.20

126

618

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

108

353

3.21

26.33

7.4

4.2

786.65

512.33

mg/l

0.58

180

Laparoscopic right hemicolectomy

190

830

2.41

26.30

4.5

3.2

383.98

373.03

mg/l

0.02

117

335

Benign neoplasm: Ascending colon

379

2117

1.84

26.25

3.5

3.1

385.16

406.36

mg/l

0.10

183

924

Peripheral arterial reconstruction

449

2634

1.75

26.13

3.2

3.1

522.12

541.92

mg/l

0.06

241

1175

Other viral diseases, including avohilmo

837

5619

1.49

25.87

4.6

3.7

730.59

385.12

mg/l

1.21

501

2764

Urticaria and erythema

824

5582

1.50

25.67

3.5

622.55

400.28

mg/l

0.52

391

2550

Basal cell carcinoma

972

4584

1.46

25.61

3.3

2.8

575.46

589.97

mg/l

0.02

410

1667

Other intervertebral disc disorders

1840

8378

1.32

25.60

2.9

3.4

360.37

524.18

mg/l

1.18

763

4003

Undetermined asthma, excluding more controls

305

1598

1.95

25.55

3.5

2.9

560.08

491.79

mg/l

0.11

125

648

Mycoses, including avohilmo

2118

12622

1.29

25.36

3.3

3.4

799.00

458.45

mg/l

1.02

969

5995

Secondary uncertain malignant neoplasm

324

1740

1.91

25.34

3.3

2.6

368.13

503.96

mg/l

0.46

190

659

Rheumatism, unspecified

317

1691

1.92

25.31

3.1

3.3

247.72

333.94

mg/l

0.70

676

Other diseases of pericardium

139

534

2.73

25.23

4.4

3.9

503.83

345.28

mg/l

0.59

238

Mycoses

665

4328

1.56

25.22

4.1

3.3

997.53

415.72

mg/l

1.13

355

1969

Other diseases of intestine

375

2109

1.82

25.22

4.1

3.2

326.07

418.43

mg/l

0.85

242

965

Symptoms and signs involving the nervous and musculoskeletal systems

1361

10093

1.36

25.18

2.8

3.5

408.06

469.88

mg/l

0.35

545

4753

Cytomegalovirus infection, IBD co-morbidity

278

3.53

25.13

8.6

4.0

1005.46

290.71

mg/l

1.10

138

Gonarthrosis [arthrosis of knee](FG)

1569

6753

1.35

25.08

2.9

3.4

514.78

622.37

mg/l

0.24

620

3205

Sequelae of cerebrovascular disease

904

5335

1.47

25.01

3.0

3.1

1018.09

563.06

mg/l

0.57

420

2387

Acidosis

260

3.62

24.88

4.2

3.7

1875.75

223.80

mg/l

0.64

113

Ischaemic heart disease, wide definition

1724

8075

1.33

24.86

3.4

429.11

512.47

mg/l

0.62

815

3666

Gout due to impairment of renal function

139

4.89

24.81

8.4

2.9

378.96

275.35

mg/l

0.85

Cytomegaloviral disease

280

3.50

24.81

8.6

4.2

1005.46

274.24

mg/l

1.14

140

Other arrhythmias

1336

7342

1.37

24.81

2.7

3.5

698.55

427.46

mg/l

0.67

531

3329

Other external causes of accidental injury

1829

6992

1.32

24.79

3.3

3.6

399.48

465.19

mg/l

0.39

825

3355

Disorders of skin appendages

1105

7910

1.40

24.67

4.2

3.4

339.56

437.78

mg/l

1.16

576

3677

Viral pneumonia

328

1784

1.88

24.67

4.7

3.1

565.86

335.86

mg/l

0.73

197

811

Other skin changes

504

3096

1.66

24.58

4.9

3.2

830.11

447.21

mg/l

0.59

241

1364

Abnormal findings on antenatal screening of mother

166

701

2.43

24.34

2.6

2.9

282.04

292.39

mg/l

0.06

302

Other female pelvic inflammatory diseases

354

1979

1.83

24.32

2.4

3.0

347.83

418.90

mg/l

0.39

118

720

Other renal tubulo-interstitial diseases

224

3.75

24.27

5.8

2.9

405.30

237.59

mg/l

1.09

Diseases of the myoneural junction and muscle

327

1792

1.88

24.13

3.1

3.3

493.24

388.49

mg/l

0.29

165

818

Familial hypercholesterolemia, with ischemic heart disease

268

1379

2.01

24.12

3.8

3.0

416.01

509.77

mg/l

0.30

139

610

Benign neoplasm: Caecum

298

1588

1.94

24.12

3.6

3.1

310.45

449.10

mg/l

1.18

144

696

Substance abuse

1297

8919

1.36

24.05

3.4

747.26

457.44

mg/l

0.80

656

4468

Other follicular disorders

203

942

2.23

24.03

5.0

3.5

337.45

331.52

mg/l

0.02

113

444

Insulin, fast-acting (human)

320

1740

1.88

24.03

5.4

3.2

724.91

366.00

mg/l

3.94

233

795

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

238

1174

2.09

23.99

4.2

3.4

352.11

374.06

mg/l

0.12

125

510

Phlebitis and thrombophlebitis (not including DVT)

525

3275

1.63

23.99

4.1

3.2

631.07

344.86

mg/l

0.98

240

1411

Cytomegaloviral disease, including avohilmo

286

3.42

23.98

8.6

4.1

1005.46

273.26

mg/l

1.14

141

Migraine

1059

5881

1.41

23.92

3.2

3.5

285.78

420.80

mg/l

2.25

449

2720

Fissure and fistula of anal and rectal regions

523

3265

1.63

23.73

3.2

619.55

376.61

mg/l

0.69

223

1497

Tobacco use

162

690

2.45

23.66

2.7

3.5

330.21

385.60

mg/l

0.24

312

Other neurological diseases

1682

10013

1.31

23.64

3.2

3.3

629.01

541.70

mg/l

0.23

759

4581

Viral and other specified intestinal infections, including avohilmo

624

3903

1.56

23.57

4.9

3.3

530.71

415.00

mg/l

0.49

358

1861

Asthma, hospital admission 2, infections

1391

10186

1.34

23.55

3.5

369.92

528.60

mg/l

1.27

672

4786

Asthma-related infections

1391

10186

1.34

23.55

3.5

369.92

528.60

mg/l

1.27

672

4786

Mental and behavioural disorders due to tobacco

230

1129

2.10

23.54

4.2

3.3

572.52

379.05

mg/l

0.35

103

516

Congenital malformations of gallbladder, bile ducts and liver

137

4.84

23.50

5.6

6.8

138.67

403.53

mg/l

2.40

False labour

502

1887

1.67

23.50

2.5

3.2

241.81

489.98

mg/l

1.55

197

824

Poisoning by drugs, medicaments and biological substances

513

3196

1.63

23.49

3.4

3.5

271.84

432.32

mg/l

2.72

238

1522

Early onset COPD, excluding more controls

435

2599

1.70

23.41

3.3

3.1

316.44

531.45

mg/l

1.20

228

1223

Hepatic failure, not elsewhere classified

128

492

2.75

23.39

3.5

394.54

271.85

mg/l

0.85

211

Elevated blood glucose level

237

1180

2.08

23.37

3.7

3.8

398.96

458.32

mg/l

0.27

148

523

Failed induction of labour

133

517

2.65

23.36

2.4

3.0

418.63

368.15

mg/l

0.18

231

Hypoparathyroidism

122

459

2.81

23.26

2.7

3.1

377.40

463.18

mg/l

0.16

173

Acquired haemolytic anaemia

318

3.25

23.24

4.7

3.6

643.66

286.21

mg/l

1.44

141

Mental and behavioural disorders due to psychoactive substance use

1329

9089

1.35

23.24

3.4

733.84

455.56

mg/l

0.78

674

4541

Undetermined asthma

305

1651

1.89

23.17

3.5

2.9

560.08

496.27

mg/l

0.10

125

678

Malignant neoplasm of rectosigmoid junction

195

3.96

23.11

7.3

2.6

230.13

315.20

mg/l

0.75

Fungal Sepsis

134

530

2.65

23.02

4.9

3.6

855.88

245.85

mg/l

1.62

226

Congenital malformations, deformations and chromosomal abnormalities

1243

8728

1.36

22.98

4.3

3.5

626.47

421.14

mg/l

0.65

680

4113

Small fibre neuropathy

111

401

2.96

22.97

3.4

3.9

390.00

289.87

mg/l

0.47

184

Implicit fungal Sepsis

124

473

2.76

22.92

4.9

3.6

914.10

246.16

mg/l

1.63

200

Malignant neoplasm of bladder, including Hilmo

289

1526

1.92

22.89

3.1

2.6

1319.36

518.78

mg/l

0.40

161

611

Accidents

1811

6992

1.31

22.89

3.3

3.6

397.10

465.19

mg/l

0.41

823

3355

Myocardial infarction, without ST-elevation

976

6281

1.42

22.87

3.1

3.2

530.60

571.68

mg/l

0.16

480

2887

309

1688

1.87

22.86

3.9

3.3

390.50

467.48

mg/l

0.33

177

801

Other/unspecified seropositive rheumatoid arthritis

598

3890

1.56

22.83

3.2

3.1

280.47

433.32

mg/l

2.56

274

1585

Smoking dependency

230

1144

2.08

22.73

4.2

3.3

572.52

374.03

mg/l

0.37

103

525

Other/unspecified cytomegaloviral diseases

251

3.55

22.68

8.9

4.1

1113.51

249.58

mg/l

1.23

126

Seropositive rheumatoid arthritis, wide

604

3944

1.56

22.67

3.2

3.1

283.72

433.40

mg/l

2.52

277

1606

Vitreous haemorrhage

271

1429

1.95

22.63

6.1

3.1

723.87

380.67

mg/l

2.46

192

615

Ventral hernia

571

3688

1.58

22.53

4.0

3.1

752.31

514.50

mg/l

0.37

298

1656

Viral warts

256

1326

1.99

22.48

6.0

3.6

336.73

380.81

mg/l

0.23

168

612

Cardiomyopathy in other diseases

7.53

22.48

2.2

3.0

596.43

243.61

mg/l

0.93

Chronic ulcer of skin, not elsewhere classified

203

971

2.17

22.38

3.2

816.99

352.22

mg/l

1.25

117

412

Non-Hodgkin lymphoma, all, including Hilmo

303

1661

1.87

22.29

2.8

2.7

633.21

499.38

mg/l

0.28

158

633

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

587

3824

1.56

22.28

3.1

274.75

438.34

mg/l

2.81

270

1554

All influenza (not pneumonia)

344

1960

1.79

22.17

5.2

3.3

347.82

366.26

mg/l

0.10

198

930

Injuries to the thorax

1079

7877

1.38

22.13

3.2

3.4

538.80

501.04

mg/l

0.09

498

3755

Selective serotonin reuptake inhibitors

2248

9310

1.26

21.95

3.2

3.5

489.92

486.74

mg/l

0.01

1032

4562

Cyst of kidney

207

1006

2.14

21.93

3.1

405.29

444.44

mg/l

0.15

112

424

Gestational [pregnancy-induced] hypertension

462

2848

1.64

21.86

2.7

3.0

378.33

313.90

mg/l

0.48

245

1089

Arthrosis

1496

6208

1.33

21.86

2.9

3.5

327.90

539.82

mg/l

1.90

609

3051

Ischaemic Stroke, excluding all haemorrhages

1326

7325

1.35

21.85

3.1

3.3

583.49

549.25

mg/l

0.09

622

3306

Single delivery by caesarean section

324

1004

1.87

21.80

2.9

3.5

321.96

543.81

mg/l

0.61

167

433

Postpartum care and examination

235

722

2.08

21.74

2.9

3.1

304.89

668.74

mg/l

0.66

117

273

Diabetic retinopathy

879

3822

1.45

21.67

4.5

3.3

712.87

600.82

mg/l

0.49

535

1914

Myocardial infarction

1129

5781

1.38

21.62

3.2

3.3

451.64

480.59

mg/l

0.14

565

2706

Viral pneumonia (known virus, not influenza)

109

404

2.88

21.53

6.7

3.9

231.39

335.61

mg/l

1.22

188

Tubulo-interstitial nephritis, not specified as acute or chronic

167

749

2.30

21.50

4.0

2.8

449.16

332.50

mg/l

0.44

272

Cholecystectomy

1577

10347

1.31

21.43

3.2

391.18

541.78

mg/l

1.18

689

4573

Major coronary heart disease event excluding revascularizations

1374

6842

1.34

21.42

3.3

478.52

523.58

mg/l

0.22

670

3176

Phobic anxiety disorders

288

1569

1.87

21.32

3.8

435.03

475.16

mg/l

0.13

137

757

Fracture of rib(s), sternum and thoracic spine

735

5060

1.47

21.31

3.1

3.3

559.38

503.10

mg/l

0.09

319

2382

Ovarian cyst

687

2616

1.52

21.29

2.9

3.1

370.88

451.36

mg/l

0.33

274

1068

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

578

3744

1.55

21.19

5.3

3.4

354.23

391.61

mg/l

0.32

343

1778

Epilepsy

691

4687

1.49

21.17

3.5

3.7

318.18

429.53

mg/l

1.30

367

2317

Bipolar affective disorders

388

2315

1.70

21.13

3.3

656.16

450.09

mg/l

0.21

186

1087

Calcific aortic valvular stenosis, including rheumatic fever

740

4913

1.47

21.04

3.3

3.0

636.33

610.22

mg/l

0.04

374

2194

Migraine without aura

412

2500

1.67

20.97

3.1

3.7

283.91

427.02

mg/l

1.51

178

1174

Exclusions for E4_PCOS_CONSORTIUM

1517

7253

1.32

20.96

3.1

3.4

410.71

449.36

mg/l

0.18

659

3131

Acute bronchitis

960

6808

1.40

20.95

3.9

3.3

773.31

539.14

mg/l

0.30

495

3108

Calcific aortic valvular stenosis, diagnosis (helper)

737

4901

1.47

20.90

3.3

3.0

637.66

610.16

mg/l

0.04

372

2186

Operations 2 for CAVS

737

4901

1.47

20.90

3.3

3.0

637.66

610.16

mg/l

0.04

372

2186

Calcific aortic valvular stenosis, operated

738

4912

1.47

20.84

3.3

3.1

639.23

610.41

mg/l

0.04

373

2197

Calcific aortic valvular stenosis

738

4912

1.47

20.84

3.3

3.1

639.23

610.41

mg/l

0.04

373

2197

Use of pramipexole

522

3369

1.58

20.77

3.3

3.1

472.24

435.35

mg/l

0.17

213

1425

External causes of morbidity and mortality

1419

5377

1.33

20.65

3.3

3.6

479.91

439.71

mg/l

0.16

637

2592

Localized swelling, mass and lump of skin and subcutaneous tissue

729

5044

1.47

20.57

3.3

382.32

447.93

mg/l

0.34

337

2294

Mental and behavioural disorders due to opioids

105

389

2.81

20.49

3.1

3.9

269.05

412.59

mg/l

0.54

202

Other diseases of upper respiratory tract

2505

10608

1.24

20.46

3.4

363.48

581.48

mg/l

2.42

1109

5134

Other disorders starting during childhood or adolecense, excluding more controls

132

519

2.51

20.45

5.7

6.2

261.31

485.56

mg/l

1.33

316

Endometriosis

658

2549

1.52

20.41

2.9

3.1

294.29

455.14

mg/l

1.58

240

1041

Disorders of synovium and tendon

1163

7359

1.35

20.33

3.4

3.5

554.31

535.74

mg/l

0.04

482

3599

Unspecified fall

1206

8908

1.34

20.32

3.5

711.35

519.20

mg/l

0.48

585

4153

Cardiomyopathy

391

2364

1.68

20.30

2.8

3.5

375.42

456.23

mg/l

0.34

216

1146

Disease of hard tissues of teeth, NOS

1182

4573

1.37

20.28

3.1

3.2

533.28

595.70

mg/l

0.13

493

2219

Other CVD

509

3287

1.58

20.20

3.2

3.1

1320.61

467.97

mg/l

0.77

253

1423

Other and unspecified drugs and medicaments

223

1146

2.01

20.16

4.1

3.4

350.48

414.00

mg/l

0.32

118

491

Spontaneous rupture of synovium and tendon

211

1064

2.04

20.10

3.1

3.5

379.75

478.61

mg/l

0.42

471

Acute suppurative otitis media

547

3334

1.55

20.10

4.9

3.6

454.46

437.87

mg/l

0.06

320

1676

Hepatocellular carcinoma, including Hilmo

350

2.93

20.06

3.8

2.9

361.54

289.52

mg/l

0.29

133

Other specified/unspecified necrotizing vasculopathies

167

4.01

20.06

3.1

3.4

445.06

282.58

mg/l

0.78

Diabetic maculopathy

339

1875

1.76

19.97

5.6

3.3

775.22

595.40

mg/l

0.68

253

936

Fracture of femur

675

4162

1.48

19.95

3.1

3.0

739.74

587.47

mg/l

0.22

309

1770

Viral and other specified intestinal infections

467

2888

1.60

19.91

5.4

3.4

372.00

408.58

mg/l

0.25

294

1397

Diaphragmatic hernia

827

5891

1.42

19.90

3.3

3.2

761.23

487.05

mg/l

0.31

381

2556

Urticaria

648

4412

1.49

19.85

3.5

630.33

413.14

mg/l

0.38

296

2031

Coxarthrosis, primary

1383

8814

1.32

19.82

2.9

3.2

446.99

611.49

mg/l

0.77

542

3981

Diseases of middle ear and mastoid

1233

7601

1.34

19.79

3.7

3.4

643.31

458.49

mg/l

0.34

631

3622

Candidiasis

341

2005

1.74

19.78

4.0

3.3

671.82

405.69

mg/l

0.74

185

848

Sulfonylureas

793

4434

1.44

19.78

3.5

3.1

902.97

577.23

mg/l

0.60

418

1940

Other viral diseases, not elsewhere classified

421

2604

1.64

19.75

5.4

4.0

924.40

406.15

mg/l

0.94

265

1275

Hypocalcemia

327

3.02

19.74

5.9

3.4

1745.93

246.73

mg/l

0.65

142

Degeneration of macula and posterior pole

1156

6676

1.35

19.69

3.0

3.1

772.56

593.23

mg/l

0.34

508

2880

Exclusions for E4_PCOS_BROAD

408

2514

1.65

19.68

4.0

304.21

431.24

mg/l

1.49

218

1260

Other disorders of penis

243

1293

1.93

19.68

3.8

4.2

329.65

525.90

mg/l

0.78

138

805

Abnormal results of function studies

227

1183

1.97

19.67

3.6

334.65

379.98

mg/l

0.17

116

543

Cirrhosis of liver, NAS

164

762

2.25

19.63

3.1

3.4

330.51

369.52

mg/l

0.16

106

335

Other and unspecified urticaria

444

2796

1.62

19.62

3.5

3.6

300.48

443.48

mg/l

1.64

194

1282

Benign neoplasm of urinary organs

143

628

2.38

19.60

2.9

3.3

346.77

300.82

mg/l

0.32

253

Convalescence

136

583

2.42

19.57

2.6

2.7

350.71

381.77

mg/l

0.09

232

Inflammatory diseases of prostate (prostatitis)

294

1663

1.81

19.57

2.8

3.5

733.98

576.44

mg/l

0.15

115

995

Non-selective monoamine reuptake inhibitors

813

5548

1.42

19.55

2.9

3.3

842.78

507.71

mg/l

0.53

276

2443

Pericarditis

104

394

2.76

19.50

4.0

3.7

982.98

230.96

mg/l

1.17

186

Misadventures to patients during surgical and medical care

340

2006

1.73

19.49

4.2

3.1

356.69

418.41

mg/l

0.42

184

859

Zoster [herpes zoster]

454

2882

1.61

19.46

5.2

3.1

448.81

376.76

mg/l

0.25

239

1223

Gestational diabetes (for exclusion)

619

2849

1.51

19.40

2.5

3.0

384.57

423.67

mg/l

0.18

288

1182

Nonhereditary hypogammaglobulinemia

113

4.68

19.34

4.5

4.1

487.00

216.19

mg/l

0.94

Respiratory insufficiency

202

1014

2.04

19.30

3.0

2.7

350.09

716.04

mg/l

0.79

427

Disorders of psychological development

295

1551

1.80

19.21

5.0

4.7

267.16

422.62

mg/l

1.83

185

862

Other diseases of lip and oral mucosa

932

6812

1.38

19.19

3.5

3.3

1135.47

424.97

mg/l

0.87

394

3066

Otitis externa

523

3439

1.55

19.10

4.1

3.5

292.00

408.31

mg/l

1.79

260

1632

Paroxysmal tachycardia

408

2086

1.65

19.09

3.1

3.2

672.09

380.34

mg/l

0.34

200

891

Injuries to the hip and thigh

1140

7689

1.34

19.09

3.0

3.3

580.96

594.77

mg/l

0.03

519

3447

Other local infections of skin and subcutaneous tissue

262

1444

1.86

19.09

5.6

3.5

405.44

407.98

mg/l

0.01

154

653

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

455

2514

1.60

19.06

3.8

4.0

598.34

411.72

mg/l

0.27

249

1389

Sicca syndrome [Sjögren]

209

1072

2.01

19.03

2.8

3.2

348.63

398.09

mg/l

0.17

405

Leisure time condition

430

2715

1.61

18.85

3.4

1182.68

429.41

mg/l

0.74

189

1240

Coronary atherosclerosis

1419

6906

1.31

18.76

3.4

458.77

501.76

mg/l

0.24

701

3180

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

1348

9476

1.31

18.71

4.1

3.4

610.08

438.08

mg/l

0.54

714

4461

Benign neoplasm: Colon, unspecified

597

4055

1.50

18.70

3.5

3.1

547.89

537.78

mg/l

0.02

282

1818

Other noninflammatory disorders of uterus, except cervix

441

1842

1.62

18.67

3.1

431.61

459.73

mg/l

0.06

156

717

Gonarthrosis

1332

5745

1.32

18.62

2.9

3.5

545.59

554.49

mg/l

0.02

550

2807

Other respiratory disorders and diseases

492

3220

1.56

18.43

3.6

3.2

683.55

458.83

mg/l

0.32

241

1468

Other diseases of the respiratory system

492

3220

1.56

18.43

3.6

3.2

683.55

458.83

mg/l

0.32

241

1468

Hypotension

446

2858

1.59

18.40

3.1

3.0

1449.25

489.12

mg/l

0.77

224

1224

Pain and other conditions associated with female genital organs and menstrual cycle

408

2121

1.63

18.38

2.9

3.2

271.56

376.74

mg/l

1.33

155

900

Other and unspecified myopathies

233

1256

1.91

18.31

3.1

3.4

574.55

414.51

mg/l

0.31

114

557

Mental and behavioural disorders due to use of other stimulants, including caffeine

278

3.05

18.27

3.7

248.64

441.86

mg/l

0.62

155

Other and unspecified local infections of skin and subcutaneous tissue

248

1363

1.87

18.27

5.7

3.6

419.73

407.82

mg/l

0.04

146

614

Other infective otitis externa

166

796

2.16

18.27

4.2

3.4

255.92

319.61

mg/l

0.60

343

Agranulocytosis

271

1530

1.82

18.26

5.6

3.4

406.67

394.07

mg/l

0.03

178

647

Malignant neoplasm of brain

379

2.73

18.22

6.8

4.0

172.98

322.31

mg/l

2.14

155

Other/unspecified rheumatoid arthritis

299

1738

1.76

18.20

3.0

317.05

380.90

mg/l

0.45

127

684

Other maternal disorders predominantly related to pregnancy

1015

4688

1.37

18.18

3.1

334.45

427.54

mg/l

0.75

443

1772

Asthma (diagnoses ohter than nonallergic)

1957

12779

1.24

18.11

3.3

3.4

597.53

530.60

mg/l

0.19

872

6054

Benign neoplasm: Kidney

113

464

2.56

18.11

2.6

3.3

313.29

333.23

mg/l

0.10

187

Abnormal findings on diagnostic imaging of other body structures

336

2020

1.70

18.00

3.2

330.63

468.82

mg/l

0.90

171

835

Suicide or other Intentional self-harm

501

3305

1.54

18.00

3.4

283.78

439.64

mg/l

2.34

220

1567

Disorders of adult personality and behaviour

567

3836

1.50

17.98

2.8

3.5

534.47

429.77

mg/l

0.15

273

1842

Nonalcoholic fatty liver disease

236

1284

1.88

17.94

3.5

326.99

438.12

mg/l

0.55

111

597

Pregnancy examination and test

251

838

1.88

17.74

2.9

3.1

411.59

619.70

mg/l

0.37

104

320

Cholangitis (primary sclerosing, PSC)

174

860

2.09

17.68

3.9

3.8

309.28

293.73

mg/l

0.06

111

389

Other viral diseases, not elsewhere classified, including avohilmo

575

3892

1.49

17.64

4.7

3.8

794.95

385.87

mg/l

0.95

340

1913

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

739

5275

1.42

17.63

3.3

3.5

792.16

399.36

mg/l

0.65

340

2361

Haemolytic anaemias

113

470

2.53

17.63

5.2

4.1

563.49

417.76

mg/l

0.38

222

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

378

2353

1.63

17.54

3.4

3.0

500.49

404.26

mg/l

0.22

147

946

Injuries to the knee and lower leg

2676

12034

1.21

17.52

3.2

3.5

354.56

545.13

mg/l

2.67

1234

5727

Poisoning by medicine

442

2856

1.57

17.48

3.3

3.4

253.21

431.88

mg/l

3.07

203

1350

Nonsuppurative otitis media

508

2925

1.53

17.37

4.0

3.5

862.76

403.80

mg/l

0.42

289

1436

Other headache syndromes

849

6194

1.38

17.27

2.8

3.3

944.45

438.23

mg/l

0.57

370

2753

Later onset COPD, excluding more controls

492

2469

1.54

17.24

2.7

2.8

495.94

564.37

mg/l

0.16

234

1037

Other complications of surgical and medical care, not elsewhere classified

232

1273

1.87

17.18

3.6

3.2

593.17

351.80

mg/l

0.56

124

525

Acetic acid derivatives and related substances

622

2186

1.49

17.16

3.0

4.0

506.91

516.89

mg/l

0.02

274

1212

Other congenital malformations of urinary system

5.87

17.13

9.8

7.6

239.64

236.95

mg/l

0.01

Other symptoms and signs involving the nervous and musculoskeletal systems

915

6790

1.36

17.13

2.8

3.4

412.97

475.77

mg/l

0.29

346

3191

Mixed hyperlipidaemia

112

469

2.49

17.12

3.9

3.1

520.81

409.24

mg/l

0.31

192

993

7401

1.34

17.06

3.4

3.6

393.74

414.19

mg/l

0.09

483

3510

Exposure to other specified factors

1774

12276

1.25

17.05

3.4

3.5

719.35

443.63

mg/l

0.85

834

5906

Injury, poisoning and certain other consequences of external causes

1169

4436

1.33

17.02

3.4

3.6

385.01

375.98

mg/l

0.04

532

2136

Disorders of sclera, cornea, iris and ciliary body

1192

9196

1.31

16.96

3.6

3.3

710.61

490.12

mg/l

0.56

569

4285

Malignant neoplasm of eye, brain and central nervous system

118

508

2.41

16.93

6.3

3.7

193.41

427.45

mg/l

1.09

198

Vascular disorders of the intestines

172

859

2.06

16.91

3.3

2.9

371.19

334.79

mg/l

0.26

356

Decubitus ulcer and pressure area

175

882

2.05

16.87

3.4

3.2

500.71

349.89

mg/l

0.88

107

370

Malignant immunoproliferative diseases

127

4.20

16.69

2.0

3.3

1013.03

254.35

mg/l

0.53

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

168

836

2.07

16.69

5.5

3.3

183.64

428.30

mg/l

2.26

121

323

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

145

682

2.18

16.65

3.8

3.2

475.38

388.77

mg/l

0.26

243

Budesonide

301

1794

1.71

16.64

3.4

3.1

259.29

481.51

mg/l

2.71

134

790

Acquired absence of limb

4.66

16.62

4.0

3.9

601.39

248.59

mg/l

1.59

Fracture of lower leg, including ankle

1211

9210

1.30

16.61

3.6

3.4

525.86

566.15

mg/l

0.10

576

4265

Procreative management

653

3775

1.44

16.60

4.3

4.0

303.98

447.00

mg/l

1.04

374

1883

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

337

2070

1.66

16.57

3.4

3.5

261.04

458.70

mg/l

2.38

151

989

Gonarthrosis,primary

1942

9512

1.24

16.56

3.0

3.4

509.00

596.30

mg/l

0.24

773

4464

Secondary and unspecified malignant neoplasm of lymph nodes

194

1019

1.95

16.50

2.5

2.8

486.64

416.85

mg/l

0.18

101

387

Asthma-related pneumonia or sepsis

851

6269

1.37

16.40

3.9

3.3

371.44

476.92

mg/l

0.69

417

2830

Asthma, hospital admissions 3, pneumonia

851

6269

1.37

16.40

3.9

3.3

371.44

476.92

mg/l

0.69

417

2830

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

296

1747

1.71

16.35

3.5

2.5

947.57

460.55

mg/l

0.37

125

625

Asthma-related pneumonia

849

6256

1.37

16.34

3.9

3.4

371.44

477.82

mg/l

0.70

417

2822

Disorders of magnesium metabolism

4.76

16.28

5.4

3.8

217.73

268.58

mg/l

0.29

Disturbances of skin sensation

568

3927

1.46

16.20

3.1

3.2

770.29

385.16

mg/l

0.65

264

1761

Special screening examination for neoplasms

131

599

2.24

16.15

8.0

3.6

361.61

284.56

mg/l

0.69

336

Functional dyspepsia

561

3877

1.47

16.05

2.9

3.3

402.28

394.19

mg/l

0.04

216

1694

Pyogenic arthritis

165

828

2.05

16.05

3.7

3.4

353.35

445.70

mg/l

0.40

392

Disorders of continuity of bone

227

1264

1.84

16.04

3.3

3.5

359.51

392.99

mg/l

0.15

100

562

Other abnormalities of plasma proteins

209

3.30

16.04

4.5

3.5

520.54

269.80

mg/l

1.12

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, including Hilmo

4.80

16.03

2.0

2.4

1137.58

252.07

mg/l

0.48

Crystal arthropathies, rheuma endpoint

241

3.10

15.93

3.2

2.8

223.43

541.57

mg/l

0.67

100

Covid-19 suspected case

449

2975

1.53

15.88

3.3

305.62

393.00

mg/l

0.79

192

1373

Endocarditis

100

412

2.53

15.87

3.9

3.8

475.09

232.59

mg/l

1.31

184

Hypoplasia of dental enamel, prenatal , including avohilmo

5.05

15.82

17.6

10.2

348.26

307.69

mg/l

0.09

Disorder of lipoprotein metabolism, unspecified

303

1837

1.68

15.80

4.7

3.0

396.89

459.03

mg/l

0.33

170

750

Nonsuppurative otitis media, including avohilmo

661

4067

1.42

15.72

3.7

3.4

752.80

412.61

mg/l

0.38

358

1942

Acute pancreatitis

437

2889

1.54

15.69

3.7

3.3

423.57

455.42

mg/l

0.16

223

1362

Laparoscopic left hemicolectomy

217

3.22

15.68

5.5

3.4

173.15

219.24

mg/l

0.58

Personality disorders

528

3624

1.47

15.65

2.8

3.4

259.78

438.95

mg/l

2.74

245

1723

malignant neoplasm of female genital organs, including Hilmo

361

2177

1.61

15.63

4.7

2.5

243.05

410.74

mg/l

1.74

182

596

Hyperkinetic disorders, excluding more controls

240

1270

1.79

15.62

3.7

4.2

328.08

496.89

mg/l

1.06

120

701

Lack of expected normal physiological development

228

2.99

15.59

7.5

6.8

329.68

263.85

mg/l

0.38

150

Artificial joint operation, meniscal resection

1981

10393

1.23

15.54

2.9

3.4

609.91

564.91

mg/l

0.11

791

4939

Anogenital herpesviral [herpes simplex] infection, including avohilmo

233

1319

1.80

15.53

3.9

3.1

227.14

408.02

mg/l

1.78

132

596

Colonic or urogenital fistula

575

4020

1.45

15.52

3.5

3.3

594.67

403.19

mg/l

0.60

257

1843

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

129

599

2.23

15.48

3.7

2.9

635.94

408.49

mg/l

0.31

228

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

1094

8142

1.31

15.43

3.4

3.5

301.61

536.41

mg/l

4.01

481

4005

Maternal care for known or suspected abnormality of pelvic organs

408

1774

1.57

15.35

2.7

3.1

375.43

451.35

mg/l

0.29

197

762

Coxibs

615

2241

1.45

15.33

2.7

4.1

351.30

520.69

mg/l

0.79

262

1252

Dermatitis due to substances taken internally

146

714

2.11

15.32

4.2

3.4

1337.66

300.03

mg/l

0.53

309

Speech and linguistic disorders

227

1227

1.82

15.32

5.5

5.2

227.45

427.86

mg/l

2.85

148

712

Transport accidents

999

6333

1.32

15.25

3.2

3.5

719.60

464.37

mg/l

0.55

477

3069

Respiratory disorders in diseases classified elsewhere

169

3.52

15.24

5.4

3.2

363.97

232.30

mg/l

0.57

Chronic pancreatitis

288

1741

1.69

15.24

4.0

3.5

475.36

371.11

mg/l

0.64

164

849

COPD

1031

6415

1.32

15.15

2.9

3.3

423.98

510.49

mg/l

0.52

506

3018

Other diseases of biliary tract

223

1261

1.81

15.08

4.0

3.4

504.75

374.20

mg/l

0.28

135

538

Squamous cell neoplasms and carcinomas of the skin

238

1369

1.78

15.07

3.7

2.4

1099.37

344.38

mg/l

0.49

492

Status post-ami

614

3294

1.43

15.00

3.3

3.2

1137.01

511.59

mg/l

0.60

313

1600

Spondyloarthritis

374

2414

1.57

14.96

3.5

3.3

338.37

437.50

mg/l

0.82

197

1113

COPD related to multimorbidity

905

5771

1.34

14.95

2.9

3.2

778.49

524.34

mg/l

0.33

441

2697

Suppurative and unspecified otitis media

724

4682

1.38

14.83

4.1

3.5

425.76

416.58

mg/l

0.04

395

2294

Varicose veins

1286

7663

1.28

14.79

3.2

3.1

593.49

574.14

mg/l

0.05

521

3294

Zoster [herpes zoster], including avohilmo

1159

8752

1.29

14.78

3.9

3.1

762.29

481.06

mg/l

0.69

551

3822

Personal history of other diseases and conditions

238

1369

1.76

14.77

5.1

3.8

484.73

343.29

mg/l

0.71

132

651

Papulosquamous disorders

834

6249

1.35

14.77

3.3

316.17

416.40

mg/l

1.47

396

2819

Pruritus

270

1618

1.70

14.76

4.3

3.2

1496.16

360.60

mg/l

0.51

134

662

Other crystal arthropathies

252

2.96

14.73

3.2

223.43

554.36

mg/l

0.79

109

Shoulder lesions

1582

7632

1.25

14.69

2.9

3.5

469.26

591.16

mg/l

0.39

621

3747

Generalized skin eruption due to drugs and medicaments

113

510

2.31

14.65

4.3

3.6

1557.35

323.10

mg/l

0.48

221

Anosmia

121

3.75

14.58

2.8

1.9

114.42

165.35

mg/l

0.69

Combinations of oral blood glucose lowering drugs

598

4260

1.42

14.58

2.7

3.4

1175.07

485.37

mg/l

0.92

296

1997

Attention to artificial openings

113

513

2.29

14.41

3.4

3.1

2890.64

250.49

mg/l

0.54

223

Visual disturbances

1071

8337

1.30

14.36

3.3

3.4

412.60

481.99

mg/l

0.35

485

3784

Umbilical hernia

583

4150

1.42

14.28

3.7

3.5

423.28

452.76

mg/l

0.11

292

2101

Benign neoplasm: Rectum, anus and anal canal

457

3114

1.49

14.25

3.2

319.12

421.95

mg/l

1.16

216

1385

Other forms of systemic lupus erythematosus

4.67

14.23

4.5

2.4

362.67

272.38

mg/l

0.20

Hidradenitis suppurativa

422

2.41

14.12

4.0

3.9

315.28

284.71

mg/l

0.13

190

Other specified/unspecified bacterial intestinal infections

167

882

1.95

14.12

3.9

3.3

390.62

364.94

mg/l

0.10

385

Other chronic obstructive pulmonary disease, including avohilmo

1198

7756

1.28

14.12

3.0

3.3

711.84

536.00

mg/l

0.28

565

3598

Post-traumatic stress disorder

174

929

1.91

14.07

3.3

3.4

214.75

524.12

mg/l

2.41

437

Specific personality disorders

453

3085

1.49

14.06

2.6

3.3

633.11

438.49

mg/l

0.23

210

1441

Abscess of anal and rectal regions

187

1024

1.87

14.02

5.4

3.6

324.36

370.85

mg/l

0.21

111

507

Anogenital herpesviral [herpes simplex] infection

143

717

2.05

13.98

4.7

3.2

223.63

323.21

mg/l

1.07

315

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

157

3.40

13.89

5.7

3.3

128.26

346.81

mg/l

1.37

Malignant neoplasm of ovary, including Hilmo

141

706

2.05

13.88

6.7

2.5

147.05

335.22

mg/l

4.34

198

Other arthrosis

1068

5549

1.30

13.88

3.0

3.5

381.87

551.69

mg/l

0.82

421

2727

Emotionally unstable personality disorder

244

1446

1.72

13.87

2.3

3.4

1002.14

469.56

mg/l

0.34

105

677

720

4567

1.37

13.87

2.8

2.9

902.16

677.59

mg/l

0.25

297

1896

Renal agenesis and other reduction defects of kidney, including avohilmo

5.08

13.86

4.2

6.3

219.80

263.55

mg/l

0.25

Acute pancreatitis (for exclusion)

437

2971

1.49

13.77

3.7

3.2

423.57

470.92

mg/l

0.25

223

1397

Traumatic subdural haemorrhage

301

1760

1.63

13.76

2.9

3.4

856.63

541.75

mg/l

0.27

152

896

Thiazolidinediones

253

1522

1.70

13.71

3.2

3.3

684.68

390.19

mg/l

0.72

121

671

Bacterial pneumoniae

856

5698

1.33

13.71

3.8

3.1

426.24

595.64

mg/l

1.03

469

2558

Primary gonarthrosis, bilateral

1149

7580

1.28

13.66

2.8

3.3

594.74

596.31

mg/l

0.00

400

3450

Amputation of foot

363

2.53

13.64

5.2

3.3

727.13

254.64

mg/l

3.04

158

Gonarthrosis, primary, with knee surgery

1281

7951

1.26

13.62

2.8

3.3

410.69

608.59

mg/l

1.07

451

3650

Other symptoms and signs involving the circulatory and respiratory systems

165

879

1.93

13.55

2.9

3.2

338.45

380.01

mg/l

0.21

411

Intestinal malabsorption

124

599

2.14

13.54

3.4

3.8

503.01

287.25

mg/l

0.87

263

Alcohol use disorder, Swedish definition

1145

8213

1.28

13.53

3.3

3.4

792.04

463.14

mg/l

0.85

606

4139

532

3512

1.43

13.47

3.1

2.8

760.28

655.02

mg/l

0.11

224

1407

Anterior Iridocyclitis

427

2903

1.49

13.46

3.4

3.3

848.50

417.35

mg/l

0.55

200

1327

Pacemaker

841

5940

1.33

13.45

2.9

3.2

1370.79

539.82

mg/l

0.76

371

2732

Acute and subacute iridocyclitis

403

2711

1.51

13.40

3.5

3.3

885.09

404.55

mg/l

0.60

190

1226

Adenomyosis (Endometriosis of uterus)

261

1587

1.67

13.39

2.8

3.1

266.44

434.51

mg/l

1.11

639

1270

8829

1.26

13.38

3.3

3.4

737.90

463.77

mg/l

0.76

673

4413

Psoriasis

587

4236

1.40

13.30

3.4

299.41

457.50

mg/l

1.90

291

1943

Iridocyclitis

479

3337

1.45

13.29

3.5

3.3

791.16

395.24

mg/l

0.58

226

1505

Other chronic obstructive pulmonary disease

980

6218

1.30

13.27

2.9

3.3

742.22

518.03

mg/l

0.31

483

2938

Diagnoses used for exclusion with ILD

547

3907

1.42

13.19

3.6

3.2

995.55

462.01

mg/l

0.46

268

1779

Malignant neoplasm of bladder

159

845

1.93

13.12

2.8

2.5

2035.40

325.46

mg/l

0.52

325

COPD-related respiratory insufficiency

277

1727

1.64

13.06

3.0

3.2

378.87

454.75

mg/l

0.29

139

782

Assault

264

1625

1.65

13.00

4.0

3.5

324.24

462.68

mg/l

0.92

143

843

Certain conditions originating in the perinatal period

198

998

1.80

12.96

5.8

5.0

350.54

417.87

mg/l

0.32

125

569

Schizophrenia or delusion, excluding more controls

555

3932

1.41

12.92

3.0

3.3

577.96

470.68

mg/l

0.14

257

1872

Infection due to other mycobacteria

176

3.20

12.89

3.8

2.9

1603.26

234.71

mg/l

0.83

Psoriasis vulgaris

392

2647

1.50

12.82

3.8

3.5

333.53

423.55

mg/l

0.79

206

1269

Oesophageal varices

113

539

2.18

12.82

3.0

3.8

279.40

405.17

mg/l

0.51

234

Discitis, unspecified

215

2.97

12.79

3.7

3.2

514.66

315.16

mg/l

0.53

Diseases of tongue

138

706

2.00

12.78

4.1

3.0

303.75

385.54

mg/l

0.31

307

Intracranial injury

1297

9747

1.25

12.76

3.0

3.5

730.26

487.29

mg/l

0.53

575

4644

Autoimmune hepatitis, wide definition

111

526

2.18

12.72

3.9

3.3

297.00

286.66

mg/l

0.05

225

Benign neoplasm: Rectum

405

2760

1.49

12.71

3.2

317.38

383.80

mg/l

0.68

199

1227

Other congenital malformations of the digestive system

131

658

2.05

12.67

6.4

5.5

256.45

314.37

mg/l

0.38

378

Care involving use of rehabilitation procedures

1194

8581

1.26

12.63

3.5

2.9

549.59

579.21

mg/l

0.07

626

3654

Malignant neoplasm of brain, including Hilmo

118

574

2.12

12.63

6.3

3.6

166.90

305.68

mg/l

3.05

225

Acute generalized exanthematous pustulosis

119

582

2.12

12.62

4.3

3.6

1464.97

311.74

mg/l

0.48

257

Noninflammatory disorders of female genital tract

748

2788

1.36

12.58

3.3

3.2

403.52

448.78

mg/l

0.17

280

1166

Postmenopausal atrophic vaginitis

486

1834

1.46

12.58

3.0

3.2

2993.10

456.09

mg/l

0.87

101

724

Coxarthrosis, primary, with hip surgery

1035

7564

1.28

12.54

3.0

3.2

464.22

605.98

mg/l

0.52

397

3371

Impingement syndrome of shoulder

482

3399

1.44

12.53

2.6

3.7

533.38

459.04

mg/l

0.17

157

1664

Thrombotic microangiopathy

4.96

12.53

6.5

3.5

562.13

328.42

mg/l

0.50

Deforming dorsopathies

587

4278

1.39

12.51

3.2

3.6

792.38

489.78

mg/l

0.39

244

1958

In situ neoplasms

870

6722

1.31

12.47

3.7

3.0

453.16

506.40

mg/l

0.20

394

2816

Other or unspecified common variable immunodeficiency

6.64

12.45

4.3

3.4

144.63

533.69

mg/l

0.56

Stomatitis and related lesions

430

2975

1.47

12.43

3.5

305.11

424.90

mg/l

1.09

209

1368

Osteonecrosis

151

806

1.93

12.42

3.8

3.4

549.23

393.21

mg/l

0.24

345

Other diseases of stomach and duodenum

154

827

1.91

12.41

3.4

3.3

1012.95

386.32

mg/l

0.82

340

Impacted cerumen

281

1782

1.61

12.39

3.4

3.3

313.13

385.58

mg/l

0.53

104

807

Other disorders of glucose regulation and pancreatic internal secretion

201

1171

1.76

12.33

5.0

3.8

657.70

317.49

mg/l

2.93

135

549

Cervical disc disorders

740

5605

1.33

12.26

2.8

3.5

273.63

553.87

mg/l

3.52

287

2671

Herpesviral [herpes simplex] infections

256

1591

1.64

12.22

5.1

3.2

657.34

429.82

mg/l

0.46

149

683

Alcohol abuse, main dg, excluding more controls

290

1854

1.59

12.22

3.3

3.5

312.14

471.61

mg/l

1.51

148

953

Cholecystitis

317

2071

1.56

12.18

3.5

3.1

331.60

372.11

mg/l

0.31

168

915

Hepatocellular carcinoma

266

2.68

12.18

4.0

2.7

426.23

294.47

mg/l

0.41

Other and unspecified immunodeficiencies with predominantly antibody defects

151

3.35

12.17

3.8

5.4

242.67

455.78

mg/l

0.89

Renal agenesis and other reduction defects of kidney

5.08

12.15

4.6

6.9

231.48

269.53

mg/l

0.19

Infection due to other mycobacteria, including avohilmo

193

3.01

12.15

3.7

2.9

1603.26

256.77

mg/l

0.81

Other diseases of oesophagus

214

1273

1.72

12.14

3.4

3.2

1128.99

366.28

mg/l

0.43

570

Other metabolic disorders

267

1679

1.62

12.10

3.7

3.1

277.69

546.64

mg/l

1.72

147

646

Somatoform disorder

322

2114

1.55

12.06

2.6

3.2

203.03

466.60

mg/l

3.84

114

912

Orchitis and epididymitis

200

1171

1.74

12.01

4.6

3.8

1176.37

557.84

mg/l

0.43

116

700

Redundant prepuce, phimosis and paraphimosis

400

2701

1.47

12.00

3.7

4.0

333.89

493.36

mg/l

1.12

224

1680

Carrier of infectious disease

292

2.58

11.97

5.1

3.3

444.23

309.70

mg/l

0.51

126

Cerebral cysts

140

738

1.95

11.96

3.2

3.7

392.73

320.76

mg/l

0.49

330

Barrett oesophagus

125

635

2.03

11.94

3.1

3.4

428.42

393.81

mg/l

0.10

297

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

174

982

1.81

11.91

3.2

2.9

634.95

439.49

mg/l

0.70

355

Myocardial infarction, strict

985

5476

1.28

11.84

3.1

3.3

413.76

480.69

mg/l

0.47

492

2584

Spondylopathies (FG)

265

1674

1.61

11.79

3.3

3.4

313.93

463.63

mg/l

1.11

136

782

Sciatica+with lumbago

1056

7434

1.27

11.76

3.0

3.5

294.22

525.86

mg/l

3.33

455

3519

Other and unspecified tonsillitis

626

3853

1.36

11.74

4.2

3.6

611.64

436.79

mg/l

0.36

359

1975

Other disorders of bladder

263

1663

1.61

11.72

3.6

3.2

440.78

374.44

mg/l

0.27

138

780

Car occupant injured in other and unspecified transport accidents

378

2582

1.48

11.69

3.1

3.3

511.83

437.69

mg/l

0.19

179

1209

COPD, hospital admissions

988

6571

1.28

11.69

2.9

3.2

740.43

521.96

mg/l

0.31

485

3062

Other blood glucose lowering drugs, excl. Insulins

335

2236

1.52

11.68

3.1

3.2

470.15

472.46

mg/l

0.01

175

940

Cardiomyopathies, Primary/intrinsic

253

1586

1.62

11.67

2.8

3.7

313.20

429.35

mg/l

0.52

139

778

Meniscus derangement

1088

5740

1.27

11.64

3.0

3.5

1046.29

543.85

mg/l

0.83

452

2842

Pediculosis, acariasis and other infestations, including avohilmo

353

2381

1.50

11.63

3.3

3.7

496.59

421.62

mg/l

0.19

167

1166

Other disorders of bone

384

2636

1.48

11.58

3.5

299.31

419.86

mg/l

1.30

182

1212

945

6692

1.28

11.58

3.5

3.0

647.82

631.91

mg/l

0.02

371

2920

Chronic lower respiratory diseases

2605

11813

1.17

11.52

3.2

3.5

572.23

466.13

mg/l

0.42

1208

5682

Kela reimbursement Agammaglobulinemia (D80-84)

106

3.81

11.52

3.3

4.9

274.41

409.86

mg/l

0.42

1197

8647

1.24

11.45

3.3

3.4

764.69

467.42

mg/l

0.79

636

4347

Excessive attrition of teeth

1234

9927

1.24

11.43

4.0

3.4

470.65

448.01

mg/l

0.09

599

4715

Other disorders of patella

317

2101

1.53

11.37

2.9

3.6

592.05

433.86

mg/l

0.18

127

1026

Herpesviral [herpes simplex] infections, including avohilmo

504

3647

1.40

11.30

4.2

3.1

560.42

419.75

mg/l

0.41

269

1582

Other symptoms and signs involving cognitive functions and awareness

1041

7365

1.26

11.29

3.1

3.3

883.72

564.95

mg/l

0.39

453

3368

Osteopathy in diseases classified elsewhere

4.17

11.28

4.4

3.2

501.73

276.24

mg/l

0.62

Ankle and foot

3.95

11.27

3.8

3.3

326.44

259.02

mg/l

—

Other inflammatory liver diseases

154

854

1.85

11.26

4.1

3.3

314.63

369.46

mg/l

0.26

369

Irregular menses

860

5022

1.29

11.26

3.2

3.1

698.09

427.94

mg/l

0.28

353

2031

Benign neoplasm: Descending colon

171

980

1.79

11.22

3.8

3.2

437.92

387.32

mg/l

0.16

429

Chronic sinusitis

841

6550

1.29

11.21

2.9

3.3

442.97

539.44

mg/l

0.36

336

3087

Viral warts, including avohilmo

447

3176

1.42

11.19

4.8

3.5

278.40

425.64

mg/l

2.22

268

1495

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

145

774

1.88

11.18

5.4

5.9

261.60

430.35

mg/l

1.37

487

Other extrapyramidal and movement disorders in other diseases

535

3920

1.38

11.18

2.9

3.2

325.70

455.02

mg/l

1.42

204

1691

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

147

805

1.87

11.17

3.6

2.8

598.53

387.25

mg/l

0.32

309

Primary coxarthrosis, bilateral

633

4761

1.35

11.14

3.0

3.1

374.42

556.12

mg/l

0.78

253

2051

Unspecified contracted kidney

4.75

11.12

6.0

3.7

1481.41

213.10

mg/l

0.69

COPD, early/later onset

992

6617

1.27

11.12

2.9

3.3

740.06

521.01

mg/l

0.31

486

3087

Superficial injury of lower leg

546

4018

1.37

11.05

3.0

3.4

428.57

417.20

mg/l

0.04

253

1851

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

143

780

1.87

10.97

3.6

3.8

340.59

446.38

mg/l

0.40

403

Migraine with aura

461

3301

1.41

10.96

3.1

3.4

246.47

399.34

mg/l

2.47

186

1486

Open wound of head

1203

9199

1.24

10.95

3.7

3.5

666.55

488.87

mg/l

0.30

595

4491

Inflammatory diseases of the central nervous system

188

1113

1.73

10.94

4.3

3.4

285.46

445.04

mg/l

0.75

100

514

Oter anti-inflammatory and antirheumatic agents, non-steroids

468

1818

1.43

10.92

2.7

3.9

319.40

520.31

mg/l

1.51

182

988

Duodenal ulcer

237

1488

1.62

10.91

3.1

3.2

424.66

462.54

mg/l

0.12

139

690

Erosion of teeth , including avohilmo

531

3899

1.38

10.90

4.3

3.5

515.35

393.74

mg/l

0.45

283

1870

Bacterial pneumonia, not elsewhere classified

796

5423

1.30

10.89

3.8

3.1

420.95

614.45

mg/l

1.16

437

2423

Recurrent and persistent haematuria

4.01

10.86

3.4

4.1

651.20

232.61

mg/l

1.10

Vitamin deficiency, wide

118

608

2.00

10.85

3.3

3.5

336.49

398.57

mg/l

0.21

263

Vitamin deficiency

118

608

2.00

10.85

3.3

3.5

336.49

398.57

mg/l

0.21

263

Migraine without aura and triptan purchases

302

2002

1.53

10.84

2.8

3.5

224.45

431.45

mg/l

2.97

129

936

Crohn disease

265

1710

1.57

10.82

3.0

3.4

266.87

460.36

mg/l

2.03

121

819

Absence of one kidney, including avohilmo

5.42

10.81

4.3

6.4

265.41

306.93

mg/l

0.17

Collagenous colitis

208

1270

1.67

10.77

4.3

3.4

240.17

418.42

mg/l

1.65

118

526

Disorders of myoneural junction and muscle in diseases classified elsewhere

4.00

10.74

4.3

3.0

438.12

178.41

mg/l

0.93

Migraine with aura and triptan purchases

296

1960

1.53

10.69

2.8

3.5

218.18

429.28

mg/l

2.89

112

926

Cardiomyopathy (excluding other)

255

1637

1.58

10.67

2.8

3.7

313.20

520.46

mg/l

0.81

139

794

Other condition

301

2005

1.52

10.63

3.6

3.4

569.46

438.89

mg/l

0.30

139

927

Sequelae of external causes of morbidity and mortality

547

4055

1.36

10.62

3.7

3.2

772.50

479.31

mg/l

0.56

304

1810

Absence of one kidney

6.11

10.60

4.6

7.7

276.69

312.54

mg/l

0.13

ILD, hospital admission 2, with pulmonary infections

219

1360

1.64

10.59

3.2

2.8

351.27

487.45

mg/l

0.46

124

585

Recurrent aphthous stomatitis , including avohilmo

314

2113

1.51

10.57

3.5

3.4

330.18

410.96

mg/l

0.44

148

938

Other embolism and thrombosis

270

1760

1.56

10.57

4.6

3.1

596.14

374.52

mg/l

0.52

157

746

Polyarteritis nodosa and related conditions

164

3.04

10.57

3.4

3.9

393.81

319.26

mg/l

0.29

Left bundle-branch block

156

886

1.80

10.51

3.4

282.01

339.44

mg/l

0.31

370

Maternal care for other conditions predominantly related to pregnancy

311

2032

1.51

10.51

3.1

3.0

259.16

343.27

mg/l

0.66

148

820

Appendectomy

1274

9973

1.22

10.50

3.5

3.3

350.36

500.21

mg/l

1.36

568

4663

Mixed specific developmental disorders

333

2.34

10.49

6.9

8.9

359.67

357.33

mg/l

0.01

257

Other congenital malformations of the digestive system, including avohilmo

142

781

1.86

10.49

5.8

5.4

250.96

330.78

mg/l

0.58

101

441

Scabies, including avohilmo

296

1970

1.52

10.47

3.2

3.8

554.87

428.49

mg/l

0.29

141

976

Skin changes due to chronic exposure to nonionizing radiation

888

6365

1.27

10.45

3.5

3.0

606.65

640.54

mg/l

0.05

344

2774

Actinic keratosis

865

6212

1.28

10.44

3.5

3.0

614.29

649.06

mg/l

0.05

333

2706

Lumbar disc prolapse

1298

7904

1.22

10.40

2.8

3.5

268.31

516.06

mg/l

4.54

537

3793

Inflammatory bowel disease

622

4713

1.33

10.38

3.3

3.5

340.50

403.60

mg/l

0.31

311

2274

Right bundle-branch block

434

2.16

10.36

3.0

3.5

313.39

247.13

mg/l

0.47

186

Other disorders of nervous system

157

899

1.79

10.36

3.9

3.5

557.36

388.85

mg/l

0.68

413

Other and unspecified follicular disorders

105

530

2.04

10.29

5.5

3.5

431.29

300.22

mg/l

0.47

245

Coeliac disease

254

1644

1.57

10.29

3.3

3.7

1653.86

322.60

mg/l

0.54

120

747

Other infectious diseases, including avohilmo

205

1263

1.66

10.27

5.0

3.3

983.42

403.41

mg/l

0.44

118

560

Other diseases of arteries and capillaries

199

1217

1.67

10.25

4.0

3.2

543.74

397.10

mg/l

0.81

111

531

Hyperhidrosis

351

2.29

10.25

2.3

3.3

5337.55

256.43

mg/l

0.48

146

Allergic contact dermatitis

265

1732

1.55

10.24

3.0

3.3

353.73

370.71

mg/l

0.06

104

715

Selective deficiency of immunoglobulin G [IgG] subclasses

4.06

10.20

5.6

4.5

259.29

435.61

mg/l

0.35

Chronic rhinitis, nasopharyngitis and pharyngitis

644

4914

1.32

10.20

3.5

326.85

462.56

mg/l

1.19

275

2330

Hereditary hypogammaglobulinemia

5.86

10.20

3.3

4.1

412.31

150.11

mg/l

0.41

Congenital iodine-deficiency syndrome/hypothyroidism

353

2.30

10.19

2.8

3.4

320.81

295.75

mg/l

0.13

136

Pure hyperglyceridaemia

272

2.49

10.17

5.0

4.3

331.30

296.69

mg/l

0.17

121

Internal derangement of knee

727

5584

1.30

10.14

3.0

3.5

725.52

469.11

mg/l

0.38

343

2787

Other benign neoplasms of skin

780

6117

1.29

10.07

3.6

3.2

642.83

480.08

mg/l

0.31

353

2654

Serous carcinoma of ovary, including Hilmo

374

2.24

10.06

8.7

2.5

117.78

367.25

mg/l

3.30

103

Otitis media, unspecified

239

1408

1.59

10.05

5.7

4.2

375.26

350.99

mg/l

0.09

153

704

Focal epilepsy

447

3239

1.40

10.03

3.9

3.7

285.86

411.44

mg/l

1.93

252

1576

Other disorders of adrenal gland

113

591

1.97

10.00

4.6

4.0

318.91

309.69

mg/l

0.05

280

Injuries to the shoulder and upper arm

1844

12126

1.18

9.96

3.3

3.4

401.36

565.66

mg/l

1.44

799

5804

KRA_PSY_EATING, excluding more controls

148

832

1.79

9.94

2.8

3.6

224.49

413.57

mg/l

1.77

402

Mental retardation, excluding more controls

471

2.07

9.91

4.9

6.6

366.68

323.89

mg/l

0.20

288

Other diseases of pancreas

191

1169

1.67

9.86

3.7

3.4

391.29

353.67

mg/l

0.17

525

Eosinophilic disease (BM)

176

2.87

9.85

2.6

2.9

235.86

274.05

mg/l

0.20

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

253

2.53

9.77

6.6

5.2

290.66

289.07

mg/l

0.01

127

Restless leg syndrome

301

2044

1.50

9.74

3.1

278.96

452.02

mg/l

1.72

107

851

Crohn's disease of small intestine

148

848

1.78

9.73

2.7

3.4

198.86

366.87

mg/l

1.56

396

Endometriosis of pelvic peritoneum

272

1638

1.53

9.72

2.7

3.2

247.60

362.20

mg/l

1.27

679

Reactive arthropathies

179

1081

1.69

9.69

3.0

3.6

1932.44

443.21

mg/l

0.45

513

Other and unspecified nerve root and plexus disorders, also in other diseases

403

2888

1.41

9.69

3.3

3.4

897.84

385.90

mg/l

0.49

145

1351

Nonorganic sleeping disorders, excluding more controls

371

2620

1.43

9.66

3.1

3.3

520.25

471.58

mg/l

0.11

174

1229

Alcoholic liver disease

213

1347

1.61

9.61

3.3

3.5

453.51

355.85

mg/l

0.69

107

659

Spinal instabilities

324

2.30

9.54

3.3

4.0

438.25

288.23

mg/l

0.23

155

Emotional disorders starting during childhood or adolecense, excluding more controls

479

2.03

9.51

4.8

5.7

230.53

470.77

mg/l

1.38

274

Haemorrhage in early pregnancy

441

3121

1.38

9.50

2.9

3.0

349.85

427.25

mg/l

0.33

185

1202

Specific development disorders of speech and language

152

852

1.76

9.48

4.9

5.2

223.30

386.56

mg/l

1.97

495

Brain glioblastoma and astrocytoma

197

2.71

9.45

7.9

2.9

174.95

257.91

mg/l

1.13

Idiopathic hypercalciuria

4.28

9.45

1.8

4.3

154.33

299.06

mg/l

—

Adrenocortical insufficiency

445

2.09

9.38

4.8

3.7

321.02

334.05

mg/l

0.06

196

Hypoglycaemia, other or unspecified

158

933

1.73

9.37

5.0

3.9

592.74

281.63

mg/l

2.78

108

445

Nail disorders

185

1138

1.66

9.36

5.3

3.6

396.52

427.31

mg/l

0.08

528

Common variable immunodeficiency

4.11

9.36

4.2

3.9

152.00

448.91

mg/l

0.94

Other disorders starting during childhood or adolescence

135

755

1.82

9.35

5.8

6.0

256.71

393.63

mg/l

1.10

493

Fracture of skull and facial bones

433

3160

1.39

9.34

4.0

3.6

975.94

422.10

mg/l

0.86

235

1554

Chronic hepatitis, not elsewhere classified

419

2.12

9.34

3.9

3.5

261.76

289.25

mg/l

0.14

169

Antenatal screening

316

1198

1.49

9.30

2.7

3.2

349.28

590.49

mg/l

0.69

134

462

Disorders of vitreous body and globe

1079

8369

1.23

9.27

3.7

3.2

607.71

491.95

mg/l

0.32

506

3661

Postpartum haemorrhage

381

2239

1.42

9.19

2.3

3.2

324.92

409.38

mg/l

0.41

160

930

Diseases of inner ear

1141

9011

1.22

9.19

3.1

3.2

408.01

520.70

mg/l

0.56

441

4020

Left hemicolectomy

305

2.33

9.17

4.8

3.5

1730.50

263.82

mg/l

0.48

126

Benign neoplasm of other and unspecified endocrine glands

272

1834

1.51

9.16

2.9

3.2

860.57

445.54

mg/l

0.33

132

793

Vasculitis limited to skin, not elsewhere classified

350

2.23

9.16

4.0

3.5

373.69

404.95

mg/l

0.06

147

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma

4.76

9.15

2.3

1.9

268.00

218.56

mg/l

0.20

Inflammatory disease of uterus

248

1639

1.53

9.14

2.8

3.0

217.63

398.30

mg/l

2.09

109

653

Sarcoidosis

261

1746

1.52

9.13

3.5

3.3

498.42

424.70

mg/l

0.14

123

777

Non-Hodgkin lymphoma, all

102

533

1.97

9.08

2.5

2.7

487.81

309.93

mg/l

0.53

195

Other and unspecified vasculitis limited to skin

313

2.30

9.05

3.9

3.3

347.87

422.16

mg/l

0.14

130

Other respiratory diseases principally affecting the interstitium

394

2851

1.40

9.04

3.1

420.70

465.22

mg/l

0.23

207

1276

Sequelae with surgical and medical care as external cause

428

3138

1.38

9.04

3.9

3.1

902.92

427.01

mg/l

0.80

239

1373

Cholangitis (primary sclerosing, PSC), with reimbursement 202

220

2.57

9.01

4.2

4.3

132.83

257.50

mg/l

2.45

109

Vertigo of central origin

191

2.70

8.97

3.2

2.9

308.60

272.68

mg/l

0.11

Complications of genitourinary prosthetic devices, implants and grafts

301

2.31

8.95

4.9

3.0

267.53

281.94

mg/l

0.10

115

Neuralgia and neuritis, unspecified

112

606

1.89

8.94

3.2

3.7

240.37

442.67

mg/l

0.82

266

Secondary malignant neoplasm of other and unspecified sites

203

2.63

8.93

4.8

2.3

247.00

273.81

mg/l

0.14

Diffuse large B-cell lymphoma, including Hilmo

108

579

1.92

8.91

2.9

2.8

708.75

297.40

mg/l

0.54

211

Diffuse large B-cell lymphoma, helper endpoint

108

579

1.92

8.91

2.9

2.8

708.75

297.40

mg/l

0.54

211

Diffuse large B-cell lymphoma

108

579

1.92

8.91

2.9

2.8

708.75

297.40

mg/l

0.54

211

Other specified disorders of kidney and ureter

400

2.12

8.91

6.9

4.2

551.32

326.30

mg/l

0.81

175

Malignant neoplasm of liver and intrahepatic bile ducts

373

2.16

8.91

3.9

2.9

865.34

304.96

mg/l

0.60

141

Other specified congenital malformation syndromes affecting multiple systems

234

2.52

8.89

4.4

7.0

463.72

319.77

mg/l

0.50

163

Lichen simplex chronicus and prurigo

144

842

1.75

8.89

3.5

3.3

268.86

306.51

mg/l

0.26

360

Open wound of lower leg

325

2281

1.44

8.88

4.0

3.4

285.34

454.48

mg/l

2.17

157

1049

Pediculosis, acariasis and other infestations

134

769

1.78

8.83

3.6

3.8

363.80

397.88

mg/l

0.11

372

Congenital vesicoureteral reflux

3.82

8.81

8.4

6.8

191.05

306.86

mg/l

0.48

Medical abortion

1174

5241

1.22

8.80

3.0

697.93

531.85

mg/l

0.20

455

2000

Postmenopausal bleeding

471

1812

1.37

8.78

3.0

3.2

387.13

448.20

mg/l

0.13

156

709

Other coagulation defects

161

973

1.69

8.77

3.7

3.5

570.31

302.26

mg/l

0.49

414

Extrapyramidal and movement disorders

818

6568

1.26

8.74

2.8

3.2

304.50

515.81

mg/l

2.69

314

2919

Transient ischemic attack

1105

7270

1.22

8.69

3.1

3.2

765.96

553.49

mg/l

0.41

477

3244

Abnormal involuntary movements

281

1928

1.48

8.69

2.9

3.5

249.26

394.43

mg/l

1.95

113

890

Disorders of vitreous body

1044

8176

1.22

8.69

3.8

3.2

612.94

499.09

mg/l

0.30

489

3568

Thoracic aortic aneurysm

306

2135

1.46

8.68

3.2

3.4

790.23

604.90

mg/l

0.15

155

1051

Mental and behavioural disorders due to alcohol

1019

7971

1.22

8.66

3.2

3.5

842.55

469.14

mg/l

0.85

531

4038

Fibroblastic disorders

467

3493

1.35

8.64

3.0

3.4

696.47

461.54

mg/l

0.29

216

1714

Hydrocele

233

1540

1.53

8.64

4.7

3.7

543.98

513.27

mg/l

0.07

133

921

Organic, including symptomatic, mental disorders

1147

6683

1.22

8.64

2.9

3.2

373.44

591.32

mg/l

1.91

477

3056

Malignant neoplasm of small intestine, including Hilmo

345

2.19

8.61

5.1

3.3

349.90

269.15

mg/l

0.47

123

Spontaneous abortion

791

4214

1.26

8.60

3.2

3.0

332.52

485.20

mg/l

0.74

304

1644

Persistent mood disorders

365

2628

1.40

8.60

3.4

3.2

731.52

443.67

mg/l

0.28

169

1153

Neuromuscular dysfunction of bladder

188

1187

1.61

8.58

3.5

3.1

566.41

362.87

mg/l

0.98

550

Other specified and unspecified disorders of lens

3.46

8.58

2.4

2.3

116.67

276.87

mg/l

—

Protozoal diseases, including avohilmo

434

2.06

8.57

5.5

3.8

259.29

324.40

mg/l

0.32

196

Focal epilepsy, strict definition

410

3011

1.38

8.57

3.9

3.7

277.53

396.67

mg/l

1.83

234

1451

Non-follicular lymphoma

207

1339

1.58

8.55

3.0

3.2

683.29

411.43

mg/l

0.58

104

600

Thrombocytopenia, unspecified

167

1027

1.66

8.54

3.6

3.7

367.92

384.06

mg/l

0.07

462

Speech disturbances, not elsewhere classified

204

1316

1.58

8.52

3.4

3.1

1211.46

405.14

mg/l

0.40

572

Focal epilepsy, mode (most common among epilepsy diagnosis)

388

2830

1.39

8.47

3.7

3.6

303.01

408.02

mg/l

1.29

219

1360

Drug-induced osteoporosis

168

2.78

8.45

5.1

3.3

434.55

186.64

mg/l

0.68

malignant neoplasm of female genital organs

293

1992

1.46

8.42

5.0

2.5

270.24

428.59

mg/l

1.31

148

536

Artificial joint re-operation

162

994

1.67

8.40

3.1

700.10

376.93

mg/l

0.40

403

Benign neoplasm: Adrenal gland

170

1057

1.64

8.33

2.8

3.3

1247.64

423.92

mg/l

0.44

450

Myositis

298

2.26

8.29

3.3

4.4

271.84

265.12

mg/l

0.04

138

Acute pharyngitis

285

1957

1.46

8.28

5.6

3.6

365.60

443.53

mg/l

0.43

174

983

Polyhydramnios

403

2.05

8.26

3.4

3.3

259.60

355.67

mg/l

0.76

176

Aortic aneurysm

481

3567

1.34

8.26

3.0

3.3

662.94

615.78

mg/l

0.05

240

1750

Female genital prolapse

496

2067

1.34

8.25

2.8

3.1

266.99

444.40

mg/l

1.55

160

814

Thyrotoxicosis, other and/or unspecified

387

2834

1.38

8.25

3.1

1134.35

376.06

mg/l

0.68

176

1148

Protozoal diseases

420

2.05

8.23

5.5

3.8

265.11

327.10

mg/l

0.29

191

Retinal detachments and breaks

727

5802

1.26

8.23

3.9

3.1

870.80

461.24

mg/l

0.76

371

2591

Thyroiditis, ILD-related definition

224

1488

1.53

8.15

3.4

3.5

416.64

441.97

mg/l

0.09

101

615

Family history of certain disabilities and chronic diseases leading to disablement

100

538

1.90

8.15

2.9

3.5

197.12

275.06

mg/l

1.02

241

Maternal care for known or suspected malpresentation of fetus

259

1248

1.49

8.15

2.7

3.3

380.45

487.21

mg/l

0.29

119

561

Other symptoms and signs involving the urinary system

209

1369

1.55

8.14

3.0

3.4

481.62

377.98

mg/l

0.47

114

669

Extreme obesity with alveolar hypoventilation

519

1.92

8.12

2.9

3.7

244.19

298.78

mg/l

0.39

220

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

208

1363

1.55

8.11

4.3

3.2

730.86

415.52

mg/l

0.75

118

586

Chorioretinal inflammation

381

2.09

8.11

4.3

3.6

472.48

222.96

mg/l

1.28

167

Vasomotor and allergic rhinitis

714

5560

1.26

8.10

3.5

3.6

389.42

421.68

mg/l

0.13

303

2747

Background retinopathy and retinal vascular changes

263

2.34

8.09

5.6

3.4

479.31

277.45

mg/l

1.43

110

Nonischemic cardiomyopathy

213

1403

1.54

8.07

3.4

3.5

524.11

387.10

mg/l

0.29

125

676

Polyp of the female genital tract

515

2207

1.33

8.06

2.9

3.1

532.74

445.20

mg/l

0.19

197

886

Other infectious diseases

169

1058

1.63

8.06

5.4

3.3

1075.57

421.61

mg/l

0.42

102

456

Symptoms and signs involving speech and voice

675

5358

1.27

8.02

3.2

3.1

1272.74

513.48

mg/l

0.68

284

2319

Disorders of ocular muscles, binocular movement, accommodation and refraction

949

7740

1.22

8.01

3.9

3.5

317.13

438.14

mg/l

2.01

469

3682

Other encephalitis

349

2.14

8.00

4.3

3.9

389.12

367.50

mg/l

0.04

162

Keratitis

707

5643

1.26

7.99

3.7

3.3

697.76

412.42

mg/l

0.64

337

2607

Cardiac arrest

118

566

1.80

7.96

3.4

3.2

496.35

287.35

mg/l

0.78

247

Early onset COPD

435

3264

1.35

7.95

3.3

3.5

316.44

516.81

mg/l

1.78

228

1569

Social phobias

157

966

1.65

7.94

3.5

4.0

390.61

482.00

mg/l

0.28

485

Haemorrhage, not elsewhere classified

466

1.96

7.93

4.3

3.1

512.40

252.15

mg/l

1.11

198

Hand

4.20

7.93

3.1

3.4

683.33

252.26

mg/l

—

Other bursopathies

262

1807

1.47

7.92

3.0

3.5

1034.71

383.55

mg/l

0.46

109

858

Spondylosis

1081

7027

1.21

7.90

2.9

3.5

567.38

539.11

mg/l

0.05

426

3316

Assault by bodily force

151

923

1.66

7.89

3.8

3.7

378.30

440.92

mg/l

0.25

485

Conjunctivitis (acute, non atopic)

568

4404

1.29

7.87

4.4

3.6

579.48

369.39

mg/l

0.78

297

2138

Acute posthaemorrhagic anaemia

433

2.00

7.86

3.5

2.9

432.67

412.19

mg/l

0.04

167

Exclusion endpoint for clefts

286

2.26

7.84

4.1

6.4

443.10

334.97

mg/l

0.37

190

Other hammer toe(s) (acquired)

334

2187

1.40

7.83

2.6

3.2

390.36

519.55

mg/l

0.22

111

895

Other and unspecified effects of external causes

528

4077

1.31

7.82

3.6

3.4

568.93

415.49

mg/l

0.22

256

1932

Vitamin B12 deficiency anaemia

215

1430

1.53

7.81

3.1

2734.09

375.42

mg/l

0.89

109

583

Impotence

121

700

1.77

7.81

4.3

3.7

2549.49

350.00

mg/l

0.50

423

Myocarditis

398

2.02

7.79

3.2

2.9

387.85

255.20

mg/l

0.58

176

Mixed and other personality disorders

146

888

1.67

7.78

2.7

3.7

238.31

404.44

mg/l

1.18

428

Primary biliary cholangitis, wide definition

248

2.34

7.78

3.9

3.5

286.87

319.06

mg/l

0.18

106

Tonsillectomy and adenotomy

1009

5802

1.22

7.76

3.9

3.7

600.35

404.53

mg/l

0.56

496

2937

Corns and callosities

147

898

1.67

7.76

4.9

3.6

1407.13

362.82

mg/l

0.55

387

Hypopituitarism

158

983

1.64

7.73

4.1

4.5

316.63

370.03

mg/l

0.25

561

Disorders of vestibular function (Vertigo)

966

7787

1.22

7.71

3.2

410.76

510.84

mg/l

0.40

366

3392

Scabies

105

586

1.83

7.68

3.2

4.0

406.50

399.32

mg/l

0.02

298

Pregnancy with abortive outcome

1216

5315

1.20

7.61

2.9

3.0

740.81

527.98

mg/l

0.28

468

2026

Total colectomy

523

1.89

7.61

4.9

4.0

367.48

322.01

mg/l

0.22

250

Total colectomy operation

523

1.89

7.61

4.9

4.0

367.48

322.01

mg/l

0.22

250

Other autoimmune haemolytic anaemias

154

2.75

7.59

3.7

3.1

596.62

265.65

mg/l

0.59

Postprocedural disorders of digestive system, not elsewhere classified

418

2.00

7.58

4.9

4.1

1612.43

353.28

mg/l

0.43

179

Other shoulder lesions

185

1199

1.57

7.58

3.6

265.32

401.91

mg/l

1.13

544

Encephalitis

377

2.06

7.58

4.2

3.9

376.50

359.39

mg/l

0.03

178

Adverse effects, not elsewhere classified

381

2825

1.36

7.55

3.7

3.4

263.78

448.26

mg/l

2.63

188

1293

Other specified/unspecified spondylopathies

317

2.16

7.54

3.3

3.1

281.00

436.98

mg/l

0.36

133

Childhood asthma (age<16), excluding more controls

210

1083

1.53

7.54

4.4

3.1

430.30

535.52

mg/l

0.18

122

547

Otitis externa, unspecified

233

1588

1.49

7.53

4.7

3.6

319.32

392.05

mg/l

0.53

135

735

Mental and behavioural disorders due to alcohol, excluding acute intoxication

867

7058

1.23

7.51

3.0

3.5

956.54

457.96

mg/l

1.02

448

3598

Childhood asthma (age<16)

211

1091

1.52

7.49

4.5

3.0

427.54

532.05

mg/l

0.18

123

552

Disorders of phosphorus metabolism and phosphatases

4.17

7.48

4.5

5.1

300.13

302.83

mg/l

0.01

Injuries to the neck

443

3363

1.33

7.47

3.1

3.4

894.13

391.01

mg/l

0.74

212

1605

Unspecified acute lower respiratory infection

312

2246

1.41

7.46

4.3

3.5

468.63

410.85

mg/l

0.15

174

1065

Endometriosis of ovary

283

1882

1.43

7.44

2.8

3.1

298.77

380.17

mg/l

0.45

770

Alcohol use disorder, ICD-based

805

6572

1.23

7.43

3.0

3.5

996.64

468.83

mg/l

0.99

413

3339

Seborrhoeic dermatitis

212

1423

1.51

7.42

4.3

3.4

2169.74

357.77

mg/l

0.68

106

658

Drug-induced neutropenia

153

956

1.63

7.41

6.2

3.6

422.50

306.67

mg/l

0.24

105

416

Complications of cardiac and vascular prosthetic devices, implants and grafts

267

2.26

7.41

3.9

3.3

1288.76

294.51

mg/l

1.01

113

Crohn's disease NAS

134

810

1.69

7.38

3.0

3.6

340.56

308.49

mg/l

0.17

387

Other and unspecified acquired haemolytic anaemias

111

3.07

7.37

2.2

2.9

1017.41

358.98

mg/l

0.83

Dermatopolymyositis (FG)

150

2.72

7.37

2.4

3.7

291.56

640.44

mg/l

0.45

Female infertility

469

2131

1.33

7.37

2.7

3.1

456.93

383.83

mg/l

0.25

230

885

Subjective visual disturbances

505

3912

1.30

7.36

2.9

3.2

312.00

393.93

mg/l

0.93

220

1701

Seropositive rheumatoid arthritis, strict definition

293

2093

1.42

7.35

2.8

3.1

285.86

442.34

mg/l

1.54

136

851

Salpingitis and oophoritis

297

2125

1.41

7.35

3.2

297.90

390.51

mg/l

0.60

105

784

Mucinous and mucinous cystic tumor of rectum

4.12

7.32

5.9

2.3

128.53

262.56

mg/l

1.16

Left ventricular outflow tract obstruction (LVOTO), broad definition

200

1330

1.53

7.32

4.1

4.4

460.13

398.69

mg/l

0.33

119

698

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

141

867

1.66

7.27

2.6

3.8

259.73

409.66

mg/l

1.00

411

Soft tissue disorders related to use, overuse and pressure

537

4199

1.29

7.26

3.4

3.5

546.08

412.16

mg/l

0.37

259

1977

Benign neoplasm of other and ill-defined parts of digestive system

357

2640

1.37

7.26

3.3

3.2

498.42

447.75

mg/l

0.14

196

1114

ILD, hospital admissions 3, with pneumonia sepsis

183

1197

1.56

7.25

3.3

3.0

364.88

502.96

mg/l

0.40

101

518

Olecranon bursitis

135

822

1.68

7.25

3.2

3.7

301.99

426.60

mg/l

0.74

434

Enthesopathies of lower limb, excluding foot

425

3222

1.33

7.25

3.4

3.5

289.86

394.15

mg/l

1.34

177

1504

Premature rupture of membranes

303

1537

1.41

7.24

2.4

3.1

234.70

362.23

mg/l

1.63

100

656

Thyrotoxicosis

485

3746

1.31

7.23

3.1

1022.93

421.24

mg/l

0.69

231

1499

Retinal vascular occlusion

259

1817

1.45

7.23

3.6

2.9

1147.04

490.35

mg/l

0.57

136

770

Other prurigo

129

2.86

7.21

3.8

3.6

362.85

182.43

mg/l

1.02

Anti-inflammatory and antirheumatic products, non-steroids

614

2425

1.28

7.20

3.2

4.6

282.87

493.29

mg/l

2.59

268

1417

Striking against or struck by other objects

658

5268

1.26

7.19

3.6

3.8

553.95

416.44

mg/l

0.38

308

2723

Oxicams

461

1986

1.33

7.17

2.7

4.0

447.87

504.54

mg/l

0.14

187

1098

Excessive vomiting in pregnancy

132

800

1.67

7.16

2.8

3.0

376.31

417.04

mg/l

0.11

300

Postprocedural endocrine and metabolic disorders, not elsewhere classified

225

1539

1.48

7.14

3.3

3.0

233.03

494.51

mg/l

1.95

120

582

Inflammatory disease of cervix uteri

120

712

1.72

7.11

2.4

3.1

264.11

410.45

mg/l

0.59

256

Other and unspecified mood [affective] disorders

135

825

1.66

7.10

2.9

3.7

274.87

453.86

mg/l

0.85

397

Malignant neoplasm of ureter, including Hilmo

3.24

7.08

2.6

2.3

354.69

258.84

mg/l

0.32

Other and unspecified rosacea

178

1163

1.55

7.08

4.0

3.3

291.99

395.06

mg/l

0.44

473

Fall on and from stairs and steps

529

4145

1.29

7.07

3.0

3.4

1010.80

406.70

mg/l

0.75

244

1868

Other specified/unspecified systemic involvement of connective tissue

119

706

1.72

7.06

2.8

3.3

369.12

297.83

mg/l

0.29

287

Asthma, hospital admissions , main diagnosis only

1685

12772

1.15

7.06

3.3

3.4

610.43

516.39

mg/l

0.25

761

6016

COPD, hospital admission 2, with asthma infections

674

4668

1.25

7.05

3.0

3.2

867.55

516.21

mg/l

0.36

342

2178

Reactive arthropathies, FINNGEN

136

835

1.66

7.05

3.1

3.5

372.42

429.76

mg/l

0.17

378

Sacroiliitis, not elsewhere classified

528

1.84

7.05

2.8

3.4

265.79

360.19

mg/l

0.43

263

Unspecified maternal hypertension

108

3.00

7.04

2.6

3.1

124.85

371.85

mg/l

1.03

Pneumocystosis

254

2.26

7.02

5.9

3.9

297.66

230.79

mg/l

0.24

113

Pneumocystosis, including avohilmo

254

2.26

7.02

5.9

3.9

297.66

230.79

mg/l

0.24

113

Psoriatic and enteropathic arthropathies

207

1398

1.50

7.01

2.7

3.4

241.33

477.73

mg/l

1.86

634

Other otitis externa (chronic)

146

915

1.63

7.00

3.2

3.5

339.22

422.15

mg/l

0.36

401

Malignant neoplasm of small intestine

260

2.23

7.00

5.4

3.4

410.14

275.07

mg/l

0.73

Allergic urticaria

165

1064

1.58

6.97

3.9

3.7

1405.24

387.75

mg/l

0.60

499

Deficiency of other B group vitamins

241

2.28

6.96

3.4

3.3

259.50

247.35

mg/l

0.06

Retinal vascular disorders

260

1839

1.43

6.95

3.7

2.9

1139.31

485.95

mg/l

0.57

137

782

Additional codes for the location of defect, injury or illness

129

786

1.68

6.94

3.1

3.5

427.51

372.78

mg/l

0.21

354

Marginal zone B-cell lymphoma, including Hilmo

179

2.51

6.93

2.5

2.8

855.09

292.65

mg/l

0.62

Abnormal blood-pressure reading, without diagnosis

107

620

1.76

6.93

3.5

4.3

204.19

360.66

mg/l

0.94

292

Degenerative macular diseases

253

1782

1.44

6.93

3.8

2.9

517.36

387.77

mg/l

0.51

118

723

Mental and behavioural disorders due to sedatives or hypnotics

133

816

1.66

6.93

3.0

3.5

687.48

415.40

mg/l

0.26

390

Rotator cuff syndrome

1211

7083

1.18

6.93

2.7

3.5

505.19

615.07

mg/l

0.26

474

3470

Explicit fungal Sepsis, including avohilmo

3.43

6.89

4.6

6.4

545.35

335.24

mg/l

0.71

Eosinophilia

211

2.38

6.89

2.6

4.3

235.86

332.26

mg/l

0.52

Disorders of muscles

200

1348

1.50

6.87

3.0

3.6

287.95

404.62

mg/l

1.06

656

Other interstitial pulmonary diseases

322

2366

1.38

6.86

2.9

3.2

341.74

462.69

mg/l

0.73

168

1059

Malignant neoplasm of other and ill-defined digestive organs, including Hilmo

180

2.48

6.83

4.7

2.4

266.76

285.16

mg/l

0.10

Other noninflammatory disorders of vagina

143

896

1.62

6.82

2.7

3.0

832.66

360.22

mg/l

0.51

352

Angina pectoris

1134

6363

1.19

6.82

3.1

3.3

505.97

489.79

mg/l

0.05

501

2910

Female infertility, associated with anovulation

124

749

1.68

6.81

2.4

3.0

404.86

344.93

mg/l

0.30

327

Abnormal findings on diagnostic imaging of central nervous system

108

631

1.75

6.80

3.3

4.0

1724.22

415.75

mg/l

0.42

284

Other disorders of white blood cells

123

745

1.69

6.80

3.0

3.6

295.10

309.11

mg/l

0.09

336

Benign intracranial hypertension

3.12

6.79

2.6

3.4

128.33

405.16

mg/l

—

Malnutrition

304

2.12

6.78

4.0

5.3

186.80

326.76

mg/l

1.90

154

Anomalies of dental arch relationship, including avohilmo

367

2484

1.35

6.78

5.0

3.6

470.48

394.58

mg/l

0.22

186

1199

ILD, hospital admissions

317

2329

1.38

6.77

2.9

3.2

345.87

471.36

mg/l

0.75

164

1042

Atopic dermatitis, strict definition with reimbursement

543

4118

1.28

6.76

4.0

3.7

370.00

388.44

mg/l

0.07

285

1990

Algoneurodystrophy

344

2.03

6.75

3.0

3.6

217.42

326.01

mg/l

0.73

144

Diseases of salivary glands

634

5104

1.25

6.74

3.0

3.3

573.91

385.35

mg/l

0.30

269

2279

Other chondrocalcinosis

170

2.54

6.72

2.6

3.1

216.68

288.17

mg/l

0.47

Carcinoma in situ of skin of other and unspecified parts of face

200

1357

1.50

6.72

3.9

2.8

376.99

351.49

mg/l

0.11

528

Erythema nodosum

325

2.06

6.69

3.4

3.1

229.89

305.26

mg/l

0.52

126

Acute bronchiolitis

142

805

1.62

6.66

7.4

5.6

433.12

395.53

mg/l

0.10

475

Viral infections of the central nervous system

143

903

1.61

6.65

4.3

3.5

1448.31

382.04

mg/l

0.49

407

Interstitial lung disease

322

2379

1.37

6.65

2.9

3.2

341.74

465.53

mg/l

0.76

168

1066

Interstitial lung disease endpoints

322

2379

1.37

6.65

2.9

3.2

341.74

465.53

mg/l

0.76

168

1066

Other/unspecified synovitis and tenosynovitis

215

1480

1.47

6.64

3.6

3.5

534.50

418.43

mg/l

0.19

676

Morphin

246

2.22

6.62

5.8

2.4

254.24

291.24

mg/l

0.14

Other degenerative diseases of the nervous system

539

3095

1.28

6.62

2.7

3.4

312.03

501.06

mg/l

1.46

200

1494

Fracture of shoulder and upper arm

741

6070

1.23

6.59

3.5

3.4

457.10

557.61

mg/l

0.41

355

2773

Postpartum hemorraghe, all women as controls

381

2812

1.33

6.58

2.3

3.0

324.92

353.51

mg/l

0.21

160

1199

Dermatophytosis

280

2026

1.40

6.58

4.5

3.3

1518.49

368.97

mg/l

0.91

147

937

Disorders of conjunctiva

1710

11606

1.15

6.57

3.7

3.4

535.59

501.17

mg/l

0.14

777

5429

Other and unspecified types of non-Hodgkin lymphoma, hilmo

557

1.79

6.55

2.4

3.3

771.35

303.28

mg/l

1.08

236

Implicit parasitic Sepsis

4.03

6.54

4.7

3.5

256.23

222.79

mg/l

0.18

Injuries to the ankle and foot

1426

10548

1.16

6.54

3.4

3.5

439.80

462.57

mg/l

0.14

721

5065

Dermatopolymyositis

172

2.49

6.53

2.4

4.4

291.56

299.72

mg/l

0.03

Disorders of speech understanding and production

113

664

1.71

6.52

4.3

5.9

202.81

376.27

mg/l

1.68

391

!Aliquae complicationes praecoces traumatis

101

587

1.76

6.51

3.3

3.8

549.31

479.19

mg/l

0.15

284

Early complications of trauma

101

587

1.76

6.51

3.3

3.8

549.31

479.19

mg/l

0.15

284

Other specific arthropathies, wide

235

2.24

6.51

3.3

3.4

407.65

521.04

mg/l

0.16

103

Benign neoplasm: Rectosigmoid junction

566

1.78

6.50

3.4

3.1

289.93

287.03

mg/l

0.01

236

Personal history of certain other diseases

178

2.43

6.48

2.3

4.5

184.53

235.84

mg/l

0.39

Maternal care for known or suspected fetal abnormality and damage

215

1254

1.46

6.44

3.1

3.2

339.10

372.94

mg/l

0.15

552

Bronchiectasis

175

1167

1.53

6.42

2.9

3.0

1623.65

329.53

mg/l

0.69

474

Other congenital malformations

175

1166

1.52

6.39

3.6

4.8

303.62

322.44

mg/l

0.12

104

612

Perforation of tympanic membrane

201

1379

1.48

6.37

3.3

3.5

424.26

402.48

mg/l

0.07

616

Poor fetal growth

191

1295

1.49

6.37

3.4

2.9

339.47

366.28

mg/l

0.13

559

Alcohol abuse, main dg

290

2122

1.38

6.35

3.3

3.6

312.14

380.80

mg/l

0.66

148

1086

Artrosis, including avohilmo

1624

7756

1.15

6.34

2.8

3.5

370.86

482.60

mg/l

0.91

652

3952

Fistulae involving female genital tract

168

2.47

6.33

5.4

3.4

244.35

251.03

mg/l

0.03

COPD, hospital admissions 3, with asthma pneumonia sepsis

569

3900

1.26

6.33

3.1

3.2

451.20

554.63

mg/l

0.39

288

1800

Palindromic rheumatism

121

2.79

6.32

3.8

3.7

324.60

360.21

mg/l

—

Palmar fascial fibromatosis [Dupuytren]

304

2245

1.37

6.30

3.1

3.4

883.24

493.75

mg/l

0.32

139

1139

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

709

5743

1.23

6.27

3.2

3.6

370.49

402.84

mg/l

0.15

339

2793

Use of disulfiram, acamprosate or naltrexone

163

1075

1.54

6.27

3.0

3.8

289.85

432.58

mg/l

0.94

557

Bullous disorders

125

777

1.64

6.26

5.3

3.3

637.49

406.70

mg/l

0.28

324

Endometriosis of rectovaginal septum and vagina

137

869

1.60

6.26

2.4

2.9

306.69

363.83

mg/l

0.23

348

Congenital malformations of cardiac septa

157

996

1.56

6.25

4.5

5.8

353.60

424.07

mg/l

0.31

104

572

Propionic acid derivatives

603

2424

1.26

6.19

3.2

4.6

338.90

493.54

mg/l

0.76

271

1416

Heartburn

205

1419

1.46

6.18

3.0

3.1

393.17

466.28

mg/l

0.26

619

Myelodysplastic syndrome, including Hilmo

363

1.95

6.18

3.2

2.7

246.29

322.38

mg/l

0.64

130

Disorders of optic nerve and visual pathways

184

1249

1.49

6.17

4.1

3.7

602.51

355.59

mg/l

0.41

571

Biological medication for rheuma

316

2354

1.36

6.17

3.0

3.7

220.32

406.11

mg/l

3.58

155

1136

Congenital malformations of the circulatory system

289

2063

1.38

6.16

4.0

4.5

736.08

406.44

mg/l

0.39

189

1085

Mixed connective tissue disease

196

2.33

6.12

3.0

3.1

772.47

287.46

mg/l

0.91

Aortic valve malfunction, age under 60 years

181

1227

1.50

6.12

4.2

3.9

458.78

391.80

mg/l

0.34

103

639

Acquired absence of organs, not elsewhere classified

129

2.67

6.09

4.4

3.8

467.39

205.43

mg/l

1.33

Volvulus

309

2.03

6.08

4.0

3.2

278.35

294.01

mg/l

0.08

136

Allergic asthma (mode), excluding more controls

375

2796

1.32

6.07

3.1

3.0

205.91

390.25

mg/l

2.59

177

1241

Injuries to the elbow and forearm

1456

10893

1.15

6.04

3.6

3.4

621.87

511.10

mg/l

0.25

650

5049

Viral infections of the central nervous system, including avohilmo

150

981

1.55

6.02

4.2

3.6

1395.04

390.92

mg/l

0.48

446

Other disorders of amniotic fluid and membranes

186

1225

1.48

5.99

2.5

3.2

351.52

364.45

mg/l

0.05

537

Crossbite

160

976

1.53

5.99

7.3

5.7

535.81

368.98

mg/l

0.31

108

573

Radial styloid tenosynovitis [de Quervain]

102

608

1.71

5.99

3.0

3.7

368.45

264.44

mg/l

0.52

263

Primary biliary cholangitis (PBC)

224

2.21

5.96

3.2

1473.36

302.65

mg/l

0.51

Complications following infusion, transfusion and therapeutic injection

186

2.36

5.96

5.0

4.2

273.22

254.27

mg/l

0.09

Primary Sclerosing Cholangitis, IBD and UDCA required

271

2.10

5.96

4.7

5.6

159.84

320.72

mg/l

2.06

141

Congenital malformations of heart and great arteries

261

1843

1.39

5.94

4.1

4.7

773.42

407.71

mg/l

0.39

170

994

Hypersensitivity angiitis

3.74

5.91

5.2

3.5

896.07

263.79

mg/l

1.02

Other specified and unspecified personality disorders

159

1057

1.52

5.91

2.7

3.5

212.55

417.28

mg/l

1.92

496

Agoraphobia

326

1.97

5.90

4.0

3.7

353.93

335.80

mg/l

0.03

159

Dermatophytosis, including avohilmo

1318

11229

1.15

5.89

3.2

3.4

733.53

472.42

mg/l

0.67

569

5419

Juvenile arthritis (FINNGEN)

559

1.73

5.88

5.8

4.7

236.91

339.20

mg/l

1.07

294

Benign thyroid growths and nodules

622

4715

1.23

5.86

2.7

3.1

941.09

500.39

mg/l

0.48

241

1842

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

126

798

1.61

5.85

4.7

2.9

233.55

362.21

mg/l

1.51

303

Psychotic depression

111

681

1.65

5.84

3.4

3.3

361.52

434.53

mg/l

0.20

311

Paralytic ileus

442

1.83

5.84

4.4

3.5

1616.72

429.57

mg/l

0.40

200

Bacterial pneumonia (organism specified)

918

7035

1.19

5.81

3.8

3.2

418.64

574.17

mg/l

1.21

513

3222

Superficial injury of hip and thigh

310

2326

1.35

5.80

2.7

3.1

301.76

386.62

mg/l

0.93

129

995

Conjunctivitis

1507

10641

1.14

5.79

3.7

3.4

525.27

489.33

mg/l

0.14

680

4925

Disturbance of activity and attention

239

1680

1.40

5.77

4.4

4.3

332.02

393.69

mg/l

0.38

124

938

Pneumonia due to Streptococcus pneumoniae

510

1.76

5.77

4.4

3.6

474.70

263.37

mg/l

1.48

227

Other and unspecified vascular occlusions

197

1375

1.45

5.77

3.4

2.9

1399.02

364.23

mg/l

0.72

101

556

Lifestyle-related condition

121

2.68

5.76

4.5

3.6

579.59

229.75

mg/l

0.61

Varicose veins of other sites

128

817

1.59

5.76

3.2

3.5

252.31

366.30

mg/l

0.74

392

Osteonecrosis due to drugs

209

2.26

5.74

3.8

3.4

1204.73

260.98

mg/l

0.58

Psoriasis (vulgaris), strict definition

423

1.84

5.73

3.7

4.1

367.19

416.96

mg/l

0.12

210

Giant cell arteritis

572

1.72

5.73

2.1

3.0

883.03

405.46

mg/l

0.34

220

Other noninflammatory disorders of cervix uteri

556

1.72

5.72

2.4

3.1

1828.23

478.69

mg/l

0.62

214

Varicella [chickenpox]

572

1.71

5.70

6.0

4.6

203.37

365.20

mg/l

1.21

330

Motor disorders, excluding more controls

214

2.19

5.70

6.0

10.1

248.70

362.33

mg/l

0.90

165

Conjunctivitis (acute, non atopic), including avohilmo

2109

11386

1.12

5.69

3.6

3.4

659.08

497.27

mg/l

0.42

1009

5436

Complications following abortion and ectopic and molar pregnancy

359

1.91

5.69

2.6

3.0

257.89

263.95

mg/l

0.02

126

Diplopia

255

1864

1.38

5.69

3.5

3.2

488.88

371.99

mg/l

0.22

117

825

Persons encountering health services in circumstances related to reproduction

1009

5758

1.18

5.69

4.2

4.0

407.33

441.95

mg/l

0.17

508

2897

Hypothyroidism due to medicaments and other exogenous substances

140

2.54

5.68

7.9

3.5

233.80

218.05

mg/l

0.09

Toxic liver disease

184

2.32

5.65

4.2

3.6

218.26

215.60

mg/l

0.01

Lactose intolerance

360

1.91

5.65

3.2

3.9

335.72

437.59

mg/l

0.25

164

Atopic dermatitis

1103

7549

1.17

5.65

3.4

3.5

851.40

400.36

mg/l

0.75

522

3535

Nonalcoholic steatohepatitis

105

2.81

5.65

5.7

4.0

156.29

171.57

mg/l

0.14

Drug-induced polyneuropathy

123

2.68

5.65

4.5

6.3

142.05

305.37

mg/l

1.02

Secondary systemic amyloidosis

5.81

5.63

5.4

4.0

601.70

138.06

mg/l

—

Calculus of lower urinary tract

119

752

1.62

5.63

3.2

378.87

322.83

mg/l

0.31

345

Spirochaetal infections, other/unspecified

182

1259

1.47

5.61

3.4

3.5

399.13

401.37

mg/l

0.01

555

Mild mental retardation

362

1.91

5.60

4.2

5.9

341.00

318.81

mg/l

0.11

212

Other or ill-defined heart diseases

101

612

1.68

5.60

3.8

3.7

434.47

421.39

mg/l

0.03

295

Implicit parasitic Sepsis, including avohilmo

3.44

5.59

4.5

4.2

250.43

219.54

mg/l

0.18

Trigeminal neuralgia

111

690

1.64

5.58

2.6

3.3

261.53

344.28

mg/l

0.35

294

Urethral stricture

124

793

1.59

5.56

3.8

3.3

447.60

368.38

mg/l

0.33

392

Vitamin D deficiency

211

2.20

5.55

2.6

3.6

454.72

278.46

mg/l

0.57

Autoimmune hyperthyroidism

109

675

1.64

5.55

3.1

3.4

1698.31

271.30

mg/l

0.47

260

Pain in thoracic spine

279

2077

1.36

5.53

2.7

3.5

308.01

444.19

mg/l

1.08

113

937

Acute gastritis

145

961

1.53

5.52

2.7

3.6

496.93

355.51

mg/l

0.47

424

Malignant melanoma, including Hilmo

306

2311

1.34

5.51

3.1

2.7

310.77

494.86

mg/l

1.01

150

867

Pregnancy, childbirth and the puerperium

544

2279

1.25

5.50

3.0

3.1

302.98

588.84

mg/l

1.33

202

843

Nosocomial condition (hospital)

3.30

5.50

4.0

3.8

613.45

229.10

mg/l

0.69

Other complications of labour and delivery, not elsewhere classified

165

990

1.49

5.50

2.7

3.1

273.80

336.36

mg/l

0.57

447

Hallux valgus (acquired)

584

3395

1.24

5.50

2.8

3.3

357.93

577.40

mg/l

0.81

218

1451

ILD-related respiratory insufficiency

474

1.78

5.50

3.0

3.2

308.86

260.96

mg/l

0.29

194

Lung diseases due to external agents

276

2055

1.36

5.49

3.6

3.2

1448.94

482.25

mg/l

0.44

141

945

Other juvenile arthritis

488

1.76

5.48

6.3

5.3

252.39

361.72

mg/l

1.02

268

Eustachian salpingitis and obstruction

141

930

1.54

5.47

3.5

3.8

429.36

523.21

mg/l

0.23

456

Other disorders of optic [2nd] nerve and visual pathways

135

884

1.55

5.46

4.2

3.8

724.56

377.20

mg/l

0.45

409

Otalgia

172

1183

1.48

5.45

3.4

4.2

452.45

341.96

mg/l

0.39

565

Other pulmonary heart/vessel disease

595

1.68

5.45

2.6

3.1

292.06

421.57

mg/l

0.52

243

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

444

1.80

5.44

4.1

6.4

400.10

304.40

mg/l

0.43

281

malignant neoplasm of male genital organs, including Hilmo

503

2413

1.26

5.43

2.8

3.2

594.81

542.19

mg/l

0.06

243

1162

IBD patients in KELA-register

404

3172

1.28

5.43

3.1

3.5

405.19

458.83

mg/l

0.16

202

1555

Allergic asthma (mode)

375

2844

1.29

5.41

3.1

3.0

205.91

400.78

mg/l

2.89

177

1257

Preterm labour and delivery

376

2926

1.29

5.40

3.2

492.70

390.72

mg/l

0.25

159

1162

Other and unspecified coagulation defects

102

627

1.66

5.40

4.1

3.9

660.86

302.13

mg/l

0.45

269

Dissociative [conversion] disorders

409

1.82

5.38

3.1

3.2

334.58

366.77

mg/l

0.16

177

5-aminosalicylic acid

357

2762

1.30

5.38

3.1

3.3

1205.99

455.20

mg/l

0.63

169

1312

Unspecified/other endometriosis

147

961

1.51

5.36

2.7

3.1

217.66

382.30

mg/l

1.37

421

Cerebral palsy and other paralytic syndromes

213

1528

1.41

5.35

3.4

3.8

305.19

429.67

mg/l

1.03

110

706

Disorders of brain, other and unspecified

114

2.67

5.35

1.7

3.4

529.10

290.83

mg/l

0.76

Other sleep disorders

210

1503

1.41

5.34

3.6

270.33

465.83

mg/l

1.90

109

729

Urethritis and urethral syndrome

255

2.06

5.33

4.3

2.9

583.56

361.17

mg/l

0.31

105

FESS (DNB20)

226

1639

1.39

5.32

2.9

3.4

778.00

428.01

mg/l

0.54

773

Temporal arteritis

501

1.74

5.32

2.1

3.0

943.76

433.32

mg/l

0.34

190

Pneumonia derived septicemia

501

1.74

5.32

4.4

3.9

443.96

278.80

mg/l

0.87

242

Exposure to other specified electric current

276

2.01

5.31

2.3

4.3

183.75

301.27

mg/l

—

144

Fracture of foot, except ankle

459

3672

1.26

5.28

3.5

473.87

429.44

mg/l

0.26

214

1726

Hypogonadotropic hypogonadism

347

1.89

5.28

3.0

4.7

301.42

508.54

mg/l

0.52

211

Viral pneumonia (unknown virus, not influenza)

139

923

1.53

5.27

4.2

3.4

867.78

312.30

mg/l

0.90

437

Female infertility, cervical, vaginal, other or unspecified origin

413

2070

1.28

5.27

2.7

3.1

475.91

375.19

mg/l

0.34

207

858

Malignant neoplasm of other and unspecified urinary organs, including Hilmo

3.10

5.27

2.4

2.0

287.69

300.31

mg/l

0.06

Ethmoidectomy

232

1693

1.39

5.27

2.9

3.4

769.63

453.05

mg/l

0.48

797

Malignant neoplasm of ovary

532

1.71

5.25

6.9

2.5

168.92

347.46

mg/l

2.55

152

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

155

1054

1.49

5.24

4.0

3.3

402.47

354.14

mg/l

0.18

427

Specific development disorders of scholastic skills

596

1.66

5.24

6.6

6.3

226.04

367.96

mg/l

2.40

389

Spondylolisthesis/Spondylolysis

337

2599

1.31

5.24

2.8

3.4

645.38

402.16

mg/l

0.32

132

1162

Polyarteritis nodosa

3.18

5.23

4.0

3.1

614.15

257.11

mg/l

1.23

COPD, hospital admissions 1, only main diagnosis

700

5022

1.21

5.22

2.8

3.2

445.40

581.67

mg/l

0.55

339

2329

Scleritis

152

2.40

5.22

2.0

3.5

599.88

208.41

mg/l

0.74

Rosacea

232

1697

1.38

5.19

4.1

3.3

345.59

407.05

mg/l

0.27

111

700

Blindness, monocular

116

2.63

5.18

5.6

3.2

376.67

268.80

mg/l

0.45

Carcinoma in situ of skin of ear and external auricular canal

225

2.13

5.17

4.6

2.8

458.16

294.55

mg/l

0.41

Organ-limited amyloidosis

3.51

5.17

2.2

3.6

312.20

178.33

mg/l

—

Benign paroxysmal vertigo

573

4708

1.23

5.16

3.2

510.86

408.64

mg/l

0.27

219

1976

Pleural plaque with presence of asbestos

157

1075

1.49

5.16

2.8

3.1

2620.15

328.80

mg/l

0.49

513

Cerebral oedema

6.88

5.15

5.6

6.5

307.43

138.58

mg/l

—

Other keratitis

211

1522

1.40

5.15

3.0

3.3

597.42

406.89

mg/l

0.74

685

Other misadventures during surgical and medical care

315

1.93

5.14

3.9

3.4

233.18

292.34

mg/l

0.44

137

Other contact dermatitis

151

1025

1.49

5.14

3.2

3.4

343.48

348.10

mg/l

0.02

449

Secondary right heart disease

536

1.70

5.14

2.4

3.0

297.44

441.84

mg/l

0.51

207

Delayed milestone in childhood

342

1.87

5.11

7.2

9.8

329.06

314.89

mg/l

0.06

288

Severe visual impairment, monocular

129

2.52

5.11

7.1

3.1

475.87

234.44

mg/l

0.65

Short stature, not elsewhere classified

394

1.81

5.10

8.2

8.0

396.16

295.81

mg/l

0.37

306

Trigger finger

256

1907

1.36

5.09

3.7

3.5

1031.15

365.99

mg/l

0.50

113

873

Schizophrenia or delusion

555

4551

1.23

5.08

3.0

3.3

577.96

423.22

mg/l

0.22

257

2150

Deep bite

230

1479

1.38

5.05

7.9

4.4

362.40

372.58

mg/l

0.04

129

793

Other lesions of median nerve

324

1.90

5.04

3.3

3.2

253.48

444.77

mg/l

0.45

129

Tongue abnormality

126

829

1.55

5.03

3.9

3.4

306.56

368.65

mg/l

0.22

348

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

101

631

1.63

5.03

3.8

2.8

755.85

409.22

mg/l

0.40

233

Supervision of normal pregnancy

271

1148

1.35

5.02

2.7

3.2

506.93

598.99

mg/l

0.10

442

Chronic iridocyclitis

101

632

1.63

5.01

2.9

3.6

184.61

308.05

mg/l

1.95

284

Marginal zone B-cell lymphoma

106

2.67

5.00

2.6

2.2

1442.00

332.82

mg/l

0.60

Lesion of plantar nerve

114

734

1.58

5.00

3.1

3.3

1094.47

331.33

mg/l

0.44

299

Other enthesopathies

528

4314

1.23

5.00

2.8

3.5

349.45

377.54

mg/l

0.08

201

2046

Amputation of thigh

406

1.79

4.96

3.3

2.9

615.00

447.81

mg/l

0.35

158

Bronchitis, not specified as acute or chronic

164

1140

1.46

4.95

3.5

3.2

333.94

439.14

mg/l

0.61

520

Psoriatic arthropathies

176

1239

1.44

4.95

2.7

3.6

263.14

504.83

mg/l

1.47

586

Other and unspecified psoriasis

134

896

1.52

4.95

3.2

3.4

239.23

361.87

mg/l

0.78

399

Ankylosing spondylitis

158

1091

1.47

4.94

3.6

3.5

397.07

480.73

mg/l

0.34

533

Malignant melanoma

272

2055

1.34

4.94

3.1

2.7

328.89

479.58

mg/l

0.66

132

761

malignant neoplasm of male genital organs

491

2383

1.25

4.94

2.8

3.1

613.60

547.95

mg/l

0.07

236

1142

Atypical mycobacterium lung infection

150

2.37

4.93

3.6

3.3

1446.75

247.85

mg/l

0.46

Biological medicines for asthma

263

2.00

4.93

2.8

3.8

191.00

340.95

mg/l

0.96

119

Postprocedural disorders of nervous system

122

800

1.55

4.91

3.8

3.5

263.66

358.50

mg/l

0.51

360

Septal defects

145

967

1.49

4.91

4.8

5.9

355.02

392.42

mg/l

0.15

564

Uterine polyps

455

2125

1.26

4.90

2.8

3.1

537.64

448.17

mg/l

0.16

169

849

Other endocrine disorders

124

783

1.55

4.90

6.9

5.8

330.25

308.52

mg/l

0.11

100

479

Allergic rhinitis

548

4448

1.22

4.89

3.4

3.8

302.58

412.26

mg/l

1.27

223

2201

Other acute viral hepatitis

144

2.38

4.89

4.3

4.5

155.74

324.17

mg/l

1.03

Disorders of plasma-protein metabolism, not elsewhere classified

3.04

4.89

2.2

3.6

264.09

334.72

mg/l

0.28

L04AC Interleukin inhibitors

123

810

1.54

4.88

2.4

3.8

231.13

363.89

mg/l

0.84

396

Cervicalgia

381

3014

1.27

4.87

2.5

3.4

408.85

413.13

mg/l

0.02

139

1342

Other/unspecified crystal arthropathies

2.97

4.86

4.7

3.5

278.25

229.44

mg/l

—

Encephalopathy

120

2.53

4.85

5.2

4.0

473.88

339.86

mg/l

0.33

Ulcerative colitis

436

3506

1.25

4.84

3.4

3.5

388.94

448.17

mg/l

0.20

225

1664

Other arterial embolism and thrombosis

343

1.85

4.84

2.7

3.2

592.80

460.26

mg/l

0.27

148

Scoliosis

165

1154

1.45

4.84

3.8

3.7

1441.80

462.49

mg/l

0.43

538

Other disorders of eyelid

899

7291

1.17

4.82

3.3

3.2

844.83

512.70

mg/l

0.71

365

3187

Other peripheral vascular diseases

150

1032

1.47

4.80

2.4

3.3

239.32

324.80

mg/l

0.61

441

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

272

1.95

4.79

3.5

3.2

379.33

288.61

mg/l

0.31

111

Gluteal tendinitis

523

1.67

4.79

3.8

3.4

249.69

439.76

mg/l

0.81

225

Schizophrenia, schizotypal and delusional disorders

554

4572

1.22

4.79

3.0

3.3

572.03

423.46

mg/l

0.21

256

2155

Other and unspecified abdominal hernia

516

1.68

4.78

5.2

3.3

252.30

328.13

mg/l

0.54

210

Mixed conductive and sensorineural hearing loss

239

1783

1.36

4.77

3.3

267.84

406.01

mg/l

1.38

100

802

Complications predominantly related to the puerperium

399

3181

1.26

4.77

2.8

3.0

462.15

325.48

mg/l

0.41

169

1293

Delirium, not induced by alcohol and other psychoactive substances

261

1968

1.34

4.77

2.7

3.1

420.76

521.23

mg/l

0.40

127

880

Intracranial and intraspinal abscess and granuloma

146

2.36

4.76

3.6

3.8

202.00

201.17

mg/l

0.01

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

172

1217

1.43

4.75

3.2

3.3

533.71

414.44

mg/l

0.14

522

ILD and respiratory illness in diseases classified elsewhere

3.42

4.74

3.8

3.1

533.38

272.06

mg/l

—

Malignant neoplasm of prostate

479

2290

1.25

4.74

2.7

3.1

621.79

555.23

mg/l

0.07

231

1088

Disorders of endocrine glands in diseases classified elsewhere

6.14

4.73

10.3

12.0

310.25

330.27

mg/l

0.04

All dysplastic lesions of the vulva

464

1.71

4.73

3.1

1027.56

292.13

mg/l

0.53

164

Strabismus

496

4044

1.23

4.73

3.7

3.8

287.63

393.94

mg/l

1.89

251

1944

Giant cell arteritis with polymyalgia rheumatica

520

1.68

4.68

2.1

3.1

943.76

424.32

mg/l

0.35

197

Amenorrhoea

110

713

1.56

4.67

4.1

3.2

428.73

441.37

mg/l

0.04

324

Pleural plaque

197

1432

1.40

4.67

2.8

3.0

2139.02

482.98

mg/l

0.45

654

Adjustment and management of implanted device

326

2545

1.29

4.67

2.9

2.6

1644.22

552.00

mg/l

0.58

174

1077

Personal history of risk-factors, not elsewhere classified

147

2.32

4.66

2.9

6.3

123.06

284.62

mg/l

1.91

Migraine, single triptan purchase ok & required. ICD-code if available is included

1404

8422

1.13

4.65

2.9

3.5

699.26

447.05

mg/l

0.40

532

3975

Triptan medication for migraine, single purchase ok

1404

8422

1.13

4.65

2.9

3.5

699.26

447.05

mg/l

0.40

532

3975

Post-traumatic wound infection, not elsewhere classified

363

1.81

4.63

3.8

4.2

627.33

319.15

mg/l

0.80

172

Non-allergic asthma

1242

0.60

4.62

3.3

4.0

386.90

347.25

mg/l

0.09

584

Synovial cyst of popliteal space [Baker]

138

942

1.49

4.62

2.9

3.4

300.54

408.01

mg/l

0.47

399

Other and unspecified mononeuropathies, also in other diseases

363

1.81

4.62

3.8

3.6

319.97

285.43

mg/l

0.20

164

Parkinson's disease, excluding more controls

246

1700

1.34

4.62

2.4

3.4

205.33

389.96

mg/l

2.76

856

Hyperkinetic disorders

248

1821

1.34

4.61

4.4

327.79

380.78

mg/l

0.33

127

1031

Intentional self-harm by unspecified means

148

2.31

4.60

3.6

4.6

415.88

353.20

mg/l

—

Inflammatory bowel disease, strict (require KELA)

404

3242

1.25

4.59

3.1

3.5

405.19

408.48

mg/l

0.01

202

1585

Asthma, including avohilmo

2460

12350

1.10

4.59

3.2

3.5

545.42

504.85

mg/l

0.13

1090

5967

Unspecified jaundice

607

1.61

4.58

3.7

260.49

423.73

mg/l

0.86

270

Disorders of tooth development and eruption

282

1755

1.32

4.58

3.9

3.3

320.36

393.22

mg/l

0.41

149

853

Emotional disorders and disorders of social functioning with onset specific to childhood

107

679

1.57

4.57

4.7

5.5

221.76

423.77

mg/l

1.81

418

Adalimumab

172

1226

1.42

4.55

2.8

3.8

205.50

413.47

mg/l

2.52

592

Endometriosis ASRM stages 1,2

278

2133

1.31

4.55

2.7

3.1

244.14

424.23

mg/l

1.90

835

Triptan medication for migraine, min. 3 purchases

957

6189

1.16

4.55

2.6

3.4

478.66

422.39

mg/l

0.17

345

2801

Portal vein thrombosis

202

2.10

4.54

4.3

5.1

325.07

325.19

mg/l

0.00

Pneumococcal septicemia

486

1.69

4.54

4.5

4.1

462.38

297.84

mg/l

0.78

231

Caries of enamel

1917

11318

1.11

4.53

3.7

3.4

662.91

485.48

mg/l

0.46

954

5323

Lung transplant status

100

2.65

4.52

8.2

6.5

439.65

267.83

mg/l

0.45

Temporomandibular joint disorders, including avohilmo

793

6573

1.17

4.52

2.7

3.3

307.62

399.91

mg/l

0.49

293

2942

Lung transplantation

100

2.65

4.52

8.2

6.5

439.65

267.83

mg/l

0.45

Cachexia

3.18

4.51

4.1

3.0

2627.58

243.92

mg/l

0.57

Necrosis of pulp, including avohilmo

1080

9344

1.15

4.51

3.3

3.4

352.57

466.58

mg/l

1.00

495

4476

Impetigo

618

1.60

4.50

4.7

4.6

326.14

349.04

mg/l

0.07

322

Pulmonary oedema

223

2.03

4.49

4.6

2.9

734.68

275.89

mg/l

2.65

Arterial embolism and thrombosis

116

769

1.53

4.49

2.7

3.1

601.24

361.05

mg/l

0.91

328

Acute appendicitis

1311

10781

1.13

4.49

3.4

349.72

474.10

mg/l

1.15

594

5179

Suppurative and necrotic conditions of lower respiratory tract

115

762

1.54

4.49

3.2

3.8

483.01

378.79

mg/l

0.33

354

Infection of intervertebral disc (pyogenic)

183

2.16

4.48

6.2

3.5

254.64

245.00

mg/l

0.06

Amblyopia ex anopsia

612

1.60

4.47

5.2

5.0

339.04

337.81

mg/l

0.00

349

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

217

2.05

4.47

10.0

5.5

540.55

269.17

mg/l

0.77

125

Mixed disorders of conduct and emotions, excluding more controls

223

2.02

4.46

6.2

5.7

238.63

384.68

mg/l

0.97

135

Recurrent dislocation of patella

556

1.62

4.46

2.9

3.7

287.02

350.17

mg/l

0.30

264

3.41

4.45

3.9

3.2

533.38

282.76

mg/l

—

Malignant neoplasm of prostate, including Hilmo

482

2316

1.24

4.45

2.8

3.1

613.73

551.45

mg/l

0.07

232

1103

Endometriosis ASRM stages 3,4

378

3023

1.26

4.45

2.9

314.38

406.27

mg/l

0.63

128

1130

Infective bursitis

338

1.82

4.44

3.6

4.1

2788.48

379.26

mg/l

0.53

168

Diseases of appendix

1414

11258

1.13

4.44

3.3

3.4

356.25

484.44

mg/l

1.26

636

5396

Perineal laceration during delivery

236

1427

1.34

4.44

2.4

3.1

240.90

378.41

mg/l

1.67

608

Superficial injury of head

474

3881

1.23

4.43

3.5

725.72

419.92

mg/l

0.45

231

1810

Benign leiomyoma with endometriosis

268

2058

1.31

4.40

2.5

3.0

310.48

436.40

mg/l

0.76

724

Other localized connective tissue disorders

239

1.98

4.40

5.5

3.0

495.50

317.36

mg/l

0.31

Oesophagitis

107

702

1.55

4.38

3.0

3.3

391.52

376.42

mg/l

0.05

317

severe traumatic brain injury, does not include concussion

438

3569

1.24

4.36

2.9

3.2

725.47

494.80

mg/l

0.30

224

1654

440

1.70

4.35

9.9

8.2

301.95

431.68

mg/l

0.47

339

Disorders of purine and pyrimidine metabolism

3.21

4.34

2.9

3.2

7732.60

195.47

mg/l

—

Assault by blunt object

165

2.19

4.34

2.9

4.4

241.89

313.16

mg/l

0.34

Nontraumatic intracranial haemmorrhage

387

3113

1.25

4.34

2.8

3.1

360.92

486.55

mg/l

0.91

203

1341

Adult-onset Still disease

4.14

4.33

4.3

4.1

211.80

281.95

mg/l

—

Sequelae of other external causes

113

752

1.53

4.33

3.5

3.4

321.71

365.50

mg/l

0.19

329

Secondary thrombocytopenia

146

2.28

4.32

6.7

4.6

283.31

236.53

mg/l

0.18

Secondary malignant neoplasm of respiratory and digestive organs

199

2.07

4.32

5.3

2.0

119.45

273.69

mg/l

2.72

Respiratory and cardiovascular disorders specific to the perinatal period

420

1.70

4.30

10.0

8.7

541.38

395.96

mg/l

0.37

335

Drug-induced systemic lupus erythematosus

2.90

4.30

4.8

2.8

198.90

280.85

mg/l

—

Acute alcohol intoxication, ICD10

359

2867

1.26

4.30

3.2

3.5

291.97

419.74

mg/l

1.70

175

1463

Acute lymphadenitis

111

737

1.53

4.29

5.5

3.8

446.00

285.70

mg/l

0.76

348

Faecal incontinence

166

1190

1.41

4.29

3.4

2.9

292.39

409.10

mg/l

0.56

446

Family history of other conditions

146

2.25

4.28

3.5

4.1

184.26

219.04

mg/l

0.23

Tumor necrosis factor alpha inhibitors

272

2101

1.31

4.27

3.0

3.7

201.07

406.35

mg/l

4.17

132

1032

Chronic diseases of tonsils and adenoids

1493

8412

1.12

4.27

3.7

3.6

511.39

517.57

mg/l

0.02

694

4138

Other disorders of bone density and structure

284

1.87

4.26

1.8

3.7

253.80

260.29

mg/l

0.03

127

Malignant neoplasm of anus and anal canal, including Hilmo

147

2.26

4.25

7.6

2.5

228.92

301.35

mg/l

0.57

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

123

836

1.49

4.25

2.5

3.6

241.06

368.10

mg/l

0.97

402

Systemic sclerosis (FG)

256

1.92

4.24

3.4

3.3

300.23

518.79

mg/l

0.39

101

Crowding of teeth, including avohilmo

178

1067

1.40

4.23

7.8

4.7

540.15

351.80

mg/l

0.38

118

592

Labour and delivery complicated by fetal stress [distress]

311

1578

1.29

4.22

2.4

3.2

319.06

423.29

mg/l

0.38

147

671

Parkinson's disease, strict definition, excluding more controls

229

1612

1.34

4.22

2.3

3.3

201.52

396.10

mg/l

2.76

806

Dyshidrosis [pompholyx]

194

2.07

4.22

3.5

3.7

461.46

265.02

mg/l

0.67

Other abnormal products of conception

449

2399

1.23

4.22

2.7

3.1

329.61

401.08

mg/l

0.36

192

1015

Acne

187

1363

1.38

4.21

4.4

3.8

435.51

354.69

mg/l

0.34

115

709

Carcinoma in situ of skin of trunk

481

1.66

4.21

8.0

2.8

315.45

432.41

mg/l

0.30

185

222

1.99

4.19

3.0

4.3

254.23

388.24

mg/l

0.87

127

Mental retardation

641

1.56

4.18

5.1

6.8

363.67

296.41

mg/l

0.39

420

Lactose intolerance, other/unspecified

330

1.80

4.17

3.1

3.9

283.50

461.70

mg/l

0.46

148

Dysplasia of cervi uteri

358

2005

1.26

4.17

3.1

498.78

352.74

mg/l

0.34

134

834

Asthma and allergy, excluding more controls

194

1413

1.36

4.17

2.9

3.2

228.85

399.33

mg/l

1.35

626

1259

0.63

4.17

2.3

3.4

400.78

405.40

mg/l

0.02

613

Lesion of ulnar nerve

240

1830

1.32

4.16

2.6

3.4

300.23

407.52

mg/l

0.83

898

Other ulcerative colitis

105

694

1.54

4.16

3.1

3.5

242.12

371.33

mg/l

0.75

329

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

143

987

1.44

4.16

6.1

5.0

378.18

380.98

mg/l

0.01

104

546

Other disorders of eye and adnexa

260

2005

1.31

4.16

3.8

3.4

383.95

458.72

mg/l

0.38

138

903

Vulvovaginal ulceration/inflammation in other diseases

113

758

1.51

4.16

2.6

2.9

275.48

328.03

mg/l

0.31

290

Other diseases of peritoneum

544

1.61

4.15

2.7

3.2

365.60

303.73

mg/l

0.20

215

Mental retardation, wide definition

103

674

1.55

4.15

5.0

6.6

360.95

297.79

mg/l

0.36

434

Fracture of forearm

1087

8602

1.14

4.14

3.4

3.3

533.04

504.73

mg/l

0.05

469

3789

Vascular dementia (undefined)

570

1.59

4.13

3.1

2.8

305.32

449.66

mg/l

0.46

238

Spondylopathies in diseases classified elsewhere

169

2.16

4.13

4.5

3.2

319.65

263.03

mg/l

0.15

Drug-induced hypoglycaemia without coma

196

2.05

4.11

3.5

3.6

949.81

254.35

mg/l

1.58

Oligomenorrhoea

361

1.75

4.10

3.7

3.0

307.29

354.12

mg/l

0.25

152

Maternal care related to the fetus and amniotic cavity and possible delivery problems

625

3084

1.19

4.10

3.0

3.2

324.13

440.90

mg/l

0.77

235

1261

Carcinoma in situ of skin of lower limb, including hip

296

1.85

4.10

4.8

3.0

222.59

472.28

mg/l

0.51

103

Delivery

706

3162

1.18

4.09

2.9

3.1

292.85

650.09

mg/l

1.52

277

1185

Varicella [chickenpox], including avohilmo

106

705

1.53

4.08

6.0

5.0

228.53

343.44

mg/l

0.92

422

Other noninfective disorders of lymphatic vessels and lymph nodes

415

1.69

4.07

4.2

3.3

514.31

296.66

mg/l

0.70

162

Asthma/COPD (KELA code 203)

1942

11791

1.10

4.07

3.0

3.5

816.97

465.89

mg/l

0.83

802

5662

Other immunodeficiencies

124

2.35

4.06

4.9

4.7

588.86

307.06

mg/l

0.42

Nontoxic diffuse goitre

363

1.74

4.05

2.2

3.1

473.44

288.95

mg/l

0.35

128

Pemphigoid

379

1.73

4.04

4.8

2.9

287.10

469.94

mg/l

0.53

153

Granulomatous disorders of skin and subcutaneous tissue

319

1.80

4.03

4.3

3.8

629.72

281.11

mg/l

1.03

141

Focal brain injury

111

747

1.50

4.03

2.8

3.7

457.20

473.93

mg/l

0.03

402

Disorders of refraction and accommodation

514

4273

1.20

4.03

4.6

3.8

332.81

402.21

mg/l

0.75

262

2079

398

1.71

4.03

10.2

8.6

324.04

448.87

mg/l

0.39

314

Dementia, including avohilmo

990

5914

1.15

4.02

2.7

3.1

347.19

608.64

mg/l

2.24

378

2644

Crohn disease (strict definition, require KELA, min 2 HDR)

115

781

1.49

4.01

2.4

3.6

249.53

376.04

mg/l

0.89

378

Paralytic strabismus

139

980

1.44

4.00

3.3

3.5

351.31

374.13

mg/l

0.10

436

Hepatomegaly and splenomegaly, not elsewhere classified

106

2.45

4.00

3.1

3.9

439.31

363.44

mg/l

0.16

Fibrosis of liver

2.69

3.99

3.2

3.4

197.10

226.35

mg/l

—

Traction detachment of retina

2.56

3.98

7.4

4.2

1148.65

205.79

mg/l

1.44

Other epidermal thickening

638

1.55

3.97

4.8

3.6

239.04

279.92

mg/l

0.35

279

Unspecified privation

197

1472

1.35

3.97

3.6

3.4

498.21

393.93

mg/l

0.24

127

649

Alzheimer disease

516

4404

0.83

3.96

2.4

2.9

1187.55

678.29

mg/l

0.26

176

1832

Raynaud syndrome

159

1149

1.40

3.96

2.4

3.3

236.00

342.81

mg/l

0.92

498

Other factor of the environment

145

2.21

3.95

4.5

3.4

579.59

322.78

mg/l

0.39

Alzheimer’s disease, strict definition

380

3764

0.81

3.95

2.5

2.9

1485.81

646.19

mg/l

0.32

129

1554

Crohn disease (strict definition, require KELA)

116

792

1.48

3.95

2.4

3.6

245.50

373.33

mg/l

0.92

382

Nontoxic single thyroid nodule

132

924

1.45

3.95

3.1

3.4

2092.18

311.55

mg/l

0.54

372

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

111

752

1.50

3.94

2.7

3.2

252.53

376.21

mg/l

0.63

284

Cardiomyopathy, other and unspecified

132

924

1.45

3.94

2.9

3.7

323.22

338.45

mg/l

0.06

433

Rare circulating lymphoid malignancy, including Hilmo

374

1.72

3.93

2.9

4.2

1156.24

303.10

mg/l

0.70

164

6-mercaptopurine

396

1.70

3.93

2.1

3.8

279.50

390.29

mg/l

0.32

208

Retained placenta and membranes, without haemorrhage

179

1321

1.37

3.90

2.9

3.1

321.28

389.20

mg/l

0.27

516

Unspecified misadventure during surgical and medical care

116

796

1.48

3.88

4.9

3.2

328.91

382.15

mg/l

0.24

345

Open wound of ankle and foot

195

1461

1.35

3.87

4.3

3.4

587.76

403.37

mg/l

1.10

112

700

Patent foramen ovale

332

1.77

3.85

4.7

6.5

544.66

323.96

mg/l

0.62

197

Degenerative diseases of the nervous system

584

4947

0.84

3.84

2.4

3.0

1099.27

676.71

mg/l

0.24

199

2132

Abnormalities of forces of labour

133

936

1.43

3.84

2.5

3.2

234.12

345.37

mg/l

0.70

370

Chronic hepatitis NAS

147

2.18

3.83

4.0

3.3

205.75

249.46

mg/l

0.23

Acne vulgaris

146

1044

1.41

3.82

4.2

3.9

478.69

379.57

mg/l

0.32

538

Deviated nasal septum

591

5015

1.18

3.81

3.3

3.5

273.67

588.01

mg/l

3.65

256

2587

Other/unspecified reactive arthropathies

122

848

1.46

3.81

3.0

3.4

386.95

356.09

mg/l

0.09

383

Alcohol abuse counselling and surveillance

188

2.03

3.81

2.6

4.6

247.11

268.50

mg/l

0.10

101

Appendicitis, broad definition

1390

11205

1.12

3.81

3.4

358.20

484.94

mg/l

1.23

630

5374

Polymyositis

2.61

3.80

2.6

3.0

371.56

244.63

mg/l

—

Campylobacter enteritis

348

1.73

3.79

5.1

3.8

266.26

302.64

mg/l

0.20

161

Pilonidal cyst

143

1023

1.41

3.78

3.7

3.8

424.12

369.41

mg/l

0.18

519

Wet age-related macular degeneration

369

2895

1.24

3.78

2.5

2.8

827.15

624.97

mg/l

0.15

143

1160

Scleritis and episcleritis

108

734

1.49

3.78

2.5

3.6

503.98

376.46

mg/l

0.37

319

Other congenital malformations, including avohilmo

228

1752

1.31

3.77

3.3

4.3

295.77

373.48

mg/l

0.68

128

874

Other Crohn's disease

121

841

1.46

3.77

3.1

3.5

243.56

409.03

mg/l

1.09

410

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

129

907

1.44

3.76

3.0

3.8

338.24

491.09

mg/l

0.53

446

Radiculopathy

287

2273

1.27

3.76

2.7

3.3

1633.69

504.30

mg/l

0.44

121

1022

Acute appendicitis, no complications

983

8619

1.14

3.75

3.3

3.4

375.99

494.19

mg/l

0.75

436

4171

Single delivery by forceps and vacuum extractor

181

793

1.37

3.75

2.5

3.5

294.34

538.67

mg/l

0.56

347

Ankylosing spondylitis, ICD10

153

1110

1.39

3.74

3.6

403.84

400.43

mg/l

0.01

515

Delivery, wide proxy

595

2669

1.19

3.73

3.1

316.51

686.94

mg/l

1.26

234

999

Malignant neoplasm of eye and adnexa, including Hilmo

176

2.05

3.71

3.7

2.7

322.33

293.36

mg/l

0.10

Abnormalities of gait and mobility

242

1882

1.30

3.70

2.6

3.6

503.43

389.36

mg/l

0.21

110

885

Other or unspecified immunodeficiency

3.17

3.70

2.9

5.5

793.50

373.38

mg/l

—

Allergic contact dermatitis due to drugs in contact with skin

269

1.83

3.69

3.1

3.4

244.21

346.46

mg/l

0.72

107

Diseases of spleen

233

1.90

3.69

2.7

3.9

410.44

272.57

mg/l

0.85

103

Severe visual impairment, binocular

2.90

3.69

7.5

3.9

440.50

174.44

mg/l

—

Drug-induced gout

3.14

3.68

2.1

3.4

537.29

173.21

mg/l

—

Malignant neoplasm of adrenal gland, including Hilmo

2.51

3.66

5.9

7.2

197.71

351.68

mg/l

0.70

Onychogryphosis

4.65

3.64

6.9

3.6

648.00

175.09

mg/l

—

Systemic sclerosis

270

1.82

3.64

3.4

3.0

300.23

293.36

mg/l

0.03

109

Carcinoma in situ of skin of scalp and neck

438

1.64

3.63

4.1

2.8

355.81

274.61

mg/l

0.53

179

Hyperaldosteronism

368

1.70

3.63

3.5

3.4

253.21

292.92

mg/l

0.24

161

Valvular operations

251

1966

1.29

3.61

2.7

3.9

967.95

394.10

mg/l

0.50

133

976

Tuberculosis of other organs

249

1.86

3.61

3.9

3.2

297.26

240.04

mg/l

0.28

ILD, hospital admissions 1, main diag only

264

2083

1.28

3.61

2.9

3.2

356.16

418.91

mg/l

0.46

138

930

Hypermobility syndrome

571

1.54

3.61

3.1

3.2

202.63

318.64

mg/l

1.19

249

Benign neoplasm: Anus and anal canal

369

1.69

3.59

3.6

3.3

252.32

328.20

mg/l

0.27

152

Alzheimer’s disease (Late onset)

354

3561

0.81

3.58

2.5

2.8

1525.63

665.14

mg/l

0.32

125

1455

Other congenital malformations, not elsewhere classified

112

2.33

3.58

4.8

6.3

411.75

447.91

mg/l

0.06

Specific developmental disorder of motor function

265

1.82

3.57

6.0

9.9

248.70

372.35

mg/l

1.10

211

Nail dystrophy

2.74

3.56

4.5

3.2

138.14

164.97

mg/l

—

Other general symptoms and signs

583

1.53

3.56

3.7

3.8

192.80

290.97

mg/l

1.47

278

Hereditary deficiency of other clotting factors

2.46

3.56

5.3

3.6

280.17

270.05

mg/l

0.03

Dislocation, sprain and strain of joints and ligaments at neck level

257

2023

1.28

3.56

2.7

3.3

1023.92

432.99

mg/l

0.46

120

941

Blepharochalasis

553

4706

1.18

3.55

3.1

727.80

537.28

mg/l

0.39

203

1944

Sudden idiopathic hearing loss

185

1396

1.34

3.54

2.8

3.3

423.15

446.02

mg/l

0.07

639

Thyrotoxicosis with diffuse goitre

233

1813

1.30

3.54

3.1

3.2

1106.86

396.35

mg/l

0.54

118

711

Restrictive cardiomyopathy

3.23

3.54

3.0

4.6

339.00

243.14

mg/l

—

Ingrowing nail

101

688

1.49

3.53

5.0

3.7

304.75

387.53

mg/l

0.39

330

Family history of malignant neoplasm

177

1327

1.35

3.52

3.6

3.0

540.28

299.13

mg/l

0.33

534

Fracture of neck

121

854

1.44

3.52

3.9

3.2

806.87

335.93

mg/l

0.61

382

Other disorders of electrolyte and fluid balance, not elsewhere classified

100

2.39

3.51

4.3

3.0

376.93

229.03

mg/l

0.56

Other fall from one level to another

418

3472

1.21

3.51

3.1

3.8

434.25

403.33

mg/l

0.08

183

1783

Benign neoplasm of other and unspecified female genital organs

496

1.58

3.50

2.9

3.0

293.14

442.35

mg/l

0.43

177

Dilated cardiomyopathy

218

1686

1.31

3.50

2.9

3.5

313.23

428.08

mg/l

1.04

118

833

Other and unspecified disorders of binocular movement

2.90

3.50

4.8

6.5

154.89

233.81

mg/l

—

Dermatopolymyositis, unspecified

2.81

3.50

2.3

3.0

285.71

197.00

mg/l

—

Other inflammation of eyelid

264

2091

1.27

3.50

2.9

3.3

342.88

399.24

mg/l

0.36

120

909

Other specified/unspecified soft tissue disorders

584

1.53

3.49

3.3

3.2

548.32

337.61

mg/l

0.47

236

Unspecified protein-energy malnutrition

2.64

3.48

2.3

4.4

179.44

187.48

mg/l

—

Tuberculosis of other organs, strict

289

1.77

3.48

4.1

3.1

354.57

259.75

mg/l

0.42

106

Other and unspecified acute skin changes due to ultraviolet radiation

304

1.75

3.48

3.5

1331.22

273.88

mg/l

0.47

125

Postpartum hemorraghe, parous women as controls

381

2620

1.22

3.47

2.3

2.9

324.93

363.13

mg/l

0.29

160

1103

Tooth eruption problems

259

1976

1.27

3.47

4.7

4.1

477.66

378.76

mg/l

0.24

151

1053

Asthma and allergy

193

1448

1.32

3.47

2.9

3.1

230.35

408.32

mg/l

1.46

636

Other and unspecified acne

167

2.03

3.46

6.3

3.9

322.92

312.36

mg/l

0.03

Other and unspecified nonorganic psychotic disorders

307

2476

1.25

3.45

2.8

3.4

715.96

463.33

mg/l

0.23

160

1183

Voice disturbances

484

4084

1.19

3.44

3.2

1259.99

413.83

mg/l

0.61

212

1728

Systemic sclerosis, icd10

275

1.79

3.44

3.4

3.1

300.23

263.42

mg/l

0.15

106

Arthropathic psoriasis

192

1463

1.32

3.44

2.9

3.4

267.74

396.60

mg/l

0.99

653

Assault by unspecified means

224

1.87

3.42

4.0

4.3

293.95

254.48

mg/l

0.12

122

Recurrent dislocation and subluxation of joint

111

774

1.45

3.42

3.2

3.8

282.75

529.14

mg/l

0.99

377

Other inflammation of eyelid, including avohilmo

816

7164

1.14

3.42

3.2

3.4

564.92

393.45

mg/l

0.40

395

3296

Other disorders of conjunctiva

264

2098

1.27

3.42

3.9

3.3

555.05

372.21

mg/l

0.42

124

916

Dislocation, sprain and strain of joints and ligaments of thorax

444

1.60

3.41

2.8

3.7

272.00

295.87

mg/l

0.11

212

Eating disorder

149

1093

1.37

3.39

2.8

3.8

222.78

389.60

mg/l

1.93

520

Outcome of delivery

188

868

1.34

3.39

2.2

3.1

293.40

541.30

mg/l

0.52

328

Drug-induced adrenocortical insufficiency

218

1.88

3.39

6.4

4.4

300.55

339.92

mg/l

0.16

Kaposi sarcoma, including Hilmo

5.35

3.38

9.7

2.5

305.56

263.75

mg/l

—

Other disorders of the genitourinary system

231

1809

1.29

3.38

3.3

3.0

2303.23

399.32

mg/l

0.52

674

Other noninflammatory disorders of vulva and perineum

151

1114

1.37

3.36

3.3

3.1

674.95

354.49

mg/l

0.35

451

Other and unspecified trigeminal disorders

155

2.05

3.36

3.2

3.1

414.00

300.00

mg/l

—

Sequelae of injuries of head

663

1.48

3.35

2.8

3.7

383.33

379.43

mg/l

0.01

326

Nontoxic multinodular goitre

349

2865

1.23

3.35

2.5

3.1

256.40

394.64

mg/l

1.68

134

1063

Sequelae of injuries, of poisoning and of other consequences of external causes

405

3373

1.21

3.34

2.9

3.4

1210.11

400.14

mg/l

0.79

184

1604

Malignant neoplasm of head and neck, including Hilmo

160

1192

1.35

3.34

3.4

2.8

1233.55

416.96

mg/l

0.46

469

Nystagmus and other irregular eye movements

191

1.95

3.32

5.3

5.0

220.00

288.52

mg/l

0.32

Ulcerative colitis, NAS

235

1848

1.28

3.32

3.4

3.5

296.89

422.08

mg/l

1.00

121

878

Atopic dermatitis, strict definition

501

4158

1.18

3.31

4.1

3.8

368.56

411.50

mg/l

0.17

270

2059

Other and unspecified injuries of lower leg

140

1024

1.38

3.31

3.0

3.6

353.07

483.88

mg/l

0.57

472

Malignant neoplasm of other and ill-defined sites, including Hilmo

177

1.97

3.30

2.9

2.4

297.65

270.34

mg/l

0.10

Lichen planus

238

1877

1.28

3.30

2.6

3.2

372.24

419.84

mg/l

0.24

100

744

Poisoning by narcotics and psychodysleptics [hallucinogens]

177

1.97

3.30

4.7

4.3

309.71

311.78

mg/l

0.00

Complications of labour and delivery

999

4922

1.13

3.30

2.9

3.1

436.12

433.62

mg/l

0.01

387

1900

Tuberculosis of other organs, strict, including avohilmo

294

1.74

3.29

4.1

3.1

354.57

258.53

mg/l

0.43

107

Benign neoplasm: Stomach

180

1370

1.33

3.28

3.3

3.2

689.85

364.44

mg/l

0.60

549

Selective deficiency of immunoglobulin A [IgA]y

3.03

3.28

2.8

5.4

649.11

267.04

mg/l

—

Dementia

926

5607

1.13

3.27

2.7

3.1

363.23

620.14

mg/l

1.96

344

2490

Crohn disease (strict definition, all UC cases excluded)

634

1.49

3.27

2.5

3.7

221.11

290.61

mg/l

0.74

298

Bullous pemphigoid

280

1.76

3.27

4.7

2.7

326.25

522.35

mg/l

0.38

109

Flat foot [pes planus] (acquired)

163

1224

1.34

3.25

2.6

3.5

718.42

524.80

mg/l

0.15

529

Corneal ulcer

322

2631

1.23

3.25

3.7

3.4

1011.23

411.46

mg/l

0.60

151

1223

Other salmonella infections, including avohilmo

506

1.54

3.23

4.1

3.8

266.41

391.96

mg/l

0.50

227

Early lumbar disc prolapse, operated

140

1028

1.37

3.22

2.9

4.0

348.05

466.93

mg/l

0.45

537

Vascular diseases of the intestine

523

1.54

3.21

2.6

2.9

404.13

402.37

mg/l

0.00

220

Melanocytic naevi of trunk

214

1672

1.29

3.20

5.4

3.2

313.36

366.10

mg/l

0.43

137

749

Cutaneous lupus erythematosus

289

1.73

3.20

4.9

3.3

132.22

297.67

mg/l

2.01

111

Scissor bite

432

1.59

3.20

6.3

7.2

316.96

428.32

mg/l

0.38

292

Nonorganic sleeping disorders

371

3080

1.21

3.19

3.1

3.4

520.25

426.57

mg/l

0.23

174

1431

Eating disorders

176

1339

1.32

3.17

3.4

3.7

500.94

389.72

mg/l

0.16

626

Aneurysms, operations, SAH

289

2342

1.24

3.17

3.1

3.2

368.52

436.07

mg/l

0.47

128

995

Other lack of coordination

216

1.86

3.17

2.9

3.9

253.53

287.11

mg/l

0.10

105

Emotional disorders starting during childhood or adolescence

681

1.46

3.16

4.8

5.7

228.27

379.86

mg/l

1.35

433

Burn and corrosion of ankle and foot

173

1.96

3.16

2.4

4.5

479.93

316.65

mg/l

0.45

Testicular hypofunction

429

1.59

3.16

3.7

4.2

519.97

433.95

mg/l

0.15

255

Visual field defects

159

1196

1.34

3.16

3.5

3.2

352.06

318.47

mg/l

0.21

520

Primary adrenocortical insufficiency

125

2.15

3.15

4.8

4.0

393.87

260.35

mg/l

0.31

Benign neoplasm: Skin of ear and external auricular canal

542

1.52

3.15

2.5

3.3

473.57

312.63

mg/l

0.54

222

Venous complications and haemorrhoids in pregnancy

145

2.04

3.14

1.8

2.7

154.50

358.15

mg/l

—

Unspecified event, undetermined intent

329

1.68

3.14

5.3

4.8

2892.78

330.01

mg/l

0.46

158

Pyoderma

239

1.80

3.12

5.0

3.5

295.17

246.44

mg/l

0.19

108

Lichen simplex chronicus

447

1.57

3.11

4.3

3.7

160.40

307.82

mg/l

2.05

191

Other deformities of toe(s)

415

1.59

3.11

3.4

267.78

432.81

mg/l

0.36

183

Injuries to unspecified part of trunk, limb or body region

192

1487

1.30

3.10

3.5

531.69

390.13

mg/l

0.23

668

Other nonscarring hair loss

126

2.13

3.09

4.0

3.5

168.47

358.64

mg/l

0.84

Leiomyoma of uterus

1048

5254

1.12

3.08

2.8

3.1

480.90

446.30

mg/l

0.10

356

1948

Complications of other internal prosthetic devices, implants and grafts

553

1.51

3.07

4.2

3.2

257.29

301.07

mg/l

0.28

219

Other peripheral vertigo

170

1298

1.32

3.06

3.7

3.2

338.03

355.00

mg/l

0.06

545

Malignant neoplasm of endocrine gland, including Hilmo

130

953

1.38

3.06

4.7

3.2

186.41

336.58

mg/l

3.10

335

Adhesive capsulitis of shoulder

279

2262

1.24

3.05

3.5

493.59

365.51

mg/l

0.97

120

1043

Polyarthritis, unspecified

441

1.57

3.05

2.9

3.6

402.00

440.91

mg/l

0.08

206

Schizoaffective disorder

123

894

1.39

3.05

2.7

3.5

1744.40

405.68

mg/l

0.39

411

Cervical polyps

148

1107

1.35

3.05

2.8

3.2

312.95

334.53

mg/l

0.08

441

Behavioural disorders, excluding more controls

203

1.85

3.05

4.8

5.6

3281.40

296.94

mg/l

0.48

121

Use of amantadine

197

1.88

3.04

3.1

3.2

271.73

257.07

mg/l

0.05

Deep endometriosis

154

1160

1.34

3.04

2.7

2.9

288.04

371.21

mg/l

0.42

417

Other deformity of hallux (acquired)

2.33

3.04

2.7

3.8

116.35

1056.65

mg/l

—

Benign neoplasm: Skin of other and unspecified parts of face

192

1492

1.30

3.03

3.6

3.2

344.56

395.78

mg/l

0.18

619

Kela-code for severe mental illness

614

5339

1.15

3.02

2.9

3.3

535.70

425.11

mg/l

0.16

273

2527

Idiopathic thrombocytopenic purpura

403

1.59

3.02

5.2

4.1

352.77

326.03

mg/l

0.09

184

Other abnormal findings of blood chemistry

629

1.47

3.02

2.7

3.5

474.41

330.40

mg/l

0.43

270

Benign neoplasm: Skin of eyelid, including canthus

279

2267

1.24

3.01

3.4

3.1

1109.24

463.09

mg/l

0.48

119

946

Superficial injury of forearm

180

1388

1.31

3.01

3.6

292.07

481.63

mg/l

1.07

657

LSIL lesion of the vulva

287

1.70

2.99

2.6

3.1

1522.86

326.76

mg/l

0.49

Pre-eclampsia superimposed on chronic hypertension

3.37

2.98

2.8

2.9

853.57

266.43

mg/l

—

Papilloedema, unspecified

280

1.71

2.98

4.5

3.6

353.50

293.35

mg/l

0.19

130

Other acute skin changes due to ultraviolet radiation

420

1.57

2.98

3.5

3.4

1095.62

254.59

mg/l

0.47

177

Bell's palsy

199

1558

1.29

2.96

4.1

3.4

354.11

411.14

mg/l

0.29

714

Unknown and unspecified causes of morbidity

108

772

1.41

2.96

3.5

3.0

258.82

363.68

mg/l

0.55

331

Myelodysplastic syndrome

142

2.03

2.96

2.1

2.0

178.33

323.82

mg/l

—

Demyelinating diseases of the central nervous system

134

993

1.36

2.95

3.2

3.4

274.08

290.30

mg/l

0.11

433

Hodgkin lymphoma, hilmo

358

1.62

2.95

2.8

3.7

1582.83

315.15

mg/l

0.75

162

Other diseases caused by chlamydiae, including avohilmo

163

1.95

2.95

6.3

4.2

208.00

311.08

mg/l

0.49

Acne conglobata

2.70

2.94

2.7

4.7

541.90

205.83

mg/l

—

Acne, including avohilmo

367

2477

1.20

2.94

3.6

3.5

354.61

401.11

mg/l

0.29

210

1262

Malignant neoplasm of breast

618

3461

1.16

2.92

2.8

2.6

644.83

590.44

mg/l

0.07

215

992

Pneumothorax

129

953

1.37

2.92

3.4

3.3

241.40

367.99

mg/l

0.96

423

Malignant neoplasm of breast, HER2-negative

617

3456

1.16

2.92

2.8

2.6

644.83

591.12

mg/l

0.07

215

989

Etanercept

114

826

1.40

2.91

3.7

4.3

200.32

378.31

mg/l

1.65

386

Acute alcohol intoxication

453

3865

1.18

2.89

3.2

3.5

436.23

530.44

mg/l

0.30

223

1976

Malignant neoplasm of other and unspecified female genital organs

179

1.89

2.88

8.6

2.5

183.39

272.83

mg/l

0.50

Anorexia

179

1.89

2.88

4.0

3.3

1502.55

273.17

mg/l

0.48

Guttate psoriasis

172

1.91

2.87

3.2

3.7

258.55

304.62

mg/l

0.13

Benign neoplasm: Vagina

151

1.98

2.86

3.6

3.3

201.57

223.32

mg/l

—

Ulcer of oesophagus

122

897

1.38

2.86

2.9

3.3

414.58

380.66

mg/l

0.11

402

Open bite

102

728

1.42

2.85

5.7

5.1

316.73

371.83

mg/l

0.21

408

Autoimmune hepatitis

2.24

2.83

3.3

2.8

261.00

189.76

mg/l

0.27

Malignant neoplasm of renal pelvis, including Hilmo

138

2.02

2.81

2.7

2.3

521.53

295.14

mg/l

0.96

Benign neoplasm: Skin of trunk

556

1.48

2.81

5.4

3.5

479.59

310.69

mg/l

0.43

245

Amputation of ankle bones

293

1.68

2.81

5.1

3.4

738.46

252.37

mg/l

2.62

123

Disorders in reading

225

1.78

2.80

5.7

6.1

256.55

307.08

mg/l

0.35

157

Felty syndrome

2.55

2.79

3.4

2.4

173.00

264.56

mg/l

—

Event of undetermined intent

116

850

1.38

2.78

4.2

3.9

1707.73

430.17

mg/l

0.43

429

Osteosarcoma, including Hilmo

3.19

2.77

6.6

6.0

183.00

180.58

mg/l

—

Benign neoplasm: Parathyroid gland

139

2.01

2.77

5.2

2.8

268.00

229.09

mg/l

0.23

Fibrosarcoma

2.51

2.76

4.6

3.2

208.27

523.53

mg/l

0.64

Hypertrichosis

218

1.77

2.76

3.9

2.9

368.64

348.13

mg/l

0.05

Carcinoma in situ of other and unspecified digestive organs

625

1.45

2.76

3.8

3.1

384.54

301.34

mg/l

0.49

269

Malignant neoplasm of other and unspecified female genital organs, including Hilmo

302

1.65

2.76

8.2

2.4

156.73

372.12

mg/l

1.67

Fall on same level involving ice and snow

1119

10142

1.11

2.76

3.1

3.4

531.66

492.42

mg/l

0.09

500

4649

Malignant neoplasm of endocrine gland

112

817

1.38

2.76

4.9

3.2

188.78

339.88

mg/l

2.56

287

Carcinoma in situ of colon

397

1.57

2.75

3.8

3.4

391.97

287.62

mg/l

0.61

171

Hypermetropia

140

1057

1.34

2.75

6.1

4.6

343.37

363.02

mg/l

0.10

538

Collapsed vertebra, not elsewhere classified

2.26

2.73

2.6

2.8

532.50

221.48

mg/l

—

Other and unspecified disorders of white blood cells

535

1.48

2.73

3.4

3.8

326.20

308.44

mg/l

0.09

237

Benign neoplasm of meninges

185

1453

1.29

2.73

3.0

3.1

1393.76

404.12

mg/l

0.55

555

Hypertrophy of breast in women and men

303

2510

1.21

2.73

3.4

3.2

450.90

370.89

mg/l

0.14

115

1021

Other/unspecified enthesopathies of lower limb, excluding foot

120

887

1.37

2.72

3.1

3.7

304.05

580.27

mg/l

1.35

413

Torsion of ovary, ovarian pedicle and fallopian tube

219

1.76

2.72

3.4

3.2

596.31

327.29

mg/l

0.59

Superficial injury of abdomen, lower back and pelvis

276

2267

1.23

2.72

3.1

3.4

978.80

431.21

mg/l

0.37

110

1029

Congenital stenosis of pulmonary valve

2.30

2.71

3.5

7.3

271.57

237.10

mg/l

0.14

Diseases caused by chlamydiae, including avohilmo

147

1.95

2.70

6.2

4.3

204.30

300.04

mg/l

0.40

Nontoxic goitre/thyroid nodule

527

4579

1.16

2.69

2.6

3.1

690.29

422.89

mg/l

0.30

190

1749

Benign neoplasm: Retina

2.57

2.68

3.8

3.0

417.83

206.00

mg/l

—

Paget disease

2.67

2.68

3.1

3.8

121.67

138.65

mg/l

—

Sixth [abducent] nerve palsy

456

1.52

2.68

2.8

3.6

288.34

328.00

mg/l

0.18

206

Heart failure and hypertrophic cardiomyopathy

259

1.70

2.68

1.8

3.4

608.92

249.07

mg/l

1.00

107

Malignant neoplasm of breast, HER2-negative, including Hilmo

626

3511

1.15

2.67

2.7

2.6

646.19

583.36

mg/l

0.08

215

1016

Malignant neoplasm of stomach, including Hilmo

703

1.41

2.67

2.5

2.7

755.71

317.73

mg/l

0.44

256

Malignant neoplasm of breast, including Hilmo

626

3511

1.15

2.67

2.7

2.6

646.19

583.36

mg/l

0.08

215

1016

Corticotropin deficiency

2.23

2.67

2.1

3.8

188.00

213.17

mg/l

—

Other strabismus

381

3217

1.19

2.67

3.9

3.8

261.87

419.89

mg/l

2.90

202

1548

Transient synovitis

2.22

2.66

10.4

4.5

165.10

341.70

mg/l

—

Malignant neoplasm of other and ill-defined digestive organs

2.22

2.66

3.3

2.5

271.36

281.43

mg/l

0.04

Benign lipomatous neoplasm

518

4500

1.16

2.65

3.7

3.2

1569.43

450.92

mg/l

0.79

229

1981

Pneumoconiosis due to asbestos and other mineral fibres

267

1.68

2.65

2.9

3.0

9096.39

336.90

mg/l

0.51

115

Overjet

423

1.54

2.65

10.2

6.9

232.82

424.60

mg/l

1.20

290

Crystalline deposits in vitreous body

128

2.03

2.63

2.7

3.8

297.17

213.11

mg/l

0.53

Foreign body in genitourinary tract

107

2.12

2.62

4.0

3.1

181.14

336.46

mg/l

—

Embedded and impacted teeth

437

3037

1.17

2.62

3.4

3.6

517.89

416.43

mg/l

0.30

238

1566

Bulimia nervosa (incl. atypical)

337

1.59

2.62

2.5

3.1

186.88

285.82

mg/l

0.87

146

Malignant neoplasm of breast, ER-positive, including Hilmo

487

3125

1.16

2.62

2.5

2.6

1273.49

538.67

mg/l

0.68

160

875

Malignant neoplasm of breast, HER-positive

486

3122

1.16

2.62

2.5

2.6

1273.49

539.23

mg/l

0.68

160

874

Haemorrhagic and haematological disorders of fetus and newborn

385

1.56

2.62

4.3

9.6

258.20

414.47

mg/l

0.63

319

Melanoma of uvea

121

2.05

2.62

4.8

3.2

385.90

332.89

mg/l

—

Chondropathies

250

2042

1.23

2.62

3.6

3.5

268.26

455.47

mg/l

2.05

115

945

Hyperfunction of pituitary gland

573

1.45

2.61

3.0

3.8

173.97

294.03

mg/l

1.27

236

Embolic stroke with flimmer

283

1.65

2.61

2.8

2.7

349.68

472.26

mg/l

0.22

113

Disorders of optic nerve, not elsewhere classified

269

1.67

2.59

4.1

3.6

1340.79

287.17

mg/l

0.61

114

Residual foreign body in soft tissue

616

1.43

2.58

3.2

3.7

199.50

406.89

mg/l

1.54

312

Other enthesopathy of foot (+metatarsalgia)

166

1297

1.29

2.56

2.4

3.6

588.64

416.52

mg/l

0.18

564

Other salmonella infections

428

1.52

2.55

4.0

3.6

264.03

273.10

mg/l

0.05

185

Female infertility, tubal origin

460

1.49

2.55

2.5

3.3

234.75

409.57

mg/l

0.62

191

Fall involving bed

478

1.49

2.54

3.1

3.8

341.53

443.10

mg/l

0.27

197

Other and unspecified nail disorders

286

1.64

2.53

6.6

3.9

749.95

305.90

mg/l

0.37

118

Bacterial, viral and other infectious agents

142

1090

1.31

2.52

4.1

3.9

1388.44

456.57

mg/l

0.47

560

Motor disorders

301

1.63

2.52

6.0

9.1

248.70

366.43

mg/l

1.12

243

Monoarthritis, not elsewhere classified

511

1.47

2.52

2.9

3.9

500.32

417.87

mg/l

0.15

235

Unspecified mental disorder

673

5969

1.13

2.52

2.9

3.4

510.61

422.17

mg/l

0.14

301

2808

Intracerebral haemorrhage

234

1908

1.24

2.51

2.7

3.2

325.83

400.92

mg/l

0.59

125

825

Panniculitis, unspecified

123

2.01

2.51

2.6

3.7

238.90

273.00

mg/l

—

Universal erythroderma, KELA reimbursement

166

1.85

2.50

4.2

3.8

408.54

236.13

mg/l

0.44

Other specified/unspecified nutritional deficiencies

2.32

2.50

4.6

4.0

515.20

297.69

mg/l

—

Rheumatic fever incl heart disease

366

1.55

2.49

3.8

3.3

228.18

433.74

mg/l

0.62

159

Dissection of aorta

431

1.51

2.49

3.0

3.3

2668.64

299.99

mg/l

0.52

196

Tuberculosis, IBD comorbidity

125

945

1.34

2.49

3.9

3.1

321.37

378.27

mg/l

0.28

394

Obsessive-compulsive disorder

107

789

1.37

2.49

3.6

3.9

288.85

535.32

mg/l

1.02

398

Pneumonia due to other infectious organisms, not elsewhere classified

423

1.51

2.48

3.8

3.3

341.45

265.44

mg/l

0.28

181

Hypertrophic cardiomyopathy

580

1.44

2.48

2.6

3.6

587.06

310.94

mg/l

1.17

268

Birth trauma

2.26

2.48

9.3

6.9

419.00

381.06

mg/l

0.06

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

505

1.47

2.48

9.0

4.9

466.63

303.65

mg/l

0.53

279

Pneumonitis due to solids and liquids

152

1181

1.30

2.48

3.3

368.81

377.75

mg/l

0.03

522

Hirsprung

4.71

2.48

7.4

12.9

124.29

394.67

mg/l

—

Unstable angina pectoris

700

4889

1.13

2.47

3.2

3.3

560.04

534.90

mg/l

0.07

310

2270

Cushing syndrome

131

1.96

2.46

3.9

3.3

360.37

205.94

mg/l

0.41

Injury of other and unspecified intrathoracic organs

114

852

1.35

2.46

2.6

3.4

346.10

387.42

mg/l

0.19

409

Other specified disorders of external ear

523

1.46

2.45

3.0

3.6

245.06

305.04

mg/l

0.38

254

Fatigue fracture of vertebra

2.46

2.45

1.9

5.0

204.71

202.74

mg/l

—

Injury of intra-abdominal organs

312

1.60

2.45

3.5

4.5

479.12

251.03

mg/l

0.72

154

Retinal haemorrhage

352

1.56

2.45

3.9

3.5

1335.89

418.27

mg/l

0.48

146

Oral lichen planus and hypothyroidism or thyroxine medication

227

1.71

2.45

2.3

3.3

143.50

286.76

mg/l

—

Acute appendicitis, with complications

328

2770

1.19

2.44

3.6

3.4

277.22

408.01

mg/l

1.87

158

1306

Early lumbar disc prolapse operation

146

1130

1.30

2.44

2.8

3.7

393.62

451.46

mg/l

0.18

568

Alcohol-induced chronic pancreatitis

111

828

1.36

2.43

3.8

3.6

454.80

389.47

mg/l

0.27

425

Streptococcus and staphylococcus as the cause of diseases classified to other chapters, including avohilmo

2.14

2.43

1.6

4.5

483.50

447.42

mg/l

0.04

Trichomoniasis

104

2.10

2.43

3.2

2.5

248.40

130.77

mg/l

—

Valgus deformity, not elsewhere classified

2.28

2.42

5.5

4.2

128.71

217.76

mg/l

—

Crohn's disease of large intestine

624

1.41

2.42

3.5

3.6

276.83

281.01

mg/l

0.02

296

Haemangioma and lymphangioma, any site

158

1238

1.29

2.42

3.5

3.7

388.90

345.22

mg/l

0.13

547

Psoriatic arthropathies, ICD10

169

1335

1.28

2.42

2.7

3.4

269.36

377.21

mg/l

0.75

598

Somnolence, stupor and coma

541

1.44

2.41

3.7

396.62

382.50

mg/l

0.04

253

Obstructive hydrocephalus

198

1.76

2.41

3.0

4.1

414.30

278.65

mg/l

0.31

Folate deficiency anaemia

125

1.98

2.41

3.6

3.2

228.00

188.98

mg/l

0.31

Injury of unspecified body region

141

1090

1.31

2.40

3.4

3.5

608.31

358.77

mg/l

0.32

498

D07AA Corticosteroids, weak (group I)

264

2187

1.21

2.39

4.5

3.9

278.10

423.28

mg/l

1.08

159

1083

Malignant melanoma of skin

189

1515

1.26

2.39

3.0

2.7

258.14

537.31

mg/l

1.23

562

Hereditary ataxia

169

1.82

2.38

2.7

3.7

559.67

294.23

mg/l

—

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

195

1560

1.25

2.38

4.5

4.7

567.04

404.54

mg/l

0.25

819

Atlantoaxial subluxation

2.27

2.37

3.7

3.3

176.89

293.32

mg/l

—

Toxic effect of other and unspecified substances

140

1.90

2.36

5.7

5.1

176.50

263.26

mg/l

—

conjunctival haemorrhage

143

1111

1.30

2.36

4.1

3.4

418.57

362.36

mg/l

0.24

482

Bacterial sepsis of newborn

120

2.02

2.35

5.2

11.1

169.61

333.69

mg/l

1.51

104

Polycystic ovarian syndrome, broad definition

157

1233

1.28

2.35

2.3

2.9

403.83

423.00

mg/l

0.07

537

Malignant neoplasm of vulva, including Hilmo

155

1.85

2.35

3.9

2.4

382.00

213.97

mg/l

0.40

Placenta praevia

387

1.51

2.34

2.2

3.3

570.67

371.01

mg/l

0.19

172

Paraplegia, diplegia of upper limbs

261

1.64

2.34

2.7

3.5

419.78

347.38

mg/l

0.26

121

Disorders of oesophagus in diseases classified elsewhere

277

1.62

2.33

3.8

3.5

500.00

214.31

mg/l

0.64

118

Open wound of thorax

170

1.80

2.33

3.2

4.1

347.67

311.16

mg/l

0.07

Atrial septal defect

584

1.42

2.32

4.3

6.1

278.91

315.74

mg/l

0.23

355

Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease

2.66

2.32

3.3

12784.17

161.53

mg/l

—

Congenital deformities of hip, including avohilmo

269

1.63

2.32

5.2

5.9

286.89

379.28

mg/l

0.38

154

Erythema intertrigo

341

1.55

2.32

4.9

4.1

736.59

284.27

mg/l

0.68

148

Colitis due to radiation

127

1.95

2.31

1.6

3.4

172.88

232.61

mg/l

—

Pustular psoriasis

571

1.42

2.31

3.2

3.4

271.24

271.00

mg/l

0.00

244

Trichomoniasis, including avohilmo

113

2.01

2.31

3.1

2.6

248.40

130.64

mg/l

—

Superficial injury of wrist and hand

363

3108

1.17

2.31

3.2

3.8

519.73

440.30

mg/l

0.23

187

1516

Gastrointestinal stromal tumor and sarcoma

127

1.94

2.30

4.8

2.3

308.07

300.57

mg/l

0.02

Combined immunodeficiencies

120

1.97

2.30

7.0

4.2

1866.79

330.06

mg/l

0.48

Other specified and unspecified retinal disorders

472

1.46

2.30

3.5

3.3

289.87

378.97

mg/l

0.30

204

Chronic lymphocytic leukaemia

350

1.54

2.28

3.5

2.8

431.44

317.25

mg/l

0.33

122

Chronic lymphocytic leukaemia, helper endpoint

350

1.54

2.28

3.5

2.8

431.44

317.25

mg/l

0.33

122

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

350

1.54

2.28

3.5

2.8

431.44

317.25

mg/l

0.33

122

Carcinoma in situ, bladder

557

1.42

2.27

3.4

3.0

325.37

279.70

mg/l

0.17

249

Conductive hearing loss, unspecified

141

1099

1.29

2.27

3.7

3.6

336.68

425.14

mg/l

0.38

514

Trochanteric bursitis

240

1985

1.22

2.27

3.2

3.3

724.85

380.42

mg/l

0.49

102

814

Other puerperal infections

113

854

1.33

2.27

2.5

2.9

358.37

368.30

mg/l

0.03

360

Open wound of forearm

169

1347

1.26

2.27

3.8

3.2

648.66

434.15

mg/l

0.33

631

Other/unspecified enthesopathies, not elsewhere classified

138

1073

1.30

2.26

2.8

3.4

235.22

476.67

mg/l

1.72

474

Abdominal aortic aneurysm (AAA)

176

1398

1.26

2.26

2.9

481.17

479.93

mg/l

0.00

641

Astigmatism

121

924

1.32

2.26

5.3

4.6

350.57

373.18

mg/l

0.07

486

Progressive systemic sclerosis

2.53

2.26

3.9

2.8

333.13

159.38

mg/l

—

Carcinoma in situ of skin

161

1278

1.27

2.26

4.2

3.0

243.92

340.71

mg/l

0.79

517

Other psoriatic arthropathies

163

1295

1.27

2.25

2.7

3.4

278.33

380.54

mg/l

0.66

581

Malignant melanoma of skin, including Hilmo

228

1879

1.22

2.24

3.0

2.6

242.32

494.49

mg/l

1.45

117

695

Peritonsillar abscess

325

2765

1.18

2.24

3.1

3.5

242.76

459.50

mg/l

3.26

178

1406

Metatarsalgia

153

1207

1.28

2.24

2.4

3.6

618.92

429.49

mg/l

0.19

527

Bacterial, viral and other infectious agents, including avohilmo

150

1181

1.28

2.24

3.9

1325.54

456.19

mg/l

0.45

607

Traumatic subarachnoid haemorrhage

433

1.47

2.23

4.4

3.4

317.87

494.21

mg/l

0.48

213

Toxoplasmosis, including avohilmo

2.33

2.23

4.3

4.0

121.78

267.33

mg/l

—

Other diseases of appendix

136

1.89

2.22

1.8

3.3

135.43

190.23

mg/l

—

Malignant neoplasm of cervix uteri

180

1.76

2.22

4.2

2.8

427.94

290.48

mg/l

0.33

Benign neoplasm: Cerebral meninges

164

1307

1.27

2.22

2.9

3.1

1443.47

400.38

mg/l

0.50

500

MS-disease / Multiple Sclerosis

109

823

1.34

2.22

3.2

3.5

286.78

304.93

mg/l

0.11

363

Other and unspecified primary disorders of muscles

2.10

2.22

3.1

5.9

218.73

184.66

mg/l

0.12

Routine general health check-up of defined subpopulation

150

1.82

2.22

2.6

3.1

176.40

198.86

mg/l

0.23

Malignant neoplasm of mesothelium and soft tissue

467

1.45

2.22

4.5

2.9

239.87

300.48

mg/l

0.37

167

Postprocedural musculoskeletal disorders, not elsewhere classified

131

1016

1.30

2.22

2.8

3.4

261.18

344.27

mg/l

0.56

424

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

129

1.91

2.21

5.0

4.5

580.19

255.75

mg/l

0.91

Other diseases of gallbladder

585

1.40

2.20

3.3

3.4

279.92

320.91

mg/l

0.20

239

Viral encephalitis, not elsewhere classified/unspecified

242

1.64

2.20

5.2

4.3

628.32

259.24

mg/l

0.68

106

Plantar fascial fibromatosis

153

1210

1.27

2.20

3.0

3.5

250.00

428.37

mg/l

1.13

520

Progressive vascular leukoencephalopathy

575

0.62

2.19

3.0

2.8

466.56

443.05

mg/l

0.05

223

Tetraplegia

2.23

2.19

3.5

4.5

454.00

170.13

mg/l

—

Intermittent heterotropia

112

850

1.33

2.19

4.2

4.6

221.88

301.99

mg/l

0.88

459

Contraceptive management

595

3688

1.13

2.19

3.5

3.8

408.10

486.73

mg/l

0.26

238

1804

Melanocytic naevi

533

4711

1.14

2.18

4.6

3.3

293.22

406.99

mg/l

1.97

303

2126

Disorders of globe

322

1.55

2.18

3.5

3.3

428.46

263.52

mg/l

0.78

127

Lymphoid leukaemia

106

801

1.34

2.17

2.5

4.0

2791.83

359.69

mg/l

0.54

380

Malignant neoplasm of tongue, including Hilmo

282

1.59

2.17

3.4

2.7

212.86

326.16

mg/l

0.75

Neovascular glaucoma

553

1.41

2.17

4.0

3.5

631.14

371.36

mg/l

0.63

232

Intentional self-harm by sharp object

290

1.58

2.17

2.0

4.1

248.18

308.32

mg/l

0.24

151

Other disorders of the musculoskeletal system and connective tissue

259

2170

1.20

2.16

3.0

3.2

249.36

464.02

mg/l

2.82

104

948

Other disorders of male genital organs

461

1.45

2.16

2.5

4.0

431.90

336.77

mg/l

0.26

285

Supernumerary teeth EXCLUDE clefts and syndromes

2.56

2.16

6.3

8.7

189.43

446.03

mg/l

—

Ovarian dysfunction

112

853

1.32

2.15

3.2

2.8

416.57

377.56

mg/l

0.14

353

Dislocation of lens

160

1.78

2.13

4.3

3.0

622.27

236.07

mg/l

0.89

Malignant neoplasm of cervix uteri, including Hilmo

260

1.60

2.12

3.5

2.5

370.24

362.24

mg/l

0.02

Carcinoma in situ of other and unspecified sites

599

1.39

2.11

3.4

3.0

325.40

278.49

mg/l

0.18

268

Pediculosis and phthiriasis, including avohilmo

2.10

2.11

2.9

5.1

126.33

404.58

mg/l

—

Maltreatment syndromes

598

1.38

2.11

2.9

4.0

348.41

413.71

mg/l

0.19

293

Meningitis

624

1.38

2.11

4.5

3.5

236.87

276.47

mg/l

0.35

291

Lesion of lateral popliteal nerve

590

1.39

2.10

2.1

3.4

454.56

375.49

mg/l

0.18

281

Systemic atrophies primarily affecting the central nervous system

574

1.39

2.10

4.0

3.5

290.18

282.46

mg/l

0.04

242

Vasomotor rhinitis (mode)

123

954

1.30

2.09

3.4

719.96

432.79

mg/l

0.28

416

Postinfectious hypothyroidism

2.41

2.09

5.4

3.0

358.75

147.83

mg/l

—

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, including Hilmo

139

1.84

2.09

5.2

2.8

154.50

284.04

mg/l

1.47

Seminoma of testis, including Hilmo

2.03

2.09

3.1

3.6

205.73

220.07

mg/l

0.06

Achilles tendinitis

169

1362

1.25

2.09

3.3

3.6

294.01

479.14

mg/l

1.22

654

Tuberculosis, wide, including avohilmo

130

1016

1.29

2.09

3.9

3.2

339.30

368.70

mg/l

0.13

428

Habitual aborter

176

1.73

2.08

2.3

3.0

219.67

441.37

mg/l

0.88

Tuberculosis, wide

128

999

1.29

2.08

3.8

3.2

343.25

369.96

mg/l

0.12

417

Hypersensitivity pneumonitis due to organic dust

192

1.70

2.07

5.8

3.8

238.71

251.62

mg/l

0.09

Vascular syndromes of brain in cerebrovascular disorders

627

0.65

2.07

2.7

3.1

191.47

390.30

mg/l

1.31

280

Bitten or struck by other mammals

185

1507

1.24

2.07

3.4

3.6

268.57

433.45

mg/l

1.56

691

Benign neoplasm: Bladder

118

1.92

2.06

3.9

3.3

405.33

298.45

mg/l

—

Other and unspecified aplastic anaemias

140

1.83

2.05

4.6

3.4

175.64

219.70

mg/l

0.51

Malignant neoplasm of meninges, including Hilmo

2.93

2.04

4.8

2.2

121.89

190.88

mg/l

—

Mixed disorders of conduct and emotions

287

1.56

2.03

6.2

5.4

238.63

330.70

mg/l

0.71

175

Streptococcus and staphylococcus as the cause of diseases classified to other chapters

2.22

2.03

1.8

3.6

559.20

333.09

mg/l

—

Other disorders of Eustachian tube

385

1.48

2.02

2.9

3.2

250.71

309.15

mg/l

0.36

164

Benign neoplasm of mouth and pharynx

182

1485

1.23

2.02

3.3

375.98

409.07

mg/l

0.11

641

Viral encephalitis, not elsewhere classified/unspecified, including avohilmo

248

1.60

2.02

5.2

4.3

628.32

259.21

mg/l

0.68

110

Burns and corrosions

227

1893

1.21

2.02

3.2

3.7

274.91

413.69

mg/l

1.57

117

954

Pedal cyclist injured in collision with motor vehicle

389

0.56

2.01

3.3

3.8

261.64

451.41

mg/l

0.58

176

Viral meningitis

410

1.46

2.01

3.9

3.8

281.12

322.51

mg/l

0.14

189

Pemphigus

2.15

2.01

3.4

208.90

285.73

mg/l

—

Other and unspecified erythematous conditions

419

1.45

2.00

3.1

4.2

1119.03

308.67

mg/l

0.49

185

Alcohol dependence

449

3952

1.14

2.00

2.9

3.5

454.29

508.84

mg/l

0.16

224

2028

Persons encountering health services for specific procedures, not carried out

134

1057

1.28

2.00

3.9

2.7

343.57

411.90

mg/l

0.23

461

Other disorders of breast

215

1786

1.21

1.99

2.8

3.1

265.67

416.09

mg/l

1.07

681

Iridocyclitis in diseases classified elsewhere

249

1.60

1.99

4.0

3.6

329.00

286.32

mg/l

0.09

111

Testicular dysfunction

503

1.41

1.99

3.7

4.0

508.92

442.71

mg/l

0.12

299

Schizophrenia

240

2014

1.20

1.99

3.0

3.5

887.61

474.96

mg/l

0.26

109

974

Personal history of medical treatment

127

1.86

1.98

2.7

4.4

503.92

218.62

mg/l

0.71

Other diseases of blood and blood-forming organs

120

936

1.29

1.98

3.7

3.3

846.94

301.19

mg/l

0.83

408

Congenital malformations of posterior segment of eye

2.21

1.98

4.1

7.1

142.60

363.74

mg/l

—

Memory loss

103

1337

0.76

1.98

2.3

3.1

288.38

372.07

mg/l

0.64

577

Congenital deformities of feet, including avohilmo

487

1.41

1.97

4.0

4.2

440.41

284.75

mg/l

0.62

240

Dronedarone medication

338

1.50

1.97

2.3

3.6

290.14

213.67

mg/l

0.30

136

Benign neoplasm of other and unspecified intrathoracic organs

120

1.88

1.97

3.0

3.4

304.27

265.39

mg/l

0.08

Atopic conjunctivitis

607

1.37

1.96

5.6

4.1

518.29

327.10

mg/l

0.46

287

Malignant neoplasm of corpus uteri, including Hilmo

143

1141

1.26

1.96

3.3

2.5

289.08

400.88

mg/l

0.53

306

All dysplastic lesions of the cervix uteri, vagina or vulva

411

3512

1.15

1.95

3.1

2.9

410.56

417.78

mg/l

0.02

167

1429

Dissocial personality disorder

180

1.70

1.95

2.8

4.3

114.11

268.84

mg/l

1.53

Drug-induced tremor

2.07

1.95

3.3

5.3

157.75

263.38

mg/l

—

Other aneurysm

728

1.33

1.95

3.1

304.92

355.08

mg/l

0.19

323

Alzheimer’s disease (Atypical or mixed)

150

1834

0.80

1.95

2.6

2.8

351.80

530.95

mg/l

0.67

729

Other retinal artery occlusion

315

1.52

1.94

4.0

2.9

490.69

239.38

mg/l

1.50

125

Other specified disorders of muscle

339

1.50

1.94

3.6

4.1

311.77

378.57

mg/l

0.15

159

Benign neoplasm of ovary

271

2305

1.18

1.94

2.8

2.9

289.28

458.73

mg/l

1.20

102

789

Multiple gestation

108

832

1.31

1.94

2.8

3.3

449.12

408.60

mg/l

0.09

347

Fibrosarcoma, including Hilmo

2.06

1.94

4.6

3.3

208.27

434.20

mg/l

0.55

Malignant neoplasm, without specification of site, including Hilmo

556

1.38

1.94

5.9

2.6

278.62

304.41

mg/l

0.16

197

Myocardial infarction, unclassifiable

407

3185

1.15

1.93

3.3

3.0

1198.06

543.98

mg/l

0.39

191

1403

Lichen ruber planus, wide definition including periferal and oral lichen planus

387

3383

1.15

1.93

2.4

3.2

368.50

410.49

mg/l

0.27

146

1422

Wide developmental disorders, excluding more controls

371

1.46

1.93

5.3

6.7

259.38

470.09

mg/l

0.81

236

Malignant neoplasm of head and neck

125

983

1.28

1.92

3.4

2.8

1565.30

439.36

mg/l

0.48

382

Other disorders of amino-acid metabolism

2.40

1.92

4.7

5.3

846.00

206.18

mg/l

—

Polyglandular dysfunction

3.36

1.92

10.3

4.8

514.29

138.22

mg/l

—

Alzheimer disease, excluding more controls

322

1790

1.17

1.92

2.5

3.3

328.63

473.21

mg/l

0.68

109

873

Marfan's syndrome

2.39

1.92

2.2

5.0

737.00

315.43

mg/l

—

Palatinal maxillary operation

114

1.90

1.91

3.9

6.3

292.87

340.32

mg/l

0.13

Benign neoplasm: Liver/bile ducts

316

1.51

1.91

3.6

361.85

309.68

mg/l

0.17

133

Injury of muscle and tendon at lower leg level

248

2097

1.19

1.91

3.1

3.5

293.30

402.06

mg/l

1.16

115

1050

Malignant neoplasm of oral cavity, including Hilmo

507

1.40

1.91

3.5

2.8

214.00

344.31

mg/l

1.43

176

Injury of eye and orbit

231

1941

1.20

1.91

3.8

3.7

746.16

438.15

mg/l

0.35

113

977

Other erythematous conditions

457

1.42

1.91

3.1

4.0

1061.79

311.56

mg/l

0.49

205

Cauda equina syndrome

151

1.76

1.91

3.0

3.8

184.36

281.44

mg/l

0.65

Motor neuron disease (with DMD)

236

1.59

1.90

2.9

3.6

157.89

237.93

mg/l

0.95

127

Acute laryngitis and tracheitis

181

1463

1.22

1.89

4.4

3.7

481.51

496.48

mg/l

0.02

100

726

Puerperal sepsis

185

1524

1.22

1.89

3.1

3.0

218.54

369.25

mg/l

1.38

560

Hypersomnia

159

1.73

1.89

2.6

3.2

151.00

372.21

mg/l

1.67

Embedded teeth, including avohilmo

146

1173

1.25

1.89

3.5

3.9

615.95

440.80

mg/l

0.21

576

Shock, not elsewhere classified

100

1.95

1.89

2.4

3.2

234.50

257.27

mg/l

—

Emphysema

132

1049

1.27

1.89

2.8

3.2

2592.59

404.38

mg/l

0.45

478

Secondary polycythaemia

301

1.52

1.88

3.1

4.0

1196.03

244.64

mg/l

0.61

140

Atrophic disorders of skin

262

2229

1.18

1.88

3.0

3.1

527.57

334.71

mg/l

0.39

111

858

Hallux rigidus

223

1871

1.20

1.88

2.7

3.3

1315.73

446.80

mg/l

0.48

820

Disorder of the sleep-wake schedule

229

1.60

1.88

4.1

5.9

235.33

385.52

mg/l

1.01

119

Later onset COPD

566

4070

1.12

1.88

2.6

2.9

1104.05

543.21

mg/l

0.47

262

1805

Guillain-Barre syndrome

206

1.64

1.87

2.9

4.8

172.00

303.20

mg/l

1.18

102

Cluster headache, strict

400

1.44

1.86

3.0

3.8

5216.87

502.83

mg/l

0.47

196

Toxoplasmosis

2.20

1.86

4.0

4.1

127.00

267.33

mg/l

—

Disorders of orbit

544

1.38

1.86

2.6

3.8

1148.48

305.23

mg/l

0.81

237

Disorders of eyelid in diseases classified elsewhere

409

1.44

1.86

4.8

3.4

1088.55

291.73

mg/l

0.48

175

Haemorrhagic disorder due to circulating anticoagulants

183

1.68

1.86

3.2

2.9

503.75

283.38

mg/l

0.78

Other nutritional anaemias

115

1.87

1.86

2.3

2.8

270.45

274.76

mg/l

0.01

Premenstrual syndrome

137

1.78

1.85

5.3

3.2

392.80

385.71

mg/l

—

Malignant neoplasm of bone and articular cartilage, including Hilmo

222

1.61

1.85

5.2

3.3

162.55

334.14

mg/l

1.39

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

217

1820

1.20

1.85

3.4

3.3

3354.54

419.23

mg/l

0.89

801

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

145

1.76

1.84

3.2

4.1

543.50

308.86

mg/l

—

Cardiac murmurs and other cardiac sounds

163

1314

1.23

1.84

4.4

4.3

363.87

394.29

mg/l

0.14

644

Malignant neoplasm of bone and articular cartilage

123

1.84

5.5

3.4

137.15

258.23

mg/l

1.51

Glaucoma secondary to other eye disorders

571

1.36

1.84

4.0

3.5

631.14

374.62

mg/l

0.63

242

Nummular dermatitis

148

1196

1.25

1.84

4.1

3.3

360.09

371.18

mg/l

0.05

553

Dental pulpitis, including avohilmo

1703

10232

1.07

1.83

3.3

3.5

462.67

457.65

mg/l

0.02

777

4939

Single spontaneous delivery

662

3152

1.11

1.82

2.7

3.1

260.82

651.71

mg/l

1.74

250

1180

Tinnitus

399

3511

1.14

1.82

3.5

3.3

289.71

456.53

mg/l

1.60

171

1602

Other disorders of iris and ciliary body

386

1.45

1.82

4.3

3.6

278.69

315.93

mg/l

0.22

168

Other and unspecified injuries of thorax

231

1.59

1.82

3.4

3.6

1401.68

237.63

mg/l

0.50

103

Cramp and spasm

633

1.34

1.81

3.5

3.8

265.00

317.88

mg/l

0.28

297

Postzoster neuralgia

208

1.62

1.80

3.8

3.1

265.60

245.09

mg/l

0.11

Stenosis and insufficiency of lacrimal passages

165

1352

1.23

1.80

2.9

3.2

291.34

306.70

mg/l

0.09

553

Lichen planus, including avohilmo

327

2842

1.16

1.80

2.5

3.2

385.18

436.09

mg/l

0.30

132

1186

299

0.53

1.80

3.3

4.3

917.67

236.30

mg/l

—

139

Malignant neoplasm of other connective and soft tissue

280

1.52

1.79

4.1

2.9

144.04

306.65

mg/l

2.03

Disorders of porphyrin and bilirubin metabolism

139

1.77

1.79

6.2

4.2

118.69

239.03

mg/l

1.53

Lateral epicondylitis

193

1606

1.21

1.79

3.1

3.8

216.91

401.26

mg/l

2.00

767

Acne keloid

3.57

1.79

10.3

5.9

119.17

152.00

mg/l

—

Assault by other specified means

102

1.90

1.79

4.4

4.1

202.36

355.13

mg/l

0.47

Other eating disorders

616

1.34

1.79

3.2

4.5

200.14

378.69

mg/l

1.15

305

Impaction of intestines

2.09

1.78

3.9

4.2

158.88

237.31

mg/l

—

Juvenile rheumatoid arthirtis

232

1.57

1.78

3.0

4.2

204.43

324.52

mg/l

0.88

109

330

1.48

1.78

1.8

3.1

1400.42

274.72

mg/l

0.54

126

Viral meningitis, including avohilmo

438

1.41

1.78

4.0

3.8

273.71

311.36

mg/l

0.13

202

Erythema multiforme

289

1.51

1.78

3.8

3.9

433.26

274.51

mg/l

0.34

131

Haemangioma, any site

141

1139

1.25

1.77

3.2

3.8

391.17

356.48

mg/l

0.09

503

Alzheimer disease, including avohilmo

642

4904

0.90

1.76

2.5

3.0

1004.75

654.46

mg/l

0.21

218

2085

Traumatic ischaemia of muscle

155

1.71

1.76

2.6

4.4

517.79

297.22

mg/l

0.45

Conotruncal defects

218

1.60

1.76

3.6

8.2

301.71

361.39

mg/l

0.31

158

Toxic effects of substances chiefly nonmedicinal as to source

187

1556

1.21

1.75

4.0

3.6

1414.98

430.42

mg/l

0.54

757

Polycystic ovarian syndrome

610

1.34

1.75

2.5

2.8

503.98

427.27

mg/l

0.21

252

Postpartum haemorrhage due to anatomy

156

1275

1.23

1.75

2.0

2.8

374.50

366.98

mg/l

0.03

589

Macular pucker

288

2488

1.16

1.74

3.2

3.0

525.68

434.13

mg/l

0.19

140

1068

Benign neoplasm: Duodenum

340

1.46

1.74

3.7

3.2

442.23

259.69

mg/l

0.73

137

Social disorders starting during childhood or adolecense, excluding more controls

1.96

1.73

3.9

8.1

150.18

264.30

mg/l

1.20

Acute inflammation of orbit

2.06

1.73

4.7

6.1

781.50

277.61

mg/l

—

Perioral dermatitis

258

1.53

1.73

5.7

3.5

606.23

338.56

mg/l

0.53

Hypertension, Pulmonary Arterial

1.96

1.73

2.2

2.4

290.25

157.91

mg/l

—

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

509

4563

1.12

1.73

3.1

3.4

389.44

456.41

mg/l

0.21

205

2201

Ptosis of eyelid

198

1660

1.20

1.72

3.4

3.1

1257.38

404.49

mg/l

0.47

694

Other nonthrombocytopenic purpura

111

1.85

1.72

3.5

3.6

159.70

190.59

mg/l

—

Chondrocostal junction syndrome [Tietze]

458

1.39

1.72

3.1

3.4

195.46

435.25

mg/l

1.00

182

Previous suicide attempt

141

1.74

1.72

2.6

3.9

122.00

298.58

mg/l

1.42

Other abnormal findings in urine

211

1.60

1.71

2.4

3.9

255.31

295.58

mg/l

0.21

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

467

1.39

1.71

4.9

3.5

529.52

312.19

mg/l

0.66

199

Abnormal findings on diagnostic imaging of breast

164

1.68

1.71

3.3

2.9

155.77

286.14

mg/l

0.89

Rheumatic valve diseases

259

1.53

1.71

3.4

3.1

279.78

268.00

mg/l

0.04

103

Pollen allergy

303

2593

1.16

1.70

3.4

4.3

364.69

390.46

mg/l

0.12

133

1365

Chalazion

186

1552

1.21

1.70

3.2

3.4

636.45

423.38

mg/l

0.30

698

Pyothorax

588

1.34

1.70

3.3

3.4

575.15

290.97

mg/l

1.06

258

Twin gestation

104

814

1.28

1.70

2.8

3.3

449.12

409.43

mg/l

0.09

344

Alcohol-induced acute pancreatitis

451

1.39

1.69

4.1

3.7

544.81

416.97

mg/l

0.32

229

Drug-induced headache, not elsewhere classified

2.17

1.69

1.0

4.5

428.50

220.60

mg/l

—

Other obstructed labour

754

1.30

1.68

2.4

3.1

326.88

309.20

mg/l

0.07

288

Other secondary coxarthrosis

435

1.40

1.67

2.6

3.5

314.75

443.50

mg/l

0.34

193

Exophthalmic conditions

112

1.83

1.67

2.4

4.0

734.31

222.72

mg/l

0.85

Other ill-defined and unspecified causes of mortality

165

1365

1.22

1.67

4.0

3.1

301.67

375.32

mg/l

0.58

104

593

Other protozoal intestinal diseases

181

1.63

1.66

2.8

3.7

168.29

239.86

mg/l

0.96

Other and unspecified injuries of shoulder and upper arm

410

1.41

1.66

2.8

3.8

374.09

313.92

mg/l

0.22

198

Cardiodefibrillation

668

6070

1.10

1.66

2.8

3.3

597.50

493.03

mg/l

0.17

317

2891

Liveborn infants according to place of birth

118

1.78

1.66

11.0

8.2

657.73

321.67

mg/l

0.30

Optic atrophy, wide definition

245

1.54

1.66

4.2

5.6

422.80

287.17

mg/l

0.21

131

Abscess of lung

213

1.58

1.66

3.5

4.9

442.82

305.02

mg/l

0.23

Acute poliomyelitis

158

1.68

1.66

4.8

3.3

195.00

203.43

mg/l

0.05

Acute poliomyelitis, including avohilmo

158

1.68

1.66

4.8

3.3

195.00

203.43

mg/l

0.05

Papillary adenocarcinoma of thyroid gland

564

1.34

1.66

4.5

2.8

184.97

350.87

mg/l

1.85

186

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

595

0.68

1.65

2.8

3.8

206.67

307.28

mg/l

0.90

267

Kyphosis

158

1.68

1.65

3.4

3.1

241.40

311.61

mg/l

—

Glaucoma

1096

8654

1.08

1.64

3.3

3.2

683.44

581.00

mg/l

0.24

508

3811

Disturbances of smell and taste

522

1.36

1.64

2.7

3.5

343.42

396.93

mg/l

0.09

229

Dentofacial anomalies [including malocclusion]

1249

9122

1.07

1.64

3.3

3.4

388.84

437.97

mg/l

0.27

538

4240

Erosion and ectropion of cervix uteri

319

1.46

1.64

2.0

3.4

3979.69

257.84

mg/l

0.75

133

Myopia

201

1696

1.19

1.63

3.9

3.7

330.38

410.37

mg/l

0.50

807

Protein-energy malnutrition of moderate and mild degree

136

1.74

1.63

2.7

6.2

233.54

279.06

mg/l

0.18

Vitamin B12 deficiency anemia due to intrinsic factor deficiency

230

1.55

1.63

3.4

2.9

235.07

262.17

mg/l

0.13

Other and unspecified pemphigoid

121

1.78

1.62

6.0

3.0

242.13

254.52

mg/l

0.07

Cardiomyopathy, Hypertrophic obstructive

206

1.58

1.62

2.4

4.0

249.90

188.39

mg/l

0.38

Disorders of puberty, all

263

1.51

1.62

8.0

6.6

247.21

347.79

mg/l

0.84

183

Xerosis cutis

247

1.53

1.61

4.8

3.1

251.77

198.32

mg/l

0.35

Other and unspecified epidermal thickening

363

1.42

1.60

5.2

4.0

240.75

307.02

mg/l

0.39

162

Other acute disseminated demyelination

1.86

1.60

4.4

4.3

399.25

267.24

mg/l

—

Subarachnoid haemorrhage

175

1463

1.20

1.60

2.8

3.3

424.34

403.74

mg/l

0.10

621

Malignant neoplasm of stomach

594

1.32

1.59

2.4

2.7

829.63

319.20

mg/l

0.39

215

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

127

1029

1.24

1.58

3.5

3.4

312.75

409.77

mg/l

0.45

445

Pustulosis palmaris et plantaris

517

1.35

1.58

2.5

3.5

225.39

262.95

mg/l

0.27

222

970

0.76

1.58

2.9

428.39

395.61

mg/l

0.08

423

Optic atrophy

240

1.53

1.58

3.8

5.6

449.43

280.89

mg/l

0.25

127

Polypectomy (DHB20)

889

0.75

1.58

2.5

3.5

568.19

381.14

mg/l

0.36

425

Other and unspecified hypertrophic disorders of skin

1.98

1.57

2.5

3.3

285.60

156.44

mg/l

—

Chronic mastoiditis

348

1.43

1.56

2.3

3.2

576.60

305.08

mg/l

0.48

145

Chondrosarcoma

0.00

1.56

0.0

2.8

—

288.40

—

Mantle cell lymphoma, including Hilmo

153

1.67

1.56

4.7

2.1

2336.36

262.96

mg/l

0.51

Other other unspecified disorders of the circulatory system

467

1.36

1.56

3.9

3.4

327.00

402.05

mg/l

0.20

202

Ankylosing spondylitis, strict definition

510

1.35

1.55

2.2

4.0

174.91

486.97

mg/l

1.64

257

Retinal detachment with retinal break

216

1845

1.18

1.55

4.2

3.2

438.08

377.12

mg/l

0.33

119

844

Other abnormal immunological findings in serum

241

1.52

1.54

4.1

4.7

130.74

384.79

mg/l

2.87

109

Glucosamine medication

890

6572

1.08

1.54

2.6

3.1

420.87

586.92

mg/l

0.57

289

2773

Examination and encounter for administrative purposes

105

835

1.26

1.54

2.3

3.4

336.08

365.21

mg/l

0.10

436

Localized skin eruption due to drugs and medicaments

146

1.68

1.54

4.5

3.7

6236.92

233.88

mg/l

0.50

Obstructed labour due to malposition and malpresentation of fetus

261

2092

1.16

1.54

2.8

3.2

427.43

408.65

mg/l

0.05

121

876

Infarction of spleen

1.96

1.53

2.9

4.6

295.17

186.15

mg/l

—

Unspecified dementia

208

1589

1.18

1.53

2.6

2.8

248.60

551.95

mg/l

1.52

656

Cholesteatoma of external ear

101

1.83

1.52

1.9

3.5

600.83

250.51

mg/l

—

Other diseases of spinal cord

375

1.40

1.52

3.3

3.8

701.46

261.60

mg/l

0.86

165

Behavioural syndromes associated with physiological disturbances and physical factors

1817

11636

1.06

1.52

3.1

3.5

758.55

500.79

mg/l

0.58

791

5512

Other benign neoplasm of uterus: Corpus uteri

101

1.83

1.52

5.3

2.5

772.44

190.94

mg/l

—

Atypical virus infections of central nervous system

116

1.77

1.52

5.7

3.7

459.89

168.86

mg/l

—

Occupant of heavy transport vehicle injured in other and unspecified transport accidents

2.06

1.52

4.2

467.50

476.94

mg/l

—

Disorders of puberty

218

1.54

1.52

8.3

6.4

259.80

320.54

mg/l

0.41

152

Undefined dementia

209

1644

1.18

1.52

2.6

2.8

248.60

524.71

mg/l

1.35

640

Allergic conjunctivitis

1000

8951

1.08

1.51

3.3

3.4

482.36

439.67

mg/l

0.16

407

4016

Viral infections of central nervous system, not elsewhere classified/unspecified

116

1.76

1.51

2.5

3.8

238.75

203.50

mg/l

0.14

HSIL lesion of the vulva

202

1.56

1.51

3.9

2.9

322.33

359.69

mg/l

0.07

Exfoliative dermatitis

147

1.67

1.51

4.0

3.5

258.57

269.62

mg/l

0.04

Other specified/unspecified inflammatory spondylopathies

521

1.34

1.51

3.3

3.7

271.33

285.52

mg/l

0.07

236

Pediculosis and phthiriasis

2.33

1.51

4.1

3.4

152.60

224.68

mg/l

—

Thyroiditis

112

902

1.25

1.49

3.3

388.04

295.93

mg/l

0.34

357

Carbimazole or st.post thyroidectomy, condition for graves disease

332

2934

1.14

1.49

3.0

3.1

1390.47

439.60

mg/l

0.76

156

1188

Acute otitis externa, noninfective

211

1.54

1.48

4.8

3.5

207.69

242.56

mg/l

0.23

Other disorders originating in the perinatal period

196

1.58

1.48

12.3

9.9

383.88

384.82

mg/l

0.00

162

Atypical virus infections of central nervous system, including avohilmo

117

1.75

1.48

5.7

3.7

459.89

168.86

mg/l

—

Systemic sclerosis,strict definition

102

1.81

1.48

2.1

3.3

501.00

134.66

mg/l

—

Injury of muscle and tendon at shoulder and upper arm level

641

5871

1.10

1.47

2.9

3.4

354.34

522.76

mg/l

1.35

262

2907

LSIL lesion of the cervix uteri, vagina or vulva

191

1622

1.18

1.47

2.9

3.0

623.00

364.33

mg/l

0.38

643

Periapical abscess

816

7550

1.08

1.47

3.4

3.5

335.25

468.16

mg/l

1.69

408

3611

Iron deficiency

352

1.41

1.47

2.9

4.6

324.23

377.46

mg/l

0.24

158

Other endophthalmitis

2.03

1.47

1.6

3.0

432.43

217.17

mg/l

—

Convergent concomitant strabismus

717

1.28

1.46

3.8

4.4

282.89

408.57

mg/l

0.68

361

Brain meningioma, including Hilmo

585

1.31

1.46

3.9

2.7

2456.08

332.93

mg/l

0.54

185

Motor neuron disease ALS

220

1.52

1.45

3.1

3.4

164.53

246.99

mg/l

0.80

112

Other and unspecified bullous disorders

141

1.67

1.45

8.1

3.6

2489.08

247.49

mg/l

0.52

Malignant neoplasm of other connective and soft tissue, including Hilmo

482

1.34

1.44

4.1

3.0

175.15

357.11

mg/l

2.19

176

Malignant neoplasm of vulva

118

1.73

1.44

3.7

2.4

442.33

227.92

mg/l

—

Diffuse brain injury

396

1.38

1.44

2.4

3.4

374.77

462.18

mg/l

0.19

204

Malignant neoplasm of other and unspecified parts of tongue, including Hilmo

229

1.51

1.43

3.9

2.4

189.46

250.14

mg/l

0.55

Polycythaemia vera

388

1.38

1.43

2.7

403.14

318.73

mg/l

0.28

135

Mental and behabioural disorders of puerperum, not classified elsewhere, excluding more controls

1.85

1.43

2.2

2.8

374.86

222.03

mg/l

—

Other and unspecified mononeuropathies of lower limb

312

1.43

3.1

221.43

308.57

mg/l

0.31

130

Infectious mononucleosis, including avohilmo

125

1024

1.23

1.43

3.0

3.9

230.47

422.23

mg/l

1.59

516

Infectious mononucleosis

125

1024

1.23

1.43

3.0

3.9

230.47

422.23

mg/l

1.59

516

Type 1 diabetes, definitions combined

145

1202

1.21

1.43

3.6

4.8

1161.03

286.99

mg/l

0.59

676

Prepatellar bursitis

570

1.31

1.43

4.4

3.9

343.69

411.05

mg/l

0.24

299

Other and unspecified haemorrhagic conditions

189

1.56

1.42

4.0

4.6

207.13

367.54

mg/l

0.69

Malignant neoplasm of thyroid gland

747

1.27

1.42

4.7

2.8

180.94

331.53

mg/l

2.32

251

Neonatal jaundice from other and unspecified causes

304

1.44

1.42

3.6

9.9

260.36

334.10

mg/l

0.24

259

Other and unspecified nonscarring hair loss

1.81

1.42

3.8

3.1

134.67

378.91

mg/l

—

Ill-defined and unknown causes of mortality

177

1501

1.19

1.42

4.0

3.1

298.46

415.95

mg/l

0.98

113

655

Deaf mutism, not elsewhere classified

2.14

1.41

3.5

3.1

256.00

220.74

mg/l

—

Prurigo nodularis

330

1.41

2.8

3.2

306.38

255.33

mg/l

0.15

134

Toxic effect of contact with venomous animals

554

1.31

1.41

3.9

4.4

3083.09

321.83

mg/l

0.65

264

Other and unspecified injuries of head

131

1081

1.22

1.41

3.2

3.7

335.13

484.53

mg/l

0.66

480

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

2.06

1.41

2.9

3.7

104.43

205.43

mg/l

—

Other and specified injuries of hip and thigh

305

1.43

1.41

2.8

3.2

245.06

308.92

mg/l

0.32

127

Impacted teeth

315

2388

1.14

1.40

3.5

3.7

493.88

415.52

mg/l

0.23

170

1253

Motorcycle rider injured in noncollision transport accidents

347

1.40

3.0

4.0

188.14

310.18

mg/l

1.02

174

Other inherited muscular atrophy

2.76

1.40

14.2

3.4

189.67

184.67

mg/l

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

276

2422

1.14

1.40

3.5

474.41

396.57

mg/l

0.17

144

1168

Respiratory distress of newborn

300

1.43

1.39

9.9

9.4

539.31

275.52

mg/l

0.57

257

Inguinal hernia

1098

6828

1.07

1.38

3.4

3.5

509.55

490.60

mg/l

0.04

525

3506

Malignant neoplasm of thyroid gland, including Hilmo

103

830

1.25

1.38

4.5

2.8

169.81

334.06

mg/l

3.12

280

Bacterial meningitis

434

1.35

1.38

4.9

3.8

251.82

293.26

mg/l

0.23

200

Osteogenesis imperfecta

0.00

1.38

0.0

7.2

—

296.52

—

Other/unspecified disorders of vestibular function

565

1.31

1.38

3.2

3.5

346.17

387.21

mg/l

0.11

234

Use of interferon beta-1a

215

1.51

1.37

4.2

4.1

373.57

298.69

mg/l

0.19

Granuloma annulare

191

1.54

1.37

3.7

462.55

342.79

mg/l

0.19

Antepartum haemorrhage, not elsewhere classified

768

1.26

1.37

2.2

3.4

381.37

408.98

mg/l

0.08

343

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

111

903

1.24

1.37

3.2

2.9

171.16

410.89

mg/l

2.31

336

Infections specific to the perinatal period

208

1.53

1.37

4.6

9.2

151.46

332.79

mg/l

2.95

163

Other meningitis

183

1.55

1.36

3.6

3.7

231.00

299.80

mg/l

0.34

Malignant neoplasm of corpus uteri

127

1049

1.22

1.36

3.2

2.5

282.33

406.60

mg/l

0.58

289

Panniculitis affecting regions of neck and back

435

1.35

1.36

2.5

3.6

515.43

299.55

mg/l

0.57

200

Congenital deformities of hip

240

1.48

1.36

5.9

6.1

297.28

369.28

mg/l

0.26

139

Acute myeloid leukaemia and myelodysplastic syndromes

282

1.44

1.36

1.9

2.6

200.50

294.42

mg/l

1.12

Torticollis

208

1.51

1.35

2.9

4.6

240.83

316.95

mg/l

0.37

110

Other demyelinating diseases of the central nervous system

410

1.35

1.34

3.4

3.8

410.52

298.52

mg/l

0.45

180

Corneal scars and opacities

368

1.38

1.33

4.4

3.7

420.96

320.19

mg/l

0.43

174

Onycholysis

1.89

1.32

6.4

4.5

212.38

204.69

mg/l

—

Amiodarone users

169

1438

1.18

1.32

3.0

3.3

267.95

409.80

mg/l

1.40

652

Follicular cysts of skin and subcutaneous tissue

294

2603

1.13

1.32

3.9

3.3

235.98

427.33

mg/l

2.37

158

1197

Secondary parkinsonism, excluding more controls

292

1.42

1.32

2.8

3.4

317.21

428.10

mg/l

0.24

136

Abscess of Bartholin gland

292

1.42

1.32

4.7

2.9

163.94

317.27

mg/l

1.63

106

Infective dermatitis

185

1586

1.17

1.31

3.6

3.1

640.61

358.24

mg/l

0.51

715

Cluster headache, wide

429

1.34

1.31

3.0

3.7

5216.87

486.08

mg/l

0.47

209

Type 1 diabetes, strict (exclude DM2)

144

1206

1.20

1.30

3.6

4.8

1161.03

286.67

mg/l

0.59

677

Asthma and opportunity respiratory infection

650

1.27

1.30

2.7

3.0

1690.06

287.88

mg/l

0.75

257

Other and unspecified paralytic syndromes

178

1.54

1.28

5.0

4.6

413.99

320.82

mg/l

0.23

Benign neoplasm: Skin of lip

162

1.57

1.28

2.2

3.5

221.37

285.70

mg/l

—

Hirsutism in women

194

1.51

1.28

3.1

3.0

394.25

325.50

mg/l

—

Precocious central puberty

1.87

1.28

6.4

6.1

107.89

376.12

mg/l

—

Use of selegiline

598

1.28

2.7

3.1

151.87

326.06

mg/l

3.80

256

Ganglion

318

2835

1.13

1.28

2.9

3.4

369.55

353.42

mg/l

0.08

124

1332

Viral infections of central nervous system, not elsewhere classified/unspecifie, including avohilmod

154

1.58

1.28

2.5

3.9

228.15

194.33

mg/l

0.15

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

946

8477

1.07

1.28

3.2

3.3

476.96

422.87

mg/l

0.20

377

3762

Nasal polyp

313

2789

1.13

1.28

3.3

3.4

304.19

490.97

mg/l

1.51

144

1385

Malignant neoplasm of oral cavity

388

1.35

1.27

3.3

2.8

195.66

323.17

mg/l

1.27

135

Small cell lung cancer, helper endpoint

340

0.64

1.27

2.2

2.9

522.54

302.51

mg/l

0.44

140

Chronic myeloid leukaemia, including Hilmo

1.77

1.27

4.1

2.5

1050.09

236.80

mg/l

0.94

Other congenital malformations of intestine

123

1.67

1.27

4.4

7.0

450.79

320.38

mg/l

0.18

Burns and corrosions confined to eye and internal organs

320

1.39

1.27

2.9

4.2

292.10

317.45

mg/l

0.08

162

Cerebral aneurysm, nonruptured

136

1141

1.20

1.26

3.5

3.2

257.52

414.40

mg/l

1.12

459

Social disorders starting during childhood or adolescence

100

1.74

1.26

3.9

7.7

150.18

333.63

mg/l

1.35

Episcleritis

617

1.27

1.26

2.7

3.7

510.16

395.47

mg/l

0.28

269

Autism spe, excluding more controls

244

1.45

1.25

4.6

4.8

327.05

533.72

mg/l

0.42

144

Synovial hypertrophy, not elsewhere classified

100

1.73

1.25

3.6

4.8

453.55

311.71

mg/l

0.28

Conduct disorder

270

1.42

1.25

4.7

5.7

3174.42

301.85

mg/l

0.49

168

Ménière disease

152

1289

1.19

1.25

3.3

3.2

274.70

395.90

mg/l

0.84

522

Somnolence

139

1.61

1.25

2.9

5.3

584.58

349.75

mg/l

0.42

Malignant neoplasm of penis, including Hilmo

1.95

1.25

6.5

2.6

267.29

328.04

mg/l

—

Other and unspecified hydrocephalus

237

1.46

1.25

2.5

3.6

361.42

273.29

mg/l

0.23

Calcific tendinitis

108

1.70

1.24

3.2

4.2

220.71

258.44

mg/l

—

Chondromalacia

330

1.38

1.24

2.1

4.0

408.21

275.03

mg/l

0.47

147

Other specified/unspecified disorders of bone/cartilage

296

1.40

1.24

3.0

3.8

343.82

491.91

mg/l

0.28

132

Lymphangioma, anys site

1.76

1.24

6.8

3.3

313.56

258.67

mg/l

—

Mandibular prognathia

221

1.47

1.23

5.3

6.4

198.45

320.81

mg/l

1.01

135

Other surgical follow-up care

399

1.34

1.23

2.6

3.4

291.31

462.46

mg/l

0.48

178

Monoplegia

188

1.51

1.23

3.0

3.6

513.43

187.61

mg/l

1.32

Childhood allergy (age < 16)

235

1697

1.15

1.23

4.6

4.4

253.88

398.48

mg/l

1.40

143

992

Respiratory tuberculosis, confirmed, including avohilmo

221

1.47

1.23

4.0

3.2

368.21

272.19

mg/l

0.32

Open wound of abdomen, lower back and pelvis

417

1.33

1.23

4.1

4.6

287.33

307.32

mg/l

0.09

205

Other orthopaedic follow-up care

655

1.26

1.22

3.1

2.6

394.34

454.44

mg/l

0.14

265

Status epilepticus

452

1.32

1.22

4.2

4.0

256.53

409.30

mg/l

0.60

219

Acute and transient psychotic disorders

167

1430

1.17

1.22

3.0

3.4

1213.36

469.05

mg/l

0.35

640

Chronic Coagulation defects

297

1.40

1.22

5.5

3.8

317.95

268.42

mg/l

0.14

136

Motor- or nonmotor-vehicle accident, type of vehicle unspecified

164

1.55

1.22

2.8

4.2

121.67

277.02

mg/l

1.42

Bicipital tendinitis

558

1.28

1.21

2.9

3.8

304.04

336.56

mg/l

0.08

270

Abnormal findings in nipple discharge synovial fluid wound secretions

173

1.53

1.20

2.4

3.9

459.92

319.84

mg/l

0.25

Other bacterial agents as the cause of diseases classified to other chapters

133

1.61

1.20

5.6

4.2

656.08

215.52

mg/l

0.96

Benign lipomatous neoplasm of other sites/unspecified

139

1176

1.19

3.9

3.2

342.05

410.41

mg/l

0.30

494

Benign neoplasm: Rectum/anal canal icd-9

102

1.70

1.18

4.0

2.4

183.33

294.77

mg/l

—

Dependent personality disorder

240

1.44

1.18

4.2

3.5

442.06

307.34

mg/l

0.33

Hydrocephalus in other diseases

1.86

1.18

7.8

3.9

261.50

200.00

mg/l

—

Localized scleroderma [morphea]

174

1.52

1.17

3.7

3.0

229.92

280.52

mg/l

0.27

Distal bite

566

1.27

1.17

10.8

6.3

227.51

442.07

mg/l

1.55

358

Acromegaly and pituitary gigantism

1.85

1.17

2.8

3.3

115.00

228.50

mg/l

—

Other superficial mycoses, including avohilmo

166

1427

1.17

3.4

1112.55

336.10

mg/l

1.02

662

Seminoma of testis

1.76

1.17

3.1

3.7

96.63

226.83

mg/l

—

Benign neoplasm: Oesophagus

142

1.58

1.16

2.7

3.5

173.67

224.57

mg/l

—

Mental and behavioural disorders due to cannabinoids

291

1.39

1.16

4.2

3.8

285.79

364.75

mg/l

0.24

163

Behavioural disorders

266

1.41

1.16

4.8

5.4

3281.40

316.21

mg/l

0.48

166

Benign neoplasm: Ciliary body

0.00

1.16

0.0

3.5

—

166.73

—

Hereditary motor and sensory neuropathy

1.72

1.16

2.3

4.1

160.40

214.44

mg/l

—

Speech therapy

368

4061

0.90

1.16

2.7

3.3

257.26

442.62

mg/l

3.12

216

1764

Causalgia

150

1.55

1.16

1.8

4.1

387.83

291.15

mg/l

—

Benign neoplasm: Skin, unspecified

510

1.29

1.15

4.8

3.6

580.52

336.96

mg/l

0.35

229

Myasthenia gravis

225

1.44

1.14

2.3

3.5

162.44

244.85

mg/l

1.38

Foreign body on external eye

174

2007

0.86

1.14

3.6

3.8

331.33

373.45

mg/l

0.30

1062

Benign neoplasm: Liver

284

1.39

1.14

3.9

3.4

446.11

301.41

mg/l

0.42

118

Pedal cyclist injured in noncollision transport accidents

180

1561

1.16

1.14

3.5

3.8

295.29

430.28

mg/l

0.85

754

Congenital malformations of trachea and bronchus

127

1.61

1.14

3.5

5.6

194.50

277.57

mg/l

—

Flatulence and related conditions

111

1.65

1.14

3.0

5.0

400.89

259.48

mg/l

—

Disorders of breast

804

6616

1.07

1.14

2.6

3.1

436.60

473.24

mg/l

0.10

272

2528

Superficial injury of thorax

250

2218

1.13

3.6

3.3

431.91

390.13

mg/l

0.19

119

1035

Malignant neoplasm of eye and adnexa

1.74

1.13

3.9

2.7

441.00

220.42

mg/l

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified

121

1017

1.20

1.13

3.2

3.4

1704.53

411.41

mg/l

0.47

478

Pedestrian injured in other and unspecified transport accidents

135

1.58

1.13

3.9

3.7

154.70

245.21

mg/l

—

Inhalation and ingestion of other objects causing obstruction of respiratory tract

1.83

1.13

4.7

5.9

221.43

338.34

mg/l

—

Seronegative juvenile rheumatoid arthritis

217

1.45

1.13

5.0

5.8

239.24

448.22

mg/l

1.56

116

Ectopic pregnancy

228

2011

1.14

1.13

2.6

3.1

269.73

362.19

mg/l

0.55

789

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Protein [Mass/volume] in Urine

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS